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ABSTRACT 
Expansion of high-throughput sequencing technology has increased our understanding 
in the importance of pervasive transcription and the resulting indispensable molecules, non-
coding RNAs (ncRNAs). A significant effort has been made in determining the biological 
relevance of ncRNAs, including the small RNAs (smRNAs) and long ncRNAs (lncRNAs). 
Studies have shown that ncRNAs can have very important regulatory functions such as the 
establishment and maintenance of the epigenetic architecture of eukaryotic genomes. 
However, these studies have only revealed the surface of ncRNAs’ functions in cells.   
Motivated by the previously “hidden” transcriptome regulated by the Arabidopsis 
exosome, we examined the role of ncRNAs in regulation of gene expression in two plant 
model systems, Arabidopsis and Brachypodium. We set out to investigate whether the 
Arabidopsis exosome complex modulates gene expression through regulating ncRNAs, 
including both smRNAs and lncRNAs. Thus, the role of Arabidopsis exosome complex in 
regulating smRNA metabolism was extensively investigated and we revealed the differences 
between Arabidopsis core exosome, yeast and human exosomes in modulating smRNAs. 
 iv 
Although we have only begun to categorize the lncRNAs regulated by the Arabidopsis 
exosome, our data so far has led to intriguing speculations, including the possible role of 
exosome in transcriptional regulation via controlling lncRNAs. The challenges still remain, 
including establishing the regulatory role of specific lncRNAs regulated by the exosome and 
other factors at transcriptional or post-transcriptional levels in different cellular contexts, and 
most importantly, how the interaction between these lncRNAs and the chromatin is mediated.  
We also investigated the role of smRNAs in biotic and abiotic stress responses in 
Brachypodium. We identified a group of endogenous, stress-induced small interfering RNAs, 
sutr-siRNAs, and its novel mechanism in targeting cis elements involved in splice site 
selection. This finding will stimulate research of smRNA mediated stress responses in 
agricultural important crops. It also provides a framework for more suitable experimental 
systems, such as the Drosophila and mammalian cell cultures, to further investigate the 
associated mechanistic details of sutr-siRNAs. 
In this dissertation, we revealed new insights and detailed molecular mechanisms of 
the Arabidopsis exosome complex in regulation of gene expression, as well as provided a 
novel regulatory mechanism of endogenous siRNAs by being involved in splicing. Although 
many challenges still remain to fully determine the mechanistic details and biological 
significance of plant ncRNAs, the work presented in this dissertation has added to our 
understanding in regulation of gene expression through ncRNAs in plants.   
 v 
APPROVAL PAGE 
 
 
 
 
 
The faculty listed below, appointed by the Dean of the School of Graduate Studies, have 
examined a dissertation titled “Regulation of Gene Expression by Non-coding RNAs in 
Arabidopsis and Brachypodium”, presented by Hsiao-Lin V. Wang, candidate for the Doctor 
of Philosophy degree, and certify that in their opinion it is worth of acceptance.  
 
 
 
 
Supervisory Committee 
Julia Chekanova, Ph.D., Committee Chair 
Molecular Biology and Biochemistry 
 
Saul Honigberg, Ph.D. 
Cell Biology and Biophysics 
 
Thomas Menees, Ph.D. 
Cell Biology and Biophysics 
 
Jeffrey Price, Ph.D. 
Molecular Biology and Biochemistry 
 
Leonard Dobens, Ph.D. 
Molecular Biology and Biochemistry 
 vi 
TABLE OF CONTENTS 
ABSTRACT .............................................................................................................................  iii 
 
LIST OF ILLUSTRATIONS  ................................................................................................. viii 
 
LIST OF TABLES  .....................................................................................................................x 
 
LIST OF SUPPORTING INFORMATION ............................................................................. xi 
 
ACKNOWLEDGEMENTS  ................................................................................................... xiii 
 
Chapter 
1 INTRODUCTION ..........................................................................................................1 
1.1 Pervasive transcription  .......................................................................................1 
1.2  Overview of ncRNAs ..........................................................................................2 
 1.2.1  Micro RNAs (miRNAs) ..........................................................................3 
1.2.2  Piwi-interacting RNAs (piRNAs) ...........................................................5 
 1.2.3  Small interfering RNAs (siRNAs) ..........................................................5 
1.2.4  Long non-coding RNAs (lncRNAs) .......................................................7 
1.3 Regulation of ncRNAs by ribonucleases ............................................................8 
 1.3.1 The Exosome complex ............................................................................9 
  1.3.2 XRNs, 5’ to 3’ exoribonucleases ..........................................................11 
1.4 Functions of ncRNAs ........................................................................................12 
 1.4.1 Gene silencing, TGS and PTGS ............................................................12 
  1.4.2 RNA-directed DNA methylation pathway (RdDM) .............................13 
1.4.3 RNAi-mediated heterochromatin silencing in S. pombe .......................15 
1.4.4 Scaffold RNAs and long range-interactions by lncRNAs (in animal 
system) ..............................................................................................................16 
1.4.5 ncRNAs and environmental stresses in plants  .....................................18 
1.5 The mystery of ncRNAs in plants .....................................................................20 
 
2 THE ROLE OF THE ARABIDOPSIS EXOSOME IN SIRNA-INDEPENDENT 
SILENCING OF HETEROCHROMATIC LOCI ........................................................23 
Abstract .........................................................................................................................23 
 Author Summary ...........................................................................................................24 
Introduction ...................................................................................................................25 
 Result ............................................................................................................................29 
Discussion .....................................................................................................................51 
 Material and Methods ...................................................................................................61 
Supporting Information .................................................................................................66 
 Acknowledgements .......................................................................................................82 
Author Contributions ....................................................................................................82 
 vii 
References .....................................................................................................................83 
 
3 CHARACTERIZATION OF THE SUB-GROUP OF SMRNAS PRODUCING 
GENOMIC LOCI AFFECTED BY THE DEFECT IN ARABIDOPSIS EXOSOME 
COMPLEX ....................................................................................................................92 
Abstract .........................................................................................................................92 
 Result ............................................................................................................................94 
Material and Methods .................................................................................................107 
Acknowledgements .....................................................................................................109 
References ...................................................................................................................110 
 
4 STRESS-INDUCED ENDOGENOUS SIRNAS TARGETING REGULATORY 
INTRON SEQUENCES IN BRACHYPODIUM  .......................................................112 
Abstract .......................................................................................................................112 
Introduction .................................................................................................................113 
 Result ..........................................................................................................................118 
Discussion ...................................................................................................................147 
 Material and Methods .................................................................................................155 
Acknowledgements .....................................................................................................160 
Supporting Information ...............................................................................................161 
References ...................................................................................................................200 
 
5 CONCLUSION AND FUTURE DIRECTIONS ........................................................208 
5.1 Computational methods used to identify novel smRNAs through analyzing 
high-throughput sequencing data  ...................................................................208 
 5.2 SmRNAs and splicing in response to stresses  ...............................................210 
5.3 The role of Arabidopsis exosome in smRNAs pathway  ................................213 
5.4 The role of Arabidopsis exosome in heterochromatic silencing through 
modulating lncRNAs  ......................................................................................215 
5.5 Concluding Remarks .......................................................................................218 
  
APPENDIX .............................................................................................................................220 
Appendix I  List of associated publications  ...........................................................220 
Appendix II  CURRICULUM VITAE .......................................................................221 
 
REFERENCES (for chapter 1 and chapter 5) .........................................................................224 
 
VITA  ......................................................................................................................................239 
  
 viii 
LIST OF ILLUSTRATIONS 
Figure Page 
2.1 Characterization of up-regulated loci and smRNA populations upon 
depletion of exosome subunits RRP4 and RRP41 ................................... 
 
31 
2.2 Characterization of 20-25 nt smRNAs corresponding to transposons and 
repeats in exosome and RdDM mutants ................................................... 
 
36 
2.3 Expression of miRNAs in exosome mutants ............................................ 37 
2.4 Effect of exosome subunits depletion on expression of ncRNA 
transcripts from RdDM-regulated loci …................................................. 
 
39 
2.5 SmRNA accumulation and DNA methylation in solo LTR and AtSN1 
loci is unaltered upon exosome depletion ................................................ 
 
43 
2.6 The effect of the exosome subunits depletion on the levels of H3K9me2 
in different loci ......................................................................................... 
 
46 
2.7 Exosome associates with transcripts produced from the region adjacent 
to the solo LTR scaffold-generating area ................................................. 
 
49 
2.8 Model for the role of the exosome complex in gene silencing at solo 
LTR in Arabidopsis .................................................................................. 
 
60 
3.1 Heatmap representation of smRNA expression. Expression of 20-25 nt 
smRNA in the mutants of the exosome complex components and 
RdDM mutants ......................................................................................... 
 
 
96 
3.2 The effect of exosome depletion in smRNA generating transposable 
elements (TE) and genomic clusters ......................................................... 
 
99 
3.3 Genomic distribution of 20-25nt smRNA expressing regions 
significantly affected by depletion of RRP41 subunit .............................. 
 
105 
4.1 Heat map representation of smRNA expression in response to stresses .. 120 
4.2 Effect of abiotic stresses on Brachypodium smRNA populations ............ 121 
4.3 The pattern of smRNA production from the 3’UTR of Bradi2g25050 in 
response to various stresses ...................................................................... 
124 
4.4 Characteristics of the smRNAs originating from the 3’UTRs of various 
genes in response to salt stress ................................................................. 
 
125 
4.5 Analysis of 3’UTRs of coding genes that give rise to smRNAs with 
predicted trans-targets .............................................................................. 
 
128 
4.6 Enriched biological processes among genes producing smRNAs from 
their 3’UTRs in salt stress (Ss- 48) ........................................................... 
 
131 
 ix 
4.7 Characterization of smRNAs originating from 3’UTRs in response to 
stresses ...................................................................................................... 
 
135 
4.8 The relative frequency of each 5' terminal nucleotide among sutr-
siRNAs ..................................................................................................... 
 
136 
4.9 Enriched biological processes among genes targeted in trans by sutr-
siRNAs in response to salt stress .............................................................. 
 
139 
4.10 Sutr-siRNAs that are predicted to target branch point sequences and 
gene structure of their targets ................................................................... 
 
145 
   
   
 
 x 
LIST OF TABLES 
 
Table Page 
3.1 Summary of smRNA-generating clusters upon depletion of exosome 
subunits, RRP4 and RRP41 …................................................................. 
 
102 
4.1 Summary of sutr-siRNAs and their predicted target genes .....................  138 
   
   
   
   
   
   
   
   
   
   
   
   
 
  
 xi 
LIST OF SUPPORTING INFORMATION 
 
Chapter 2  Page 
Figure S2.1 iRNAi silencer sequences produced by rrp4-i and rrp41-i 
cassettes in response to estradiol treatment .................................. 
 
66 
Figure S2.2 miRNA families, miR-158a, miR-158b, miR-860, miR-823, 
miR-841, miR-5561 and variations in sequence length ............... 
 
67 
Figure S2.3 Effects of exosome deletion, RdDM, and other mutants .............. 68 
Table S2.1 Summary of smRNA sequence reads in the libraries of RRP4, 
rrp4-i, RRP41, and rrp41-i plants ................................................. 
 
69 
Table S2.2 Summary of smRNA sequence reads in the libraries of 
RRP41/nrpd1, rrp41-i/nrpd1, RRP41/nrpe1, rrp41-i/nrpe1, 
RRP41/rdr2, rrp41-i/rdr2, RRP41/dcl3 and rrp41-i/dcl3 plants ..  
 
 
71 
Table S2.3 Expression profiling of known mature miRNAs in the libraries of 
RRP4, rrp4-i, RRP41, and rrp41-i mutant plants ..................... 
 
74 
Table S2.4 Oligonucleotides used in this study (chapter 2) ........................... 81 
   
Chapter 4 
Table S4.1 Summary of smRNA processing .................................................. 162 
Table S4.2 Expression of mature miRNAs in response to stresses ................ 163 
Table S4.3 Summary of comparison of genomic clusters producing smRNAs 166 
Table S4.4 Gene Ontology analysis of stresses responsive genes producing 
smRNAs from their 3'UTRs ......................................................... 
 
167 
Table S4.5 Salt stress 48 hour (SS48): 3'UTRs of salt stress responsive 
genes, the 24nt smRNA sequence and target genes ..................... 
 
168 
Table S4.6 Cold stress 6 hour (CS6): 3'UTRs of cold stress responsive 
genes, the 24nt smRNA sequence and target genes ..................... 
 
169 
Table S4.7 Cold stress 24 hour (CS24): 3'UTRs of cold stress responsive 
genes, the 24nt smRNA sequence and target genes ..................... 
 
170 
Table S4.8 Heat stress air 1 hour (HSA1): 3'UTRs of heat stress responsive 
genes, the 24nt smRNA sequence and target genes ..................... 
 
171 
Table S4.9 Heat stress air 3 hour (HSA3): 3'UTRs of heat stress responsive 
genes, the 24nt smRNA sequence and target genes ..................... 
 
172 
Table S4.10 Heat stress by immersion in water 1 hour (HSW1): 3'UTRs of  
 xii 
heat stress responsive genes, the 24nt smRNA sequence and 
target genes ................................................................................... 
 
173 
Table S4.11 Heat stress by immersion in water 3 hour (HSW3): 3'UTRs of 
heat stress responsive genes, the 24nt smRNA sequence and 
target genes ................................................................................... 
 
 
174 
Table S4.12 The list of smRNA-generating 3’UTRs that are either stress-
specific or common among different stress treatments ................ 
 
175 
Table S4.13 Gene Ontology analysis of genes predicted to be targeted by sutr-
siRNAs .................................................................................. 
 
179 
Table S4.14 Target genes with the target site predicted to be located in their 3' 
UTRs ......................................................................................... 
 
180 
Figure S4.1 The analysis of genomic clusters producing smRNAs in response 
to various stresses .......................................................... 
 
183 
Figure S4.2 The analysis of genomic clusters affected in response to different 
stresses, based on abundances of smRNAs (in RPM) per each 
individual 500 bp cluster ................................................ 
 
 
184 
Figure S4.3 Fold difference in expression of smRNAs from 3’UTRs in 
response to different stresses ........................................................ 
 
185 
Figure S4.4 Enriched biological processes among genes producing smRNAs 
from their 3’UTRs in response to various stresses ....................... 
 
186 
Figure S4.5 Enriched biological processes among genes targeted in trans by 
sutr-siRNAs in response to various stresses ................................. 
 
193 
   
   
   
   
   
   
   
   
   
 
  
 xiii 
ACKNOWLEDGEMENTS 
First and foremost, I thank Dr. Julia Chekanova for the opportunity and privilege to 
work in her lab. She introduced me to the exciting world of RNA biology and unknowingly 
convinced me that RNA is the most interesting biological macromolecules. She took me into 
her lab as a inexperienced recent graduate fresh out of college, and she taught me as a student 
although I was a technician when I first joined her lab. She also showed me the potential and 
excitement of RNA research, which inspired me to start graduate school instead of medical 
school after two years. During the past five years, she supported me in attending ten 
international meetings, which exposed me to the big scientific world and became an important 
part of my graduate school training. Not only as an amazing mentor with respect to both 
bench science and career advice, her enthusiasm and dedication to science are infectious.  
I am particularly grateful to UMKC Women’s council in awarding me as merit 
recipients of GAF in the past two years; their support and funding has made attending the 
conferences possible.  
I thank my undergraduate advisor, Dr. Saul Honigberg, who took me into his lab as a 
naïve undergraduate student and taught me how to think critically and be organized 
scientifically. I also thank Sarah Piccirillo in the Honigberg lab for helping me establish 
proper organization during my very first project in molecular biology.  
I would like to thank the members of my supervisory committee, Dr. Saul Honigberg, 
Dr. Thomas Menees, Dr. Jeffrey Price, and Dr. Leonard Dobens, for their patience, good 
humor and open-mindedness, as well as casual scientific discussions we had in the hallway. 
We purposely chose to have scientists with different scientific background on my committee 
 xiv 
so I can get the best guidance and suggestions possible. Although we only had one committee 
meeting, I appreciated the distinct set of ideas we discussed during the only one committee 
meeting we had. 
I thank the current and past members of the Chekanova lab with whom I overlapped 
(Amir Valian, Brandon Dinwiddie, Junhye Shin, Jinwon Lee, Karim Pirani, Tarik El 
Mellouki, Boris Kornilayev, Aziz Hakimov, and Jessica Kawakami) for sitting through 
countless lab meetings and many hours of discussions and amusement. Junhye Shin and I 
were the co-first authors on the project presented in Chapter 2; I truly appreciate the 
contribution she made towards the project. I am especially thankful to Jessica Kawakami, for 
keeping me in sane and providing support during the past few years. Also, I thank my 
classmates in SBS, especially Divya Kamath and Anna Shipman, who organized the bi-annual 
gatherings so we can talk about science and life.  
I would like to express my gratitude to faculties who helped me during the past three 
years. To Dr. Tamas Kapros, I thank you for accommodating my travel schedule while being 
your teaching assistant for two years. To Dr. Xiaolan Yao, I thank you for your genuine 
interest in my science and the development of my career.   
Last but not least, I thank my family. I thank my parents for ensuring that I received 
the best education possible regardless where I am in the world. I greatly thank my mother who 
inspired me to pursue the Ph.D. degree and my father who gives me his full support for 
everything I do. I thank my brother and sister for all the decidedly non-scientific experiences 
that we’ve shared. To my grandmother, your persistence in life motivates me. Also, I would 
like to thank my host family, John and Delilah Osborn, for accepting me into their family ten 
 xv 
years ago and making me feel like home in this foreign country. Finally, I want to thank the 
love of my life and best friend, my fiancé, Steve Han. Your love, caring and continuous 
supported truly give me the joy for life and helped me through the non-scientific part of this 
journey.  
 1 
 
 
 
CHAPTER 1 
INTRODUCTION 
 
1.1 Pervasive Transcription 
High-throughput analyses have revealed that eukaryotic genomes are pervasively 
transcribed beyond the known boundaries of genes - up to 90% of the genomic DNA [1-5]. 
While only 1-2% encodes proteins, the majority of the transcriptional activity takes place 
outside of protein-coding genes, producing non-coding RNAs (ncRNAs) derived from 
genomic regions once thought to be transcriptionally silent, including intergenic and 
heterochromatic regions [1-5]. Pervasive transcription constitutes a risk for the cell, as it can 
be associated with expansion of transposable elements (TEs), loss of genomic stability and 
defects in gene expression. Therefore, the pervasive transcription needs to be contained and 
regulated at the levels of transcription initiation, as well as through processing and turnover of 
resulting RNAs. The examples of this include the transcription termination coupled RNA 
decay and post-transcriptional degradation. However, the complex mechanisms that 
coordinate transcription and regulation of ncRNAs remain largely unknown.   
Studies over the past several decades have begun the arduous process of deciphering 
the large pool of ncRNAs, leading to our current understanding of the well-established 
ncRNAs that are involved in translation and regulation of RNA splicing (tRNA, rRNA, 
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snoRNAs and snRNAs). Additional groups of ncRNAs have also been identified, including 
the small regulatory RNAs (smRNAs) involved in the RNA interference (RNAi) pathway and 
long ncRNAs (lncRNAs). Recent studies have shown that these additional ncRNAs have very 
important regulatory functions such as establishment and maintenance of epigenetic 
architecture of eukaryotic genomes. However, these studies may have only begun unfolding 
the complex functions of ncRNAs in cells. The advantages of fully sequenced genomes have 
enabled the large-scale survey of the genomic landscape for new coding genes and non-
coding transcriptomes. Further advancements in DNA microarray and high-throughput RNA 
sequencing technology have leading to collaborative efforts in deciphering the complex 
transcriptome in various organisms. However, many of regulatory ncRNA transcripts earned 
the term “hidden” because they remain invisible unless RNA degradation is prevented, for 
example, by inactivation of the degradation machinery [2]. This raises the very important 
question of how these ncRNAs are regulated. In addition, the functional role of ncRNA 
remains mostly elusive. In the following sections, I will provide a brief survey of previous 
related works in the area of pervasive transcriptions, including categorizing the ncRNAs and 
providing examples of the mechanistic functions of the ncRNAs.  
 
1.2 Overview of ncRNAs 
In additional to the well-established tRNAs, rRNAs, snRNAs, and snoRNAs, the 
functionalities of a large ensemble of different ncRNAs have yet to be fully determined. Most 
putative ncRNAs are expressed at substantially lower levels than mRNAs, suggesting a 
functional role. Indeed, there is mounting evidence indicating that ncRNAs have regulatory 
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roles during development, disease initiation, and progression, as well as in response to 
stresses and environmental stimuli [6]. Recent studies have also shown various regulatory 
functions of ncRNAs at the level of establishing and maintaining epigenetic architecture of 
eukaryotic genomes in a developmentally and cell-type specific manner [7].  
Regulatory ncRNAs are broadly classified according to the transcript length as long 
non-coding RNAs (lncRNAs) and small RNAs (smRNAs). The endogenous smRNAs, 
encompassing the components of the RNA interference (RNAi) pathway, can be further 
classified into three well-established groups: microRNAs (miRNAs), PIWI-interacting RNAs 
(piRNAs), and small interfering RNAs (siRNAs). Although different classes of ncRNAs seem 
well defined and distinct from each other, they are predominantly functionally overlapped. 
For example, lncRNAs can serve directly as molecular scaffolds for recruiting chromatin 
modifiers, or are processed by the RNAi machinery into short siRNAs that guide DNA 
methylation and chromatin modifications to homologous regions of the genome [8-10].  
 
1.2.1 Micro RNAs (miRNAs) 
 Evolutionarily conserved, miRNAs are 20 to 24 nucleotides (nt) long and are 
postulated to regulate gene expression at post-transcriptional level [11]. In contrast to other 
endogenous smRNAs, miRNAs are derived from double stranded RNAs (dsRNAs) with 
distinctive hairpin structures. The RNase III enzymes, including Drosha and Dicer, process 
these hairpin forming dsRNA precursors into mature miRNAs, and the mature miRNAs 
interacted with Argonaute (Ago) proteins to form RNA-induced silencing complex (RISC). 
The miRNAs-Ago RISC complex then base-pairs to mRNAs and induces miRNAs directed 
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silencing. Most animal miRNAs display imperfect complementarity to 3’UTR of target 
mRNAs, and inhibit protein synthesis by repressing translation or promoting mRNA 
deadenylation and decay. In contrast, when miRNAs are associated with AGO2, the complex 
recognizes and targets mRNAs by perfect sequence complementarity and these mRNAs 
undergo endonucleolytic cleavage and degradation. Although the AGO2-miRNA process is 
rare in animals, this is a common mode of miRNA directed degradation in plants.  
 In addition to identifying the players in miRNA biogenesis, mounting research has 
been done to establish the basic principle of miRNA functions [12,13]. Both regulations of 
miRNA metabolism and functions of miRNA require protein-protein and protein-RNA 
interactions [14]. Key regulatory events often define the context-specific functions of 
miRNAs during developmental transition or changes in cellular environments. Although 
miRNAs are extensively conserved between plants and animal, the plant miRNAs are often 
highly complementary to conserved target mRNAs, which makes the identification of targets 
more rapid using bioinformatics approaches [15]. In addition to characterizing the putative 
miRNAs targets, the well-established plant model system, Arabidopsis thaliana, has allowed 
researchers to study the genetic pathways and phenotypic consequences associated with 
miRNA-mediated regulation [16-18]. Although there is more and more focus on economical 
important plants, such as grasses, cereals and rice, the detailed mechanistic understanding of 
smRNAs, including miRNAs, is still underdeveloped [19].  
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1.2.2 Piwi-interacting RNAs (piRNAs) 
Named for their association in complex with the PIWI subfamily of Argonaute 
proteins, piRNAs are usually 24-31nt in length, which are longer than average smRNAs 
[20,21]. The primary role of piRNAs has been shown to be suppression of transposon activity 
during germ line development [22-26]. In contrast to other classes of smRNAs, piRNAs are 
generated from single-stranded precursors located within the piRNA clusters independent of 
RNase III enzymes [27]. The single-stranded transcripts from intergenic repetitive elements 
and transposons are recognized and cleaved by the antisense piRNAs and associated PIWI 
proteins generate additional sense piRNAs. This process is referred to as the “ping-pong” 
cycle, which increases the abundance of piRNAs and deeply silences the targeted transposons 
[27,28]. Although it has been suggested that piRNAs are strictly germline-specific in 
Drosophila and mammals, recent studies have shown the role of piRNAs in non-gonadal cells 
as well as in multigenerational epigenetic silencing in worms (Caenorhabditis elegans) [29-
31]. Although piRNAs are abundant in most metazoans including mammals, they are notably 
absent in plants and fungi. However, another class of siRNAs, the repeat-associated siRNAs 
(rasiRNAs), which are functionally similar to piRNAs, is found in plants [32].  
 
1.2.3 Small interfering RNAs (siRNAs) 
 Small interfering RNAs (siRNAs) were first observed during transgene-induced 
silencing in petunia and other plants, followed by studies in C. elegans [33-36]. In comparison 
to miRNAs and piRNAs, double-stranded siRNA precursors can be derived from either 
inverted repeats (IR) or transcribed by RNA-dependent RNA polymerases. These perfectly 
 6 
base-paired dsRNAs are further processed by Dicer into 20-25nt mature siRNA that direct 
silencing when loaded onto RISC [37]. In plants and other systems, siRNAs are categorized 
based on origins of biogenesis and molecular functions.  
Recent studies have been focusing on dissecting the complex groups of siRNAs in 
plants, especially in the model organism, Arabidopsis thaliana. In plants, known functional 
siRNAs include 1) trans-acting siRNAs (ta-siRNAs), which are phased siRNAs derived from 
TAS genes that involve miRNAs and RNA-dependent RNA polymerase 6 (RDR6) [38]; 2) 
repeat-associated siRNAs (ra-siRNAs), which are generated from transposons, 
heterochromatic regions and repetitive sequences [32]; 3) natural antisense siRNAs (nat-
siRNAs), which are derived from the overlapping regions of natural antisense transcript pairs 
[39-41]; 4) cis-acting siRNAs (ca-siRNAs) produced by the cis-cleavage of TAS3 transcript 
[42]; 5) DNA double-strand break induced smRNAs (diRNAs) in response to DNA damage 
[43]; 6) epigenetically activated siRNAs (easiRNAs) that silence epigenetically 
reprogrammed germline [44-46]; and 7) heterochromatic siRNAs (het-siRNAs) that originate 
from heterochromatin and facilitate heterochromatin formation [47]. Besides these groups, 
there are still a large number of unclassified siRNAs with unknown functions.  
In addition to the role of smRNAs in post-transcriptional gene silencing (PTGS), 
siRNA also play prominent roles in in directing sequence-specific transcriptional gene 
silencing (TGS) through modulating epigenetics modifications of heterochromatin, including 
both DNA methylation and histone modifications. Therefore, siRNAs are not only made 
during defense mechanisms against viruses and foreign transgenes (transposons), but are also 
derived from endogenous loci in facilitating silencing through either PTGS and TGS in order 
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to regulate a multitude of developmental and physiological processes.  
 
1.2.4 Long non-coding RNAs (lncRNAs) 
Long noncoding RNAs (lncRNAs) are broadly defined as transcripts longer than 200 
nucleotides that have limited protein coding potential and are significantly impacted during 
development and various diseases [48-54]. LncRNAs are often nuclear localized with low 
expression and sequence conservations. They may be composed of either polyadenylated 
(polyA +) and non-polyadenylated (polyA -) transcripts making classification of lncRNAs 
difficult [55,56]. However, one conventional way to define and group various lncRNAs is 
based on their proximity to protein coding genes [7,56], including 1) antisense lncRNAs 
transcribed in the opposite direction of protein coding genes, and they often overlap at least 
one exon and initiate within or at the 3’ end of coding genes; 2) intronic lncRNAs, which 
initiate inside an intron of protein coding genes in either direction and terminate without 
overlapping exons; 3) bidirectional lncRNAs are transcribed from the promoter region of 
protein coding genes in a divergent fashion, with imprecisely defined termination; and 4) 
intergenic lncRNAs, which are often referred to as large intervening ncRNAs, lincRNAs), 
have separate transcriptional units from protein coding genes, which are at least 5 kb away 
[57].  
Technological advances have improved the identification and annotation of lncRNAs; 
however, the functional interrogation still remains largely elusive. Several molecular 
functions of lncRNAs were revealed so far [9,56], including acting as 1) scaffolds for 
bringing two or more proteins in close proximity in ribonucleoprotein (RNP) formation; 2) 
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guides to recruit proteins, such as chromatin modifiers, to their molecular target, occurring 
through RNA-DNA interactions or RNA-protein interactions; 3) mediators of long-range 
chromatin interactions through chromosome lopping in an enhancer-like model; and 4) decoy, 
including sponge-like functions to sequester RNAs/proteins (such as transcription factors) 
and/or repellent-like functions to block the access of regulatory proteins, and both processes 
can titrate RNAs and proteins away from their DNA sites of action. Although these modes of 
action summarize the recently discovered molecular functions of lncRNAs, there are likely 
many other molecular mechanisms to be uncovered in different developmental and 
physiological contexts.  
 
1.3 Regulation of ncRNAs by Ribonucleases 
The eukaryotic genome is pervasively transcribed, which has led to the generation of a 
large population of ncRNAs distinct from the protein coding genes. However, many of these 
transcripts remains “hidden” due to their dynamic expression level and steady state 
abundance. These hidden and unconventional transcripts were discovered in S. cerevisiae 
when chromatin remodeling factors were inactive, affecting nucleosome organizations and 
leading to spurious intragenic transcription from cryptic promoters within the gene body [58]. 
Not usually detectable in wild-types cells, the cryptic unstable transcripts (CUTs) and stable 
unannotated transcripts (SUTs) were revealed in mutants of the RNA degradation machinery, 
including nuclear-specific catalytic subunits of the exosome complex [59-63]. Another class 
of RNAs, Xrn1-senitive unstable transcript (XUTs), was discovered upon the loss of another 
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ribonuclease, the cytoplasmic 5’ to 3’ exoribonuclease XRN1 (Arabidopsis functional 
homolog, XRN4) [64].  
These three distinct classes of RNAs were all revealed and discovered when RNA 
degradation machineries were inactivated because they are not normally detectable in wild-
type due to low abundance. This may argue that the stability and abundance of these 
transcripts is low; in fact, the “absence” of these RNAs species does not necessarily mean that 
the transcripts are not produced. However, it could also imply that these RNAs were 
transcribed and degraded so rapidly and efficiently that they cannot be detected using 
conventional methods. Although early work done in S. cerevisiae has laid the foundation for 
investigation of ncRNAs resulting from pervasive transcription, it is still an ongoing process 
to decipher them in higher eukaryotes with complex genomes. Therefore, in order to 
understanding how these ncRNAs function in higher eukaryotes, it is necessary to untangle 
the complex mechanisms that generate and regulate these ncRNAs, and these often involve 
RNA degradation machineries. 
 
1.3.1  The Exosome complex 
The machinery that plays a central role in RNA metabolism in eukaryotes is the 
exosome complex. The exosome is an evolutionarily conserved complex of RNase-like and 
RNA binding proteins that carries out 3’ to 5’ decay and processing of various RNA 
substrates, including both coding and non-coding RNAs (ncRNAs) [2,48,65-68]. The 
eukaryotic exosome complex consists of the nine subunits formed a donut-shaped core both in 
the nucleus and cytoplasm, including the hexameric ring (Rrp41, Rrp42, Rrp43, Rrp45, Rrp46 
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and Mtr3) and the trimer cap (Rrp40, Rrp4 and Csl4) [69-71]. In most organisms, the 
exosome core complex is inactive, and the endoribonuclease and exoribonuclease enzymatic 
activities are provided by either the tenth subunit, RRP44, and/or the RRP6 in the nuclear 
fraction [72-75]. However, the plant exosome might differ from yeast and human exosomes, 
as one of the ring subunits, AtRRP41p, appears to retain catalytic activity when previously 
tested in vitro [2,76]. A wide range of transcripts undergoes exosome-mediated decay; 
however, interactions between the exosome and cofactors are necessary to detect and target 
RNA substrates. Among those cofactors, the conserved TRAMP complex (Trf-Air-Mtr4 
polyadenylation) has been functionally linked to the nuclear exosome [77-79]. The TRAMP 
complex is thought to stimulate exosome activity by addition of polyA tails to RNAs, thus 
targeting them for degradation [77]. It is also shown that the stimulation by TRAMP complex 
may be dependent on its RNA binding activity independent of the polyA polymerase activity 
[80]. 
In addition to classical RNA degradation capability, the exosome complex broadly 
affects epigenetic silencing of heterochromatin and euchromatin loci by regulating a wide 
range of ncRNAs in various organisms [48,50,52-54]. Although the preponderance of work 
on exosome was done in yeasts and the mammalian system, the work done by our group using 
whole genome tiling microarrays revealed that many exosome targets in Arabidopsis 
correspond to ncRNAs [2]. Many of these transcripts originate from promoters, 5’UTRs, 
intergenic regions, repetitive elements and transposons (TEs). Other ncRNAs were found to 
be derived from centromeric and pericentromeric regions, and these heterochromatic loci are 
known to give rise to siRNAs that participate in silencing of these loci [81]. These evidences 
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suggest that the Arabidopsis exosome may participate in regulating various classes of 
ncRNAs resulting from pervasive transcription and participating in different aspect of 
silencing [2,48,65-68]. It is important to note that, the exosome’s function in gene silencing is 
not limit to RNA degradation, which often referred to as post-transcriptional gene silencing 
(PTGS), but also involvement in heterochromatin formation and the transcriptional gene 
silencing (TGS) pathway.   
 
1.3.2  XRN, 5’ to 3’ exoribonucleases 
 In addition to the exosome complex, mRNAs may also be degraded by the 5’ to 3’ 
exoribonuclease, XRN, to ensure fidelity of cellular RNA turnover in the eukaryotic cells 
[82]. Both the cytoplasmic enzyme (XRN1/PACMAN in yeast and metazoans or XRN4 in 
Arabidopsis) and nuclear enzymes (XRN2/RAT1 and XRN3) are essential in fungi, plants, 
and animals. Deficiencies of XRNs have severe developmental phenotypes and abnormal 
responses to hormonal and environmental stimuli [83,84]. XRNs degrade diverse RNA 
substrates during RNA decay and function in specialized processes integral to RNA 
metabolism, such as the nonsense-mediated decay (NMD) in the cytoplasm. NMD is a 
translation-coupled mechanism that served as an mRNA-surveillance mechanism to eliminate 
mRNAs containing premature translation-termination codons (PTCs), to further prevent the 
synthesis of truncated proteins [85].   
In Arabidopsis, XRN4 (the functional homolog of yeast XRN1) has shown to be 
involved in smRNA-associated processes. The substrates of XRN4 include miRNA targets, 
where XRN4 specifically degrades the mRNA that is guided by the miRNA/RISC complex 
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[86].  It was also shown that Arabidopsis XRN4 functions to negatively regulate the level of 
smRNAs processed from endogenous transcripts [87]. Also, studies in mammalian systems 
revealed a novel role of the nuclear enzyme, XRN2, in degrading nascent pre-mRNAs while 
RNA Polymerase II (Pol II) is paused near promoters, which further facilitate transcription 
termination [88]. Together, the evidence suggests that the XRN family of proteins not only 
regulates the levels of ncRNAs through PTGS, but also is implicated in regulation of TGS.  
 
1.4 Functions of ncRNAs 
1.4.1 Gene silencing, TGS and PTGS 
Pervasive transcription and other gene expression are through the mechanisms of gene 
silencing. The mechanisms of gene silencing can be broadly classified in coordination with 
transcription. Gene silencing can occur through transcriptional repression, termed 
“transcriptional gene silencing” (TGS), or through degradation of mRNAs, termed “post-
transcriptional gene silencing” (PTGS).  
TGS often refers to repression of transposons or repetitive sequences through 
epigenetics modifications, including DNA methylation and histone modifications. However, 
TGS can also suppress expression of protein-coding genes. The epigenetic modifications 
involved in TGS can be inherited through generations and stably maintained during DNA 
replication. Although studies investigating TGS in mammalian systems, animals, and simple 
eukaryotes emerged during the past decades, it has been especially well documented in plants 
[89].  
In contrast, PTGS is repression through RNA silencing and governs the cellular 
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pathway that silences specific genes at the mRNA level. PTGS is also known as co-
suppression, quelling, and RNA interference (RNAi), when a similar phenomenon was 
observed in plants, fungi, animals, and ciliates [33,36,90-95]. Importantly, the function of 
PTGS is conserved, including the protection against viruses and genetic damage through the 
activity of smRNAs.  
Although TGS and PTGS seem to be clearly defined and distinct processes, in reality 
they are highly connected and interrelated due to the diverse functions of ncRNAs [96,97]. 
For example, in the cytoplasm, smRNAs induce PTGS through targeting complementary 
mRNAs for degradation or translational repression. In contrast, in the nucleus, smRNAs 
promote TGS by directing epigenetic modifications to homologous regions of the genome. 
Regardless either TGS or PTGS, various mechanisms of gene silencing govern the regulation 
of RNA metabolism and gene expression inside the eukaryotic cells.  
 
1.4.2  RNA-directed DNA Methylation pathway (RdDM) 
In Arabidopsis, one of the most well characterized pathways for transcriptional gene 
silencing of repetitive elements and transposons is the siRNA-based silencing mechanism 
known as RNA-dependent DNA methylation (RdDM). Many siRNAs are known to be 
produced from transposons (transposable elements, TEs), which are mobile genetic elements 
that occupy large portions of the genome. The maintenance of TE silencing is often 
modulated through epigenetic modifications [98]. In plants, the process by which siRNAs 
direct epigenetic silencing of TEs is mediated through the RdDM pathway [99-103]. This 
silencing pathway requires two plant-specific RNA polymerase II (Pol II)-related enzymes, 
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RNA polymerase IV (Pol IV), and RNA polymerase V (Pol V) [100]. Many of the 
components involved in both the canonical and non-canonical RdDM pathways have been 
identified using genetic and biochemical approaches. In brief, the canonical RdDM pathway 
involves the following steps [103]. The Pol IV transcribes a single-stranded RNA (ssRNA) 
that is copied into a double-stranded RNA (dsRNA) by RNA-dependent RNA polymerase 2 
(RDR2). The dsRNA is processed by DICER-LIKE 3 (DCL3) into mature 24-nt siRNA and 
exported to the cytoplasm. Following loading of one strand of these siRNAs onto Argonaute-
4 (AGO4), they are re-imported back to the nucleus, where siRNA guides the targeting of 
nascent scaffold transcripts from Pol V by sequence complementarity. Ultimately, this recruits 
DNA methylatransferase activity to mediate de novo methylation of cytosines. This process 
results in transcriptional silencing at the genomic loci that are transcribed by Pol V, 
particularly TEs and other repetitive DNA. The siRNA-loaded AGO4 protein can also target 
TE for histone tail modifications to maintain the heterochromatic state [104,105].  
RNA Pol IV and Pol V are the major polymerases that function in the RdDM 
pathway; however, how Pol V regulates siRNA production remain largely unknown. 
Evidence indicates that RNA Pol IV controls the bulk of siRNA production, while emerging 
data shows the decoupling of RNA Pol IV and Pol V in regulating siRNA activity at 
heterochromatic loci [106-108]. Recently, Lee et al. identified a set of RNA Pol V-dependent 
heterochromatic siRNA-generating loci in Arabidopsis that are highly associated with short 
repetitive sequences in the intergenic regions [109]. Be that as it may, these Pol V-dependent 
clusters are also suppressed in other RdDM mutants, and their genomic features are distinct 
from known RNA Pol IV-dependent loci. This indicates that factors in the RdDM may share 
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redundant function, but they might function independently and in parallel of each other to 
reinforce heterochromatin silencing.  
 
1.4.3 RNAi-mediated heterochromatin silencing in Schizosaccharomyces pombe  
The mechanism of RNAi (siRNA)-mediated gene silencing is best understood in the 
fission yeast, which has provided evidence of how RNAi can regulate the genome at the level 
of transcription and chromatin structures [110]. In S. pombe, RNAi is critical for centromeric 
heterochromatin formation. This RNAi-based regulation of chromatin structure was first 
described in S. pombe and requires the interaction of silencing proteins with nascent 
transcripts [111,112]. The nascent transcript model was later supported by work in other 
organisms, including the RdDM in Arabidopsis [113,114]. RNA Pol II, in S. pombe, carries 
out the functions attributed to RNA Pol IV and Pol V in Arabidopsis; for example, RNA Pol 
II transcribes both nascent transcripts, also known as scaffold transcripts and siRNA 
precursors. Furthermore, the nascent transcripts are targeted by siRNA at the same locus, 
which are the subject of RNAi-mediated silencing. Genetic and biochemical evidence has 
shown that the components of RNAi were required for the establishment and maintenance of 
centromeric heterochromatin, and the chromatin-bound RNA-induced transcriptional 
silencing (RITS) complex was co-purified with Argonaute protein (Ago1) [115,116]. It was 
also shown that the noncoding centromeric transcripts interact with RITS, which enforced the 
binding of RITS to nascent euchromatic RNA, to sufficiently induce heterochromatic 
silencing of the corresponding locus [117,118]. Also, the siRNA-RITS complex is required 
for the spreading of histone H3K9 methylation in the pericentromeric regions to establish 
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heterochromatic silencing at the centromeric regions. Another complex, RNA-directed RNA 
polymerase complex (RDRC), contains RNA-directed RNA polymerase (Rdp1), putative 
polyA polymerase (Cid12), and helicase (Hrr1), is responsible for generating double stranded 
RNAs (dsRNAs) through it’s interaction with RITS [117]. RITS together with RDRC creates 
the self-propagating positive feedback loop to maintain heterochromatin by physically 
coupling the siRNA synthesis to H3K9 methylation at the centromeres [110,119].   
 
1.4.4 Scaffold RNAs and long range-interactions by lncRNAs (in animal system) 
 The lncRNAs can serve as adaptors (“scaffold”) to bring two or more proteins in close 
proximity to form ribonucleoprotein complexes (RNP) [56,120,121].  For example, the 
telomerase RNA (TERC) together with telomerase reverse transcriptase (TERT) and other 
components assemble the telomerase complex [122-124]. Many of these lncRNA guided RNP 
complexes are involved in gene regulation at the level of chromatin by engaging chromatin 
modifying complexes to maintain or establish appropriate chromatin signatures, which are 
implicated in imprinting and other cellular processes [125]. Chromatin remodeling is often 
carried by the action of chromatin modifying complexes, and the dynamic modifications of 
chromatin architecture regulate the access of regulatory transcription machineries to either 
condense or decondense genomic DNA and chromatin, and thereby control gene expression 
[126]. In other instances, the lncRNA-RNP may play a structural role, such as stabilizing 
nuclear structure or signaling complexes [127].  
One of the classic and long-term studied lncRNAs is X-inactive specific transcript 
(XIST), which regulates the X chromosome dosage compensation and establishes the X 
 17 
chromosome inactivation in mammals [128]. During inactivation of one of the two X 
chromosomes, the XIST physically associates with the Polycomb repressive complex 2 
(PRC2) to maintain the histone H3K27 trimethylation in cis [129].  Another example can be 
found in plants, where the induction of lncRNAs at the Flowering Locus C (FLC) in the 
process of vernalization controls the seasonal timing of flowering [130]. Several lncRNAs 
were found to regulate FLC expression, including the antisense lncRNAs, COOLAIR and 
ASLs [66,130] as well as the sense lncRNAs derived from the intronic regions of FLC, 
COLDAIR [131]. Although antisense COOLAIR is shown to function in silencing FLC 
expression by affecting histone H3K4 demethylation, the sense COLDAIR recruits the PRC2 
in cis to silence FLC, thus promoting flowering during vernalization [131]. However, the 
precise interactions between lncRNAs and protein complexes, such as the Polycomb complex, 
have yet to be defined. 
Many experiments have focused on the possibility that lncRNAs are regulated by 
expression level of their own genomic locus or adjacent locus in close proximity, including 
protein-coding genes. Recently, long-range intra-chromosomal interactions have been 
documented. Both XIST and COLDAIR are cis regulated, even though many lncRNAs are 
regulated by distantly located genes in trans. The best example of trans-acting lncRNAs is the 
HOTAIR discovered in human, and HOTAIR is known to be associated with PRC2 and 
modulates the PRC2 and H3K27 trimethylation localization of hundreds of loci throughout 
the genome [132,133]. Another recent report by the Rinn’s group suggests a large lncRNA, 
Firre, can act equally well both locally and distally in modulating genome organization 
[134,135]. Firre can occupy approximately a 5 Mb domain at its site of transcription on X 
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chromosomes as well as interact with five additional domains on four different autosomes. 
These interactions are accomplished by the association of multiple 156 bp repeating 
sequences on Firre and the nuclear-matrix factor HnRNPU. The overwhelming evidence 
suggest the possibility that lncRNAs can modulate the nuclear architecture through interaction 
and bridge domains across chromosomes [136]. However, the mechanistic details and 
biological relevance remain to be elucidated.    
 
1.4.5  ncRNAs and environmental stresses in plants 
Exposure to abiotic stresses triggers global changes in the expression of thousands of 
eukaryotic genes at the transcriptional and post-transcriptional levels. Specifically, plants 
have evolved an extensive array of adaptive responses to ensure survival during 
environmental changes. Specialized networks of regulatory and defense genes coordinate 
plant sensing, response and acclimation to environmental conditions such as low water 
availability, fluctuations in ambient temperatures, and toxicity of salt [137,138]. These 
networks are intertwined with processes that control plant growth and reproduction [139]. 
Despite extensive efforts in this field, large gaps exist in our understanding of different 
regulatory and defense networks that control the response of plants to changes in the 
environment. Previous efforts have advanced our understanding of signaling cascades and 
transcription factors in stress responses; however, the involvements of epigenetic factors and 
ncRNAs, such as smRNAs, have become evident only recently.  
It has been demonstrated that miRNAs play important roles in the responses to biotic 
and abiotic stimuli, in fact, abiotic stress-regulated miRNAs were first investigated in 
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Arabidopsis [140-142]. For example, in Arabidopsis, mi168 was shown to mediate the level 
of RNAi component, AGO1, in abscisic acid (ABA) and abiotic stress responses [143]. Plants 
contain mutations in mi168a were unable to response to drought and were hyposensitive to 
ABA, while the overexpression of mi168a led to ABA hypersensitivity and drought tolerance. 
Also, ABA may directly regulate the expression of mi168a by binding to the promoter 
through several cis-ABA responsive elements, and the Ago1 transcripts were negatively 
regulated by mi168a when induced by ABA. This study together with others, suggest the 
importance of miRNA abundance and the availability of RNAi components in stress 
responses and signaling transduction in plants [142,144].    
In contrast, very few studies demonstrate the mechanistic details of siRNA in abiotic 
stress responses in plants, perhaps due to the complex nature of siRNAs and difficulties in 
genetic and biochemical manipulations. One of the few examples is shown by Borsani et al, 
where they reported that the nat-siRNAs (natural antisense transcript siRNAs) are generated 
from dsRNA precursors produced from natural cis-antisense gene pairs (P5CDH and SRO5) 
during high salinity stress [39]. Many recent genome-wide surveys have reported 
accumulations of smRNAs in response to biotic and abiotic stresses [145,146]; however, the 
molecular processes that generate these stress-induced smRNA are not fully understood.  
Genome-wide tiling arrays and high-throughput sequencing have identified a wide 
range of lncRNAs in plants [81,147-150]; however, these were mainly focused on profiling 
and characterizing the transcriptome changes in response to stresses. One of the most well-
characterized examples is COOLAIR, which modulates the timing of flowering during the 
vernalization process [8,130]. Two other lncRNAs, COLDAIR and ASLs, were also found in 
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the genomic region of FLC [66,130]. It is unclear whether these lncRNAs act independently 
or in collaboration with each other to regulate FLC expression by modulating chromatin 
signatures, such as the modifications of histone H3K27 and H3K4 trimethylation. The 
complex interplay between chromatin modification and lncRNAs in response to 
environmental changes warrants further transcriptome analysis to increase our understanding 
of non-coding transcripts in plants. 
 
1.4  The Mystery of ncRNAs in Plants 
 The tremendous efforts to decipher the pervasive transcription and the resulting 
ncRNAs have been undertaken by many groups working in different model systems. Yet, the 
mechanistic details of how ncRNAs involved in developmental processes and response to 
environmental stimuli through regulating gene expression remains a mystery. 
In fission yeast (Schizosaccharomyces pombe), the exosome acts in several smRNA 
pathways to affect constitutive and facultative heterochromatin silencing, in a RNAi 
dependent or -independent manner [111,151-153]. However, in plants, the role of the 
exosome complex in regulation of smRNAs and lncRNAs is largely unknown. The work done 
by our group using whole genome tiling microarrays revealed that many exosome targets in 
Arabidopsis correspond to ncRNAs [2]. Many of these transcripts originate from promoters, 
5’UTRs, intergenic regions, repetitive elements and transposons (TEs). Many of the ncRNAs 
are derived from centromeric and pericentromeric regions, and these heterochromatic loci are 
known to give rise to siRNAs that participate in silencing of these loci [81]. A large number 
of regulatory ncRNAs earned the term “hidden” because they remain invisible unless RNA 
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degradation is prevented, raising an very important question of how these ncRNAs are 
regulated. Therefore, these results hint at the possibility that the Arabidopsis exosome may 
regulate ncRNAs metabolism, including both smRNAs and lncRNAs, and modulate 
heterochromatin formation. Also, how the exosome interact with other silencing pathway in 
plants, such as the RdDM, was particularly puzzling.  
Exposure to abiotic stresses triggers global changes in gene expression. SmRNA 
pathways and splicing both function as crucial mechanisms regulating stress-responsive gene 
expression. However, examples of smRNAs regulating gene expression remain largely 
limited to effects on mRNA stability, translation, and epigenetic regulation. Also, our 
understanding of the networks controlling plant gene expression in response to environmental 
changes, and how these regulatory pathways intersect, remain limited. Studies in Arabidopsis 
and other plants showed that miRNAs and siRNAs function in response to different abiotic 
stresses [40,41,142,154,155]. However, in the new model organism, Brachypodium 
distachyon, only a few reports investigate the changes of smRNA transcriptome in response to 
biotic and abiotic stresses [19,156]. Although work in animal systems has provided intriguing 
hints on the potential roles of smRNAs in splicing [157-163], the connection between 
smRNAs and splicing is substantially lacking in plants. Also, there is no evidence so far 
suggesting that small regulatory RNAs, such as miRNAs or siRNAs, can directly regulate 
splicing in plants in response to environmental stresses. 
These observations led us to wonder about the role of exosome in regulation of non-
coding transcriptomes and heterochromatic silencing. In particular, does the exosome function 
differently in Arabidopsis compared to other eukaryotes? Also, many different classes of 
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smRNAs have been identified so far, and is it possible that there is a novel groups of smRNAs 
that may function in a distinct way while modulating gene expression in response to 
environmental changes?  These are the questions with which my dissertation research began.  
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CHAPTER 2 
THE ROLE OF THE ARABIDOPSIS EXOSOME IN SIRNA-INDEPENDENT SILENCING 
OF HETEROCHROMATIC LOCI 
 
Keywords: Arabidopsis; exosome; smRNA sequencing; gene silencing; chromatin 
 
ABSTRACT 
The exosome functions throughout eukaryotic RNA metabolism and has a prominent 
role in gene silencing in yeast. In Arabidopsis, exosome regulates expression of a “hidden” 
transcriptome layer from centromeric, pericentromeric and other heterochromatic loci that are 
also controlled by small (sm)RNA-based de novo DNA methylation (RdDM). However, the 
relationship between exosome and smRNAs in gene silencing in Arabidopsis remains 
unexplored. To investigate whether exosome interacts with RdDM, we profiled Arabidopsis 
smRNAs by deep sequencing in exosome and RdDM mutants and also analyzed RdDM-
controlled loci. We found that exosome loss had a very minor effect on global smRNA 
populations, suggesting that, in contrast to fission yeast, in Arabidopsis the exosome does not 
control the spurious entry of RNAs into smRNA pathways. Exosome defects resulted in 
decreased histone H3K9 dimethylation at RdDM-controlled loci, without affecting smRNAs 
or DNA methylation. Exosome also exhibits a strong genetic interaction with RNA Pol V, but 
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not Pol IV, and physically associates with transcripts produced from the scaffold RNAs 
generating region. We also show that two Arabidopsis rrp6 homologues act in gene silencing. 
Our data suggest that Arabidopsis exosome may act in parallel with RdDM in gene silencing, 
by epigenetic effects on chromatin structure, not through siRNAs or DNA methylation. 
 
AUTHOR SUMMARY 
To maintain genomic stability and prevent expansion of invasive genomic sequences 
such as transposable elements (TEs), eukaryotes have evolved defensive mechanisms to 
control them. Here, we examine the role of the Arabidopsis exosome complex in such 
mechanisms. Evolutionarily conserved from archaea to humans, the exosome is a stable 
complex of RNase-like and RNA binding proteins that plays a central role in RNA 
metabolism in eukaryotes. Depletion of the exosome allows some repetitive sequences to 
escape from silencing. Most of these transcripts emanate from centromeric and 
pericentromeric chromosomal regions and other heterochromatic loci, and many derive from 
repetitive and transposable elements. In plants, TEs are targeted for de novo DNA methylation 
by smRNA-mediated pathways. However, we found that exosome depletion has only minor 
effects on smRNA populations that are acting in main silencing mechanism in Arabidopsis, 
siRNAs-dependent DNA methylation RdDM. Instead, exosome depletion affects histone 
H3K9 dimethylation, an epigenetic mark that affects chromatin structure and thus alters 
transcription. Our data suggest that the exosome collaborates in gene silencing, likely acting 
in a parallel pathway to other mechanisms. We also propose that the Arabidopsis exosome 
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may coordinate the transcriptional interplay of different RNA polymerases to modulate 
repression of some repetitive sequences.  
 
INTRODUCTION 
High-throughput analyses have revealed that eukaryotic genomes are pervasively 
transcribed [1-4], and the majority of the transcriptional activity takes place outside of 
protein-coding genes, producing non-coding RNAs (ncRNAs) derived from genome regions 
once thought to be transcriptionally silent, including intergenic and heterochromatic regions 
[1-3,5]. Pervasive transcription constitutes a risk for the cell, as it can be associated with 
expansion of TEs, loss of genomic stability and defects in gene expression. However, recent 
studies have also shown that ncRNAs themselves can have important regulatory functions, 
including the establishment and maintenance of the epigenetic architecture of eukaryotic 
genomes. In some cases, long ncRNAs serve directly as molecular scaffolds for recruiting 
chromatin modifiers [6,7], whereas in other cases ncRNAs are processed by the RNAi 
machinery into short interfering siRNAs that guide DNA methylation and chromatin 
modifications to homologous regions of the genome [8,9]. Thus, RNA-mediated 
heterochromatin formation requires an affected region to be transcribed for transcriptional 
silencing to occur. Many of the ncRNA transcripts earned the term “hidden” because they 
remain invisible unless RNA degradation is prevented, for example, by inactivation of the 
degradation machinery [1,3,4,10-14], raising the important question of how these ncRNAs are 
regulated.  
The exosome complex plays a central role in RNA metabolism in eukaryotes. 
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Evolutionarily conserved from archaea to humans, the exosome is a stable complex of RNase-
like and RNA binding proteins that catalyzes 3’ to 5’ processing and decay of various RNA 
substrates [15]. The current view of eukaryotic exosome structure is based mostly on studies 
done in yeast and human. The eukaryotic exosome has nuclear and cytoplasmic forms that 
share ten components. The key structural feature is a nine-subunit donut-shaped structure 
called the exosome ring. Six of the subunits, RNase PH domain-containing proteins Rrp41, 
Rrp42, Rrp43, Rrp45, Rrp46 and Mtr3, are organized into a hexameric ring, capped on one 
side by a trimer of subunits that contain S1 and KH RNA binding domains (Rrp40, Rrp4 and 
Csl4) [16,17]. The 9-subunit ring structure has no catalytic activity in yeast and human, due to 
amino acid replacements that disable binding of RNA, phosphate ion, or catalysis [16,17]. 
The exosome active sites are contributed by the tenth protein, Rrp44 (Dis3), which has 
endonucleolytic and exonucleolytic activities and considered to be the tenth subunit of the 
exosome core [18,19]. In addition to Rrp44, the nuclear form of the eukaryotic exosome is 
associated with a second active 3’ to 5’ exonuclease, Rrp6 [20,21]. Most functions of the 
exosome are dependent on cofactors. One of the notable complexes associated with the 
nuclear exosome is the Trf-Air-Mtr4 polyadenylation (TRAMP) complex endowed with a 
poly(A) polymerase activity that stimulates degradation [22-24]. The plant exosome might 
differ from yeast and human exosomes, as its ring subunit Atrrp41p appears to retain an active 
site and was also shown to have catalytic activity in vitro [1,25]. Our previous genome-wide 
study using tiling microarrays to examine exosome targets in Arabidopsis revealed that a large 
number of exosome substrates correspond to ncRNAs originated from promoters, 5’UTRs, 
intergenic regions, repetitive elements and TEs [1]. Many of these ncRNAs derive from 
 27 
centromeric and pericentromeric regions and other heterochromatic loci known to give rise to 
smRNAs that participate in silencing of these loci [26]. In Arabidopsis, the main and most-
studied pathway for transcriptional gene silencing of repetitive elements and transposons is 
the siRNA-based silencing mechanism known as RNA-dependent DNA methylation (RdDM) 
[9,27-29]. The effects of exosome depletion on these ncRNAs and, potentially, on smRNAs 
are unlikely to be attributable to indirect effects of exosome depletion on the expression of 
RdDM pathway components, since no genes acting in siRNA biogenesis, siRNA-mediated 
transcriptional gene silencing (TGS), DNA methylation or demethylation, or histone H3K9 
modifications were found to be affected in these lines [1].  
RdDM induces de novo methylation of cytosines in all sequence contexts at the region 
of siRNA–DNA or siRNA-RNA sequence homology. This silencing pathway requires two 
plant-specific RNA polymerases, Pol IV and Pol V, specializing in transcriptional gene 
silencing (TGS) [28], although transcriptional activity of Arabidopsis Pol II was also reported 
to be involved in siRNA-directed gene silencing [30]. The mechanistic details of RNA-
dependent silencing are not fully understood and also appear to vary from one genomic 
location to another, but the RdDM pathway likely consists of three main steps: (i) siRNA 
production from transcripts that are likely transcribed by RNA Pol IV [9], (ii) synthesis of 
non-coding RNAs that could serve as scaffolds by RNA Pol V and/or Pol II at some of the 
loci [30,31], and (iii) assembly of AGO-siRNA effector complexes to recruit methylation 
machinery to complementary sequences [9]. In siRNA biogenesis, RNA Pol IV transcripts are 
made double-stranded by RNA-DEPENDENT RNA POLYMERASE 2 (RDR2), processed 
into 24 nt siRNA by DICER-LIKE 3 (DCL3), and then incorporated into ARGONAUTE 
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(AGO4 and possibly AGO6) to form an AGO-siRNA complex [32-35]. The AGO-siRNA 
complex and other RdDM effectors [31,35-37], assemble on scaffold RNA to form a guiding 
complex that recruits DNA methyltransferases and histone methyltransferases to direct the 
silencing of specific genomic loci through a mechanism that is not fully understood. Pol IV is 
thought to initiate RdDM pathway, whereas Pol V and AGO4-associated siRNAs function 
downstream from Pol IV to promote DNA methylation by recruiting the silencing complex to 
targeted loci. RNA Pol IV, Pol V and Pol II activities in RdDM are functionally diversified 
and coordinated; however, it is not yet clear how they are functionally integrated in 
heterochromatin silencing. 
The model system in which siRNA-mediated silencing is the best understood 
mechanistically is fission yeast. In S. pombe RNA Pol II carries out the functions attributed to 
Pol IV and Pol V in plants, therefore, it generates both siRNA precursors and scaffold 
transcripts to which siRNAs bind at loci that are subject to siRNA-mediated silencing. 
Exosome defects in S. pombe were reported to result in the loss of transcriptional silencing 
from centromeric, silent mating type, and telomeric loci [38-40]. In S. pombe, in the absence 
of exosome-mediated degradation, abundant aberrant RNA species enter the RNAi pathway 
and interfere with heterochromatic silencing through competition for RNAi biogenesis 
machinery, resulting in the dramatic decrease in centromeric siRNAs [38-40]. Recently, it was 
also shown that exosome plays an important role in remodeling of facultative heterochromatin 
[41]. Earlier work in plants also suggested that aberrant RNAs could enter RNAi pathways 
unless they are degraded by the 5’ to 3’ pathway [42]. However, the role of the exosome 
complex in smRNA metabolism in Arabidopsis has not been examined. It is also not known 
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whether the Arabidopsis exosome complex interacts with the RdDM silencing pathway. 
To answer these questions we employed next-generation sequencing to profile 
populations of smRNAs in exosome-depleted plants, and in mutants of RdDM pathway genes. 
Unexpectedly, we found that loss of the exosome subunits had little effect on the global 
populations of smRNAs and had no affect on the level of DNA methylation in examined 
RdDM loci; rather, it resulted in a reduction of histone H3K9 dimethylation. We propose that 
the Arabidopsis exosome may coordinate the transcriptional interplay of RNA polymerases 
Pol II, Pol V and Pol IV, to achieve the appropriate level of transcriptional repression of 
heterochromatic loci.  
 
RESULTS 
Exosome depletion does not affect smRNA profiles 
Previously, we found that the majority of transcripts upregulated in RRP4 and RRP41 
exosome depletion mutants originate from the promoters, repeats, intergenic, and siRNA 
generating regions [1]. Most of these regions harbor repeats and TEs that are known to be 
silenced by RdDM through siRNAs.  
Since microarray experiments allow estimation of only the length of affected regions, 
but not the exact length of affected transcripts, we set out to examine whether the exosome is 
involved in down regulation of these regions through regulating either quantity or quality of 
smRNAs. To characterize any changes in smRNA populations that occur in response to 
exosome depletion, we employed next-generation sequencing to deep sequence the smRNA 
populations in depletion mutants of exosome subunits RRP4 and RRP41. Null T-DNA 
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insertion mutations in RRP4 and RRP41 are lethal; therefore, we used inducible RNA-
interference (iRNAi) constructs to reduce RRP4 and RRP41. The seedlings of RRP4 (rrp4-i) 
or RRP41 (rrp41-i) transgenic plants grown on estradiol-containing medium to induce the 
RNAi constructs subsequently exhibit a growth arrest ([1], Figure 2.1A). We selected the 
earliest time-point of estradiol treatment corresponding to the accumulation of underprocessed 
5.8S rRNA species (the hallmark of the exosome defect), but before growth retardation, to 
minimize changes in gene expression that did not result directly from exosome depletion [1]. 
Small RNA libraries for Illumina sequencing were generated from the seedlings of rrp4-i and 
rrp41-i iRNAi lines grown with and without estradiol (Table S2.1) and smRNAs between 15- 
and 32 nt in length were selected and mapped to the Arabidopsis genome (TAIR version 9).  
We first examined the smRNAs from the iRNAi transgenes used for inactivation of 
RRP4 or RRP41 [1]. As expected, these silencing cassettes generate silencer sequences 
corresponding to RRP4 or RRP41 (mapping to AT1G03360 and AT3G61620 loci). Profiling 
silencer sequences by size and by first nucleotide revealed that the majority of the silencer 
sequences are 21, 22 and 24 nt and start with 5’U or 5’A (Figure S2.1), suggesting that they 
are preferentially loaded into Ago1, Ago2 and Ago4 complexes [43] to silence their target. 
Silencer sequences produced from iRNAi transgenes were filtered out and libraries without 
silencer reads were termed FLR, for filtered reads (Table S2.1).  Each library was normalized 
either to the total number of mapped non-redundant reads or to the total number of non-
redundant filtered reads (FLR), multiplied by 106 (RPM, reads per million). Both methods of 
normalization produced similar results; therefore, only data normalized using filtered reads 
(FLR) are presented graphically in this study.  
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Figure 2.1 Characterization of up-regulated loci and smRNA populations upon depletion 
of exosome subunits RRP4 and RRP41.  
(A) Phenotypes of rrp41 iRNAi/nrpd1, rrp41 iRNAi/nrpe1, rrp41 iRNAi/dcl3, rrp41 
iRNAi/rdr2 double mutants. RRP4 and RRP41 correspond to the iRNAi lines grown without 
estradiol and rrp4-i and rrp41-i correspond to lines grown on estradiol-containing medium, to 
induce the RNAi-mediated knockdown of RRP4 and RRP41, respectively.  (B) 20-25 nt 
smRNAs sequences profiled by size in exosome depletion mutants rrp4-i and rrp41-i. (C) The 
relative frequency of each 5' terminal nucleotide among populations 20-25nt smRNAs in 
rrp4-i and rrp41-i mutants. (D) Genomic features of loci generating 20-25nt small RNAs 
upon depletion of exosome subunits, according to TAIR9 annotation units.  
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We then classified smRNAs based on their size, the nature of their first nucleotide, 
and their genomic features. The majority of functional smRNAs in A. thaliana range from 21 
to 24 nt. Our libraries were constructed using 15-32 nt smRNAs; therefore, we were able to 
detect any effect exosome depletion might have on smRNA metabolism. We found that 
exosome defect does not lead to changes in smRNAs in the 15-19 nt and 26-32 nt categories 
(data not shown). Importantly, the group of 20-25 nt smRNAs, which contains the majority of 
functional smRNAs, was present in similar proportions, although with minor variations, 
relative to the number of total reads in the libraries of both of exosome depletion mutants and 
in their corresponding non-induced lines, and constituted about half of total smRNAs mapped 
to the genome (Table S2.1, Figure 2.1B). Therefore, for simplicity we graphed only data 
corresponding either to 20-25 nt smRNAs, or to smRNAs of one specific length. 
In addition, the depletion of either RRP4 or RRP41, which are both essential for 
exosome function, with slight variations, had no effect on the smRNA size distribution 
(Figure 2.1B) or the frequencies of their first nucleotide (Figure 2.1C). All together, these 
results suggest that defects in exosome function do not lead to accumulation of un-degraded 
smRNA fragments or to any changes in the cleavage bias of Dicer proteins. Also, exosome 
depletion did not change proportions of smRNAs mapped to different classes of RNAs, such 
as mRNAs, tRNAs, rRNAs, and snoRNAs (Figure 2.1D). Therefore, unlike the situation in S. 
pombe, where exosome acts as a negative regulator of siRNA biogenesis, Arabidopsis 
exosome does not act to prevent spurious RNAs from entering RNAi pathway. 
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Exosome depletion does not affect populations of smRNAs corresponding to repeats and 
transposable elements  
In Arabidopsis, repeats and TEs are silenced by siRNAs through RdDM; therefore, we 
examined the effect of exosome loss on 20-25 nt smRNAs corresponding specifically to TEs 
and repeats.  Surprisingly, we saw no changes in the groups of smRNAs mapped to tandem 
repeats (TR), inverted repeats (IR), dispersed repeats (DR) or the group of TEs in both 
exosome mutants (Figure 2.2 A and B).  
The diverse heterochromatic siRNAs participating in TE silencing are mostly 24-mers 
and are Pol IV- and/or Pol V-dependent [9]. Most siRNA production relies on Pol IV, but 
there are also Pol V-dependent and Pol IV-independent siRNA-generating loci [44,45]. 
Therefore, to examine whether the exosome complex functionally overlaps with the 
components of the RdDM pathway, we constructed lines containing rrp4-i or rrp41-i iRNAi 
and mutations affecting Pol IV, Pol V, RDR2 and DCL3, which are nrpd1, nrpe1, dcl3 and 
rdr2 respectively (allele numbers provided in Methods). This approach also allowed us to 
confirm that smRNAs observed in exosome depletion lines are siRNAs produced by 
components of the RdDM pathway and not short RNA degradation products accumulated in 
the absence of functional exoribonucleolytic complex. 
Pol IV, Pol V, RDR2 and DCL3 are not essential for viability [27,29,46]. Combining 
mutations in nrpd1, nrpe1, dcl3 and rdr2 with rrp41-i iRNAi knock-down line did not 
exacerbate the phenotypes of single exosome depletion mutants (Figure 2.1A). 
We next analyzed the smRNAs corresponding to repeats and TEs produced in the 
rrp41/nrpd1 and rrp41/nrpe1 double mutants (Figure 2.2C) and the rrp41/rdr2 and 
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rrp41/dcl3 double mutants (Figure 2.2D). Similar to previous reports, we observed a 
significant reduction in the amount of smRNAs corresponding to TEs, TRs and IRs in nrpd1, 
nrpe1, rdr2, and dcl3 mutants [27,44,47,48]. Depletion of the exosome in nrpd1, nrpe1 and 
rdr2 mutants had no effect on the amount of TE and repeat-associated smRNAs produced in 
these mutants (Table S2.2, Figure 2.2 C and D). Depletion of rrp41 in dcl3 led to a minor 
restoration of this defect in all groups of repeats and TEs. In the absence of dcl3, other 
Arabidopsis Dicer proteins are known to process dcl3 substrates [49]; therefore this minor 
restoration most likely resulted from compensatory effects of other DICER proteins (Table 
S2.2, Figure 2.2D). Profiling repeat- and transposable element-generated smRNAs by their 
size confirmed that the exosome defect did not affect the group of 20-25 nt smRNAs even in 
Pol IV, Pol V, RDR2 and DCL3 deficient genetic backgrounds. Typically, siRNAs 
participating in RdDM are 24 nt long; therefore we profiled smRNAs mapping to transposable 
elements by length, but observed no change in abundance of 24nt smRNAs (Figure 2.2E). 
Further analysis of the 24 nt smRNAs mapped specifically to the different transposable 
element superfamilies led to the same conclusion (Figure 2.2 F and G). We therefore 
concluded that there are no significant changes in the populations of siRNAs corresponding to 
repeats and TE superfamilies in exosome depletion mutants. We also did not observe any 
significant differences in amounts of mature 21-mer miRNAs. The results of our sequencing 
analysis were confirmed by Northern blot analysis (Table S2.3, Figure 2.3, Figure S2.2). 
Together, these data suggest that the Arabidopsis exosome complex is not involved in siRNA 
metabolism on a global scale. Nevertheless, we can not exclude the possibility that exosome 
might control a small number of smRNA precursor transcripts at a few specific loci that 
 35 
would have been missed in our experiments and with the data processing approach we took 
while dissecting differences on genomic level.  
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Figure 2.2 Characterization of 20-25 nt smRNAs corresponding to transposons and 
repeats in exosome and RdDM mutants. 
(TE=transposable element; TR=Tandem repeat; IR=Inverted repeat; DR=Dispersed repeat) 
(A) Results of depletion of exosome rrp4 subunit. (B) Results of depletion of rrp41 exosome 
subunit. (C) Results of depletion of rrp41 in nrpd1 and nrpe1 genetic backgrounds. (D) 
Results of depletion of rrp41 in dcl3 and rdr2 mutants. (E) Characterization of smRNAs 
mapped to repeats and transposable elements in rrp4-i and rrp41-i libraries profiled based on 
the reads length (F, G). Classification of 24nt smRNAs corresponding to the different 
superfamilies of TEs in rrp4-i (F) and rrp41-i mutants (G) [50]. 
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Figure 2.3 Expression of miRNAs in exosome mutants. 
MiRNA families, miR-159a, miR-167a, miR-173 and variations in sequence length in each 
family. smRNAs mapped to matching mature miR-159, miR-167miR-173, and miR-167 
sequences [51](miRBase release 18) were plotted versus the sum of their normalized reads per 
million (rpm) from smRNA libraries constructed from RRP4, rrp4-i ,RRP41, rrp41-i, 
RRP41/nrpd1, rrp41 iRNAi/nrpd1, RRP4 iRNAi/nrpe1 and rrp41 iRNAi/nrpd1  mutants. 
Detection of miRNAs by Northern Blot analysis demonstrates that mature miRNA levels are 
not affected by exosome depletion, and confirms the results of bioinformatic analysis. Total 
RNA stained with ethidium bromide was used as a loading control. 
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The exosome controls expression of ncRNAs in RdDM-regulated loci 
To further investigate whether the exosome participates in gene silencing and interacts 
with the RdDM pathway, we examined the transcription patterns of several specific loci 
regulated through RdDM. solo LTR and AtSN1 are the heterochromatic loci for which the 
role of RdDM players in their silencing and interactions between them are best-understood 
[30,31,52-54]. Transcriptional silencing of solo LTR and AtSN1 heterochromatic loci are 
dependent on Pol IV and Pol V [30,31,52-54]. Based on previous studies, both solo LTR and 
AtSN1 loci can be subdivided into region A and an adjacent region B [30,31]. Region A 
represents the siRNA-generating region likely transcribed by Pol IV, and region B gives rise 
to the ncRNAs that are proposed to serve as a scaffold for recruiting siRNA-mediated 
complexes that form heterochromatin (Figure 2.4A). Pol V was proposed to produce 
transcripts which serve as the scaffolds [31], although in case of solo LTR, Pol II was also 
shown to be involved [30]. 
We then used real-time RT–PCR to examine the levels of transcript produced from 
region A, as a measure of the silencing status of each locus. We found that exosome defects 
resulted in accumulation of polyadenylated ncRNA produced from both regions A and B of 
solo LTR (Figure 2.4B). We then compared the amplitudes of the region A derepression in 
the rrp41, with rrp41 iRNAi/nrpd1 and rrp41 iRNAi/nrpe1 double mutants relative to the 
respective single mutants. As previously reported by others [30,31], we observed solo LTR to 
be significantly derepressed in Pol IV and Pol V single mutants (Figure 2.4 C and F). 
Interestingly, only the combination of exosome defect with mutation of Pol V, but not with 
mutation of Pol IV, resulted in the synergistic increase of region A transcript (Figure 2.4C).  
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Figure 2.4 Effect of exosome subunits depletion on expression of ncRNA transcripts 
from RdDM-regulated loci. 
(A) Diagrams of solo LTR and AtSN1 loci, based on analysis of transcription units by 
Wierzbicki et al. (2008). Region A corresponds to the siRNA-producing region of solo LTR, 
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region B corresponds to the adjacent to solo LTR region that produces scaffold RNA, and red 
lines mark regions amplified by RT-PCR and qPCR. The dotted line corresponds to the region 
of scaffold RNAs hypothesized to be complementary to the siRNAs produced from region A. 
(B) Depletion of exosome subunits RRP4 and RRP41 leads to an increase in noncoding 
transcripts generated from siRNA-producing region A and scaffold RNA-producing region B 
of solo LTR. RT was primed with oligo(dT). (C, D, E) Expression of region A of solo LTR in 
exosome depleted plants and various mutants. (C) Combining depletion of RRP41 with 
mutation in Pol V leads to a synergistic increase in accumulation of transcripts from region A. 
Strand-specific RT-PCR analysis revealed that both top and bottom transcripts of region A are 
affected by depletion of RRP41 subunit, but only bottom transcript is synergistically affected 
in rrp41-i/nrpe1 double mutants (D), while the amount of top transcript is decreased in both 
rrp41-i/nrpd1 and rrp41-i/nrpe1 double mutants (E). (F, G) Expression of region B of solo 
LTR in exosome depleted plants and various mutants. (F) Depletion of rrp41 leads to 
increased amounts of transcript produced from both strands of region B. (G) RT-PCR analysis 
of solo LTR top transcript. (H, I) Depletion of exosome subunit RRP41 leads to increase in 
ncRNA transcripts generated from the AtSN1 region. (H) Combining depletion of RRP41 
with mutation in Pol V leads to synergistic increase in accumulation of polyadenylated 
transcript from region A. (I) Amount of the region A bottom strand of AtSN1 is synergistically 
increased in rrp41-i/nrpe1 double mutants. 
 
 
 
 
Reverse transcription with oligo dT primers does not discriminate between transcripts 
originating from either DNA strand; thus an elevated level of polyadenylated transcript could 
result from transcription from either one of the DNA strands. Therefore, to find out which of 
the transcripts increased in abundance, we carried out strand-specific RT-PCR for the A and B 
regions.  
Following standard nomenclature, the top transcript (also called top strand RNA) 
corresponds to the transcript identical to the sequence of the DNA top strand (and therefore 
produced from the bottom DNA strand), and the bottom transcript is identical to the sequence 
of DNA bottom strand. The scaffold RNAs were reported to correspond to region B top strand 
[30,31]. Similar to previous results [30,31], we observed region A top and bottom transcripts 
to be significantly derepressed in Pol IV and Pol V single mutants (Figure 2.4 D and E), and 
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depletion of RRP41 lead to increased accumulation of the region A top and bottom transcripts 
(inserts in Figure 2.4 D and E). Interestingly, we found that the bottom transcript was 
synergistically derepressed in rrp41 iRNAi/nrpe1 double mutants relative to nrpe1 and rrp41 
iRNAi single mutants, while no change was observed in rrp41 iRNAi/nrpd1 double mutants 
(Figure 2.4D). Despite the fact that the exosome defect equally affected the levels of both top 
and bottom region A transcripts, combining the exosome defect with either Pol IV or Pol V 
mutants had no additive or synergistic effect on the level of region A top transcript. 
Surprisingly, the level of expression of region A top transcript was even somewhat decreased 
in rrp41 iRNAi/nrpd1 and rrp41 iRNAi/nrpe1, compared to nrpd1 and nrpe1 single mutants, 
opposite to the pattern we observed for the bottom strand (Figure 2.4E). Production of 
scaffold transcripts is central in silencing of the locus and it was reported that even in the 
presence of functional Pol IV and siRNAs, silencing of solo LTR fails when scaffold RNAs 
are not produced [30,31]. 
We therefore examined the scaffold-producing region B and found that the exosome 
also affects the amount of region B top transcript, but there is no synergistic increase of this 
transcript in rrp41 iRNAi/nrpe1 double mutants (Figure 2.4 F and G). When we examined 
AtSN1, we observed a very similar synergistic increase in the level of the siRNA-producing 
region A of bottom strand transcript of AtSN1 in rrp41 iRNAi/nrpe1 mutants (Figure 2.4 H 
and I).  
Together, these results suggest that the exosome participates in controlling the amount 
of top transcripts emanating from the scaffold-producing region B of solo LTR, and thus may 
contribute to the repression of region A through regulating the level of region B transcripts.  
 42 
RRP41 depletion does not affect of de novo DNA methylation in solo LTR and AtSN1 
loci 
The solo LTR, AtSN1 and IGN5 loci are silenced primarily by RdDM, through siRNA 
mediated de novo methylation of DNA [9,30,31]. We reasoned that if the exosome is involved 
in controlling the amount of RNA expressed from these loci in a siRNA-dependent manner, 
then the exosome defect might affect the amount of siRNAs generated from these regions. To 
address this question, we first compared solo LTR and AtSN1-specific smRNAs. We found 
that production of smRNAs from the siRNA-generating A regions was not altered in rrp4-i or 
rrp41-i mutants relative to WT (Figure 2.5 A and B), similar to the results of the global 
smRNA analysis we described above. The increased amount of smRNAs observed in dcl3 
mutants is because in the absence of DCL3, the other Dicer proteins process DCL3 substrates 
[49]. In order to make sure that the smRNAs produced from one strand of region A are not 
masking the smRNAs produced from the opposite strand in exosome depletion mutants, we 
also analyzed these smRNA populations in a strand-specific manner. However, the patterns of 
strand-specific siRNAs were very similar to the patterns we observed previously and siRNAs 
were not affected by exosome depletion (Figure 2.5 C and D). We examined an additional 
region controlled by RdDM, the IGN5 locus [31], and found that IGN5-specific smRNAs are 
also not affected in exosome mutants, similar to solo LTR and AtSN1 loci (Figure S2.3C). 
This implies that the increase in accumulation of transcripts in exosome-depleted plants was 
not a result of siRNA defect. To verify this directly, we examined the patterns of DNA 
methylation in these regions by using methylation sensitive restriction enzymes (Figure 
2.5E).  
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Figure 2.5 smRNA accumulation and DNA methylation in solo LTR and AtSN1 loci is 
unaltered upon exosome depletion. 
(A, B) 20-25 nt smRNAs produced from region A of solo LTR (A) and region A of AtSN1 (B) 
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in rrp4-i, rrp41-i exosome depletion lines and RdDM mutants. All locus-specific datasets of 
20-25nt smRNAs are plotted versus the sum of their normalized reads per million (rpm). (C, 
D) Strand-specific analysis of smRNAs generated at regions A and B of AtSN1 (C) and solo 
LTR (D) loci in different mutants. (E, F) DNA methylation analysis of AtSN1 and solo LTR 
loci by digestion of purified DNA with the methylation-sensitive endonucleases HaeIII for 
AtSN1 (E), AluI for solo LTR (E), and McrBC for solo LTR (D), followed by PCR. 
 
 
 
 
 
The DNA of the solo LTR region was examined by two different assays (Figure 2.5 E 
and F). We found that, consistent with the results of the region-specific siRNA analysis, de 
novo DNA methylation was not changed in rrp41-i plants (Figure 2.5 A-D). Taken together, 
these results indicate that an increase in transcript accumulation is not caused by the loss of de 
novo methylation and the region is still silenced by RdDM. It also suggests that in the 
examined loci, the exosome complex functions independently of RdDM. Interestingly, the 
increased amount of transcripts accumulated in these regions does not contribute to increased 
smRNA amounts in the exosome-depleted plants. This was observed regardless of whether 
these transcripts originated from siRNA-generating regions, or adjacent regions. Indeed, even 
several thousand-fold upregulation of region A transcript in iRNAi/nrpe1 mutants (Figure 2.4 
B, C, G and H) does not produce any increase in the amount of siRNAs (Figure 2.5 A-D). 
 
H3K9me2 levels are affected in exosome-depleted plants. 
DNA methylation and histone modification are two major epigenetic marks regulating 
gene expression and chromatin state in plants. Monomethylated histone H3 lysine 27 
(H3K27me1) and dimethylated histone H3 lysine 9 (H3K9me2) are hallmarks of 
heterochromatin, and silencing of solo LTR, AtSN1 and IGN5 loci also involves histone 
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modifications [30,31]. Although de novo methylation does not directly affect the level of 
H3K9me2, it does affect the level of H3K27me1 [31], suggesting that in addition to histone 
modification pathways, which are dependent on RdDM, other, RdDM-independent, pathways 
also contribute to transcriptional silencing of these regions. We therefore used chromatin 
immunoprecipitation (ChIP) to examine whether the exosome is involved in regulation of 
histone modifications in these loci.  
Similar to the results reported by others [30,31], we observed a significant decrease in 
the level of H3K9me2 in the solo LTR locus in nrpd1 and nrpe1 mutants, which affect Pol IV 
and Pol V, respectively. We found that RRP41 depletion also led to a decrease in H3K9me2 
but less than observed in nrpd1 and nrpe1 mutants (Figure 2.6A). The decrease in level of 
this repressive histone modification also correlated with a mild increase in RNA Pol II 
occupancy in the solo LTR region, as would be expected with a release of transcriptional 
block (Figure 2.6B).  The rrp41 iRNAi/nrpe1 double mutant did not exhibit any additive or 
synergistic effect on the loss of H3K9me2 relative to respective single mutants. 
When we examined AtSN1, we found that the level of H3K9me2 was mildly 
decreased in all mutants tested (Figure 2.6A). For AtSN1, it was previously suggested that 
RNA Pol III is the main RNA polymerase transcribing the region when the region is in a 
derepressed state [31], although RNA Pol II was also reported to be associated with this 
region [30]. We found that RNA Pol II occupancy in AtSN1 was very low but it increased 
significantly in rrp41 iRNAi/nrpe1 double mutants (Figure 2.6B), in accordance with the 
synergistic increase of the transcript level we observed (Figure 2.4 H and I).  
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Figure 2.6 The effect of the exosome subunits depletion on the levels of H3K9me2 in 
different loci. 
(A, B) The levels of H3K9me2, and Pol II occupancy at solo LTR and AtSN1 examined by 
ChIP in RRP41, rrp41-i, RRP41/nrpd1, rrp41-i/nrpd1, RRP41/nrpe1, and nrpd1/nrpe 
mutants using antibodies against H3K9me2 (A), and RNA Pol II (B), respectively. (C) Effect 
of RRP4 depletion on levels of H3K9me2 examined by ChIP at solo LTR, IGN5, REG 3, and 
REG 4 (C), and on levels of H3K27me1 at solo LTR, AtSN1, and IGN5 loci (D). No Ab, 
ChIP with no antibody, is used as a negative control. 
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Depletion of another exosome subunit, RRP4, caused a similar loss of H3K9me2 at 
solo LTR and AtSN1 loci (Figure 2.6C). We then chose several additional regions, termed 
REG3 and REG4 (Figure S2.3A), that are mildly upregulated in exosome mutants according 
to our previous microarray analysis [1], and examined them using ChIP. REG3 harbors a 
MuDR transposon, and REG4 is situated in a tandem repeat area. Neither of these loci 
produces smRNAs or is controlled by DNA methylation (Figure 2.6E and data not shown). 
We found that the H3K9me2 in these loci was similarly affected by exosome depletion 
(Figure 2.6C), while the level of H3K27 methylation in these regions didn’t show any 
difference (Figure 2.6D). These results suggest that the exosome may participate in 
maintaining chromatin structure in these regions as well, and does so by specifically affecting 
the level of H3K9me2 in addition to controlling the level of transcripts. 
 
Exosome associates with transcripts produced from a scaffold-generating area adjacent 
to solo LTR. 
We then examined exosome association with ncRNA loci. Detection of some protein–
nascent mRNA interactions by ChIP were reported previously for proteins working on RNA, 
but the results of our attempts to localize tagged exosome subunits at solo LTR locus have 
proven inconclusive. Transcripts from region A are normally below the level of detection in 
wild-type plants, but transcription from the region B adjacent to solo LTR has been previously 
documented in wild-type plants [1,30,31]. In order to confirm that the exosome directly 
associates with these transcripts, we conducted RNA immunoprecipitation (RIP) using plants 
carrying a transgene expressing RRP41-TAP, and examined the ncRNAs associated with the 
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exosome by RT-PCR. No region A transcripts were detected in immunoprecipitates, but we 
found that region B transcripts were co-precipitated with exosome (Figure 2.7A). These data 
suggest that in wild-type plants, exosome physically associates with polyadenylated 
transcripts produced from region B of solo LTR. 
In contrast to solo LTR, we did not detect a physical association of exosome with 
AtSN1 region B transcript (Figure 2.7A). This implies that exosome depletion may not 
directly affect the silencing of AtSN1. However, we observed that exosome depletion resulted 
in accumulation of transcript in the AtSN1 locus and we detected a synergistic derepression of 
the locus in rrp41/nrpe1 mutants, similar to solo LTR locus (Figure 2.4 H and I). Most likely 
the regulation of AtSN1 is more complex because an additional RNA polymerase, RNA Pol 
III, is involved. AtSN1 is transcribed mostly by RNA Pol III [31,55], suggesting that the 
double deficiency in exosome and Pol V may increase both Pol II and Pol III access to the 
locus. We also observed the increased Pol II association with AtSN1 in rrp41/nrpe1 mutants 
by ChIP assay using anti-Pol II (Figure 2.6B), which is consistent with the results of qRT-
PCR. Therefore, it is also possible that the loss of exosome function may lead to the alteration 
of chromatin structure in regions adjacent to AtSN1 and thus affect the stability of silencing in 
AtSN1 indirectly. Nevertheless, these results are similar to the interplay between exosome 
and Pol V observed for solo LTR. 
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Figure 2.7 Exosome associates with transcripts produced from the region adjacent to the 
solo LTR scaffold-generating area. 
(A). RT-PCR of RNA-immunoprecipitation using plants carrying a functional RRP41-TAP 
transgene and empty-TAP transgene to examine the association of exosome with noncoding 
transcripts produced at siRNA and scaffold RNA producing loci. Region B transcripts were 
co-precipitated with exosome, while no region A transcripts were detected in 
immunoprecipitates. Transgenic plants are in Ws ecotype. 
(B, C) Two homologous rrp6 catalytic subunits of exosome are involved in controlling the 
amount of ncRNA emanating from the solo LTR locus. (C) Expression pattern of region A of 
solo LTR locus in rrp6l3-1, rrp6l2-2, 6l1-2, and the double mutant rrp6l1-2/rrp6l2-2 
compared relative to the RNA expression in Col-0 ecotype wild-type (B), compared relative 
to the RNA expression in Ws ecotype wild-type (C). 
(D) Analysis of DNA methylation in solo LTR by McrBC treatment in Col-0, Ws, 
rrp6l1-2, rrp6l2-2, double mutant rrp6l1-2/rrp6l2-2, rrp6l3-1mutant plants. RRP41/nrpd1 
mutant DNA is used as a control. 
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RRP6 is involved in controlling levels of ncRNA from the solo LTR locus.  
The 9-subunit exosome complex is catalytically inactive in yeast and human. Instead, 
active sites are contributed by Rrp44 (Dis3) and by the subunit Rrp6, which is 
substoichiometric, nuclear-specific, and not essential for viability. Degradation of S. 
cerevisiae nuclear ncRNAs depends on polyadenylation by the TRAMP complex and 
involves Rrp6, the subunit that is also responsible for elimination of heterochromatic RNAs in 
S. pombe [20,22-24,39-41]. In Arabidopsis there are three RRP6-like proteins – nuclear 
localized RRP6L1 and RRP6L2, and cytoplasmic RRP6L3; these were suggested to be 
functional homologues of RRP6 [56]. None of the RRP6-like proteins co-purified with the 
exosome complex in our proteomic studies [1], but may have been underrepresented in our 
preparations. In addition, RRP6L2 was later shown to have at least some commonalities with 
core exosome substrates [56]. We therefore examined whether the Arabidopsis RRP6-like 
proteins control the amount of ncRNA at the solo LTR locus. To determine this, we used T-
DNA insertion alleles in RRP6L1, RRP6L2 and RRP6L3. We isolated the rrp6l1-2 allele from 
the University of Wisconsin BASTA population (Ws ecotype), and the alleles of the rrp6l2-2 
and rrp6l3-1 are SALK alleles (Col-0 ecotype). To control for effects of ecotype, we 
compared the amount of region A transcript in rrp6l3-1, rrp6l2-2, rrp6l1-2/ rrp6l2-2 mutants 
to Col-0 wild type plants, and rrp6l1-2, rrp6l1-2/ rrp6l2-2 mutants to Ws ecotype plants 
(Figure 2.7 B and C).  
We found that, similar to depletion of the core subunits RRP4 and RRP41, rrp6l1-2 
and rrp6l2-2 mutants exhibited increased accumulation of transcripts produced from region 
A. As would be expected based on cytoplasmic localization of RRP6L3 protein, no effect was 
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observed in rrp6l3-1 mutants. To our surprise, we observed a dramatic derepression of region 
A in rrp6l1-2/ rrp6l2-2 double mutants, suggesting that both RRP6L1 and RRP6L2 proteins 
are involved in the silencing of this region and might have a redundant function in this 
process. 
We also examined the status of solo LTR DNA methylation in rrp6l1-2, rrp6l2-2, and 
rrp6l1-2/ rrp6l2-2 double mutants. We found that methylation was not affected in these 
mutants regardless of the extent of derepression of the region (Figure 2.7D), consistent with 
the results obtained using rrp4-i and rrp41-i depletion mutants. Taken together, these results 
indicate that the observed increase in transcript accumulation is not caused by the loss of de 
novo methylation and the region is still methylated by RdDM. This further confirms that the 
exosome complex functions independently of the RdDM pathway. 
 
DISCUSSION 
The exosome and smRNA metabolism 
The exosome functions in virtually all aspects of RNA metabolism and it appears to 
also have a prominent role in transcriptional gene silencing in different species [1,10,38-
41,57-61]. This study examined the role of the exosome complex in metabolism of smRNAs 
and explored the possible relationship between the exosome and the RdDM pathway in gene 
silencing in Arabidopsis.  
Our results showed that exosome-mediated silencing did not produce global changes 
in smRNA profiles, nor in DNA methylation at specific loci. However, we did find effects on 
histone methylation, indicating that the exosome may regulate chromatin structure, thereby 
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playing an important role in maintenance of gene silencing on a much broader scale than the 
RdDM pathway. It is clear from our results using suppression of key exosome components 
that plants have an exosome-dependent pathway that relies on ncRNAs to target 
heterochromatin.  
Our finding that the increase in ncRNA transcribed from heterochromatic loci in 
exosome-depleted plants did not lead to an increase in levels of smRNA indicates that 
exosome function in Arabidopsis differs from that in fission yeast. In fission yeast, exosome 
defects have a dramatic effect on siRNAs leading to redistribution of the spectrum of Ago1-
associated siRNAs, from mostly repeat-associated to those derived predominantly from 
exosome substrates such as rRNA and tRNA [39], indicative of exosome acting as a negative 
regulator of siRNA biogenesis. Our data indicate that the Arabidopsis exosome most likely 
lost this function during evolution, meaning that exosome substrates do not compete with 
siRNA precursors for siRNA biogenesis machinery and spurious transcripts do not enter 
RNAi pathways in plants. Additionally, it suggests that perhaps only very few of the ncRNA 
transcripts controlled by the exosome could be bona fide siRNA precursors. One of the 
reasons for this could be the fact that plants evolved two plant-specific RNA polymerases, Pol 
IV and Pol V, which specialize in siRNA-mediated TGS. Pol IV is required for biogenesis of 
the majority of 24-nt siRNAs and is supported by Pol V, which is responsible for production 
of a subset of siRNAs [31,44,45,62]. It is also plausible that there might be other unknown 
plant-specific ribonucleases that specialize in controlling stability of siRNAs or the amount of 
siRNA precursors generated by Pol IV and/or Pol V in plants. We also cannot rule out the 
possibility that some of the transcripts controlled by the exosome in a small subset of loci are 
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legitimate siRNA precursors; this definitely warrants further in-depth investigation.  
 
Exosome and DNA methylation-independent gene silencing 
siRNA-dependent RdDM is thought to be the main pathway for transcriptional gene 
silencing of repetitive elements and transposons in plants [27,28,31,63,64], although existence 
of other DNA methylation-independent gene silencing pathways have also been reported [65-
73]. One of the DNA methylation-independent gene silencing pathways is mediated by 
MOM1 (Morpheus’ molecule 1) protein [65,67], which predominantly silences transposons 
and loci harboring sequences related to gypsy-like transposons. Activation of transcription in 
mom1 mutants occurs with no change in DNA methylation, histone modifications or 
chromatin condensation, and the investigation of the relationship between RdDM and MOM1 
revealed a very complex interplay between these two pathways [65,71,74-76]. However, a 
reduction in H3K9 dimethylation was reported in some loci in mom1 mutants and it was 
suggested that MOM1 may transduce RdDM signals to repressive histone modifications by an 
unknown mechanism [77].  
Also, a recent study of MORC family ATPases revealed that mutation of AtMORC1 or 
AtMORC6 caused derepression of DNA methylated genes and TEs without any loss of DNA 
methylation, change in histone methylation or alteration of siRNA levels [73]. These proteins 
are involved in alteration of chromosome superstructure and are likely to act downstream of 
DNA methylation. These results indicate that there are multiple parallel pathways for DNA 
methylation-independent gene silencing in Arabidopsis. The exosome-mediated silencing we 
observed here bears some similarities to the silencing observed for MOM1 and MORC; for 
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example, they show effects on repetitive sequences and an absence of effects on siRNAs, 
although there are notable differences as well. Here we show that, similar to MOM1 and 
MORC mechanisms, exosome-dependent gene silencing also affects repetitive sequences and 
acts independent of RdDM, although our results are limited in scope. Characterization of the 
relationship between these pathways remains an interesting topic for future study. 
The different silencing pathways likely have different functions, depending on the 
genomic region, the nature of the regulated sequences, and the precision and dynamics of 
silencing required. For example, methylated sequences can affect the expression of nearby 
genes. The expression of nearby genes is negatively correlated with the density of methylated, 
but not unmethylated TEs. Methylated TEs are preferentially removed from gene-dense 
regions over time and TE families that have a higher proportion of methylated insertions are 
distributed farther from genes [50], arguing that positional effects and the surrounding 
landscape most likely contributes to the choice of silencing mechanisms and the interplay 
between them. 
 
How can exosome function in gene silencing in Arabidopsis? 
There are multiple mechanisms by which the exosome can be envisioned to participate 
in gene silencing in Arabidopsis. Heterochromatin assembly is used by all eukaryotes in gene 
silencing. In addition to repressive histone modifications employed by all organisms, humans 
and plants widely use DNA methylation as well, and ncRNAs play a central role in the control 
of chromatin structure in all organisms. While ncRNA-mediated silencing proceeds through 
multiple mechanisms some of which are organism-specific, the end result appears to be the 
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same repressive histone modifications. For example, budding yeast, which lacks RNAi 
machinery, employs strategies that include, but not limited to, the use of antisense, cryptic or 
read-through transcripts, as well as transcripts originating from divergent promoters to guide 
histone modifications. Fission yeast is more similar to higher eukaryotes and uses all of the 
above strategies in addition to utilizing RNAi as well. However, DNA methylation is not used 
by budding and fission yeast. Plants, on the other hand, evolved very sophisticated epigenetic 
mechanisms that include the use of both RNAi-dependent and RNAi-independent pathways to 
guide DNA methylation and histone modifications for gene silencing [9,31-
33,44,45,47,63,70,72,77-79]. Exosome complex proved to be amazingly versatile in 
impacting gene silencing in budding and fission yeasts. In fission yeast, the organism which 
takes full advantage of RNAi machinery to regulate its gene expression, the exosome is 
involved in silencing of both facultative and constitutive heterochromatin by acting in several 
different pathways through smRNAs, produced in either an RNAi-dependent or RNAi-
independent manner [38,39,80,81]. It was also found to act through surveillance of RNA 
quantity and quality as well as by collaborating with termination machinery [40,41,59,81,82], 
similarly to the manner exosome participates in gene silencing in bakers yeast, which lacks 
RNAi machinery [57,60,61].  
In Arabidopsis, silencing of repetitive elements involves siRNA-dependent DNA 
methylation guided by homologous siRNAs [9]. Repressive histone modifications always 
appear to accompany DNA methylation, however, the mechanistic link between them is not 
yet fully understood. In budding and fission yeasts, degradation of nuclear ncRNAs depends 
on polyadenylation by the TRAMP complex and involves Rrp6. We also found that mutations 
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in two RRP6-like proteins AtRRP6 L1and AtRRP6 L2 led to significant dereperession of solo 
LTR (Figure 2.7 B, C and D) and occurred in a DNA methylation-independent manner as in 
rrp4 and rrp41 (Figure 2.7F). These results suggest that Atrrp6s may be true nuclear catalytic 
subunits of Arabidopsis exosome, or may also work independently of core exosome. It will be 
interesting to examine whether another putative exosome catalytic subunit AtRrp44a [J. Lee 
and J. Chekanova unpublished data] is involved in this process, and whether components of 
the TRAMP complex also participate. 
We also observed that the exosome physically associates with the polyadenylated 
ncRNA transcripts from scaffold producing regions. We could not reliably crosslink the 
exosome to the DNA of the target locus by ChIP (data not shown), although this could simply 
reflect the difficulty of reliably crosslinking proteins to DNA through RNA, or it could mean 
that the exosome binds to the transcripts after they are released from the locus and that 
exosome-mediated regulation of the transcripts may be important for maintenance of 
chromatin structure around the locus. H3K9 dimethylation was reported to be disturbed and 
lost when isolated Arabidopsis nuclei were treated with RNase A [83], meaning that histone 
modification may be affected by RNA level and/or RNA in close proximity to the target loci. 
In fission yeast, the mutation of Cid14, one of the subunits of the TRAMP complex, results in 
accumulation of aberrant heterochromatic RNA close to the target loci and leads to a mild 
decrease in H3K9 methylation. It was recently shown that decrease of H3K9 methylation in 
yeast is the result of HP1 protein (Heterochromatin Protein1), which binds to H3K9me2 
heterochromatin and propagates H3K9me2 spreading, being titrated by an excess of 
heterochromatic RNA [84]. In our study, we also observed a combination of the transcripts 
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accumulation in exosome mutants relative to WT with a weak decrease in H3K9me2 levels in 
solo LTR (Figure 2.6A). Taken together, these data could suggest that a similar mechanism to 
regulate the stability of chromatin structure might operate in plants. However, LHP1 (Like-
HP1), the closest Arabidopsis homolog of yeast HP1, has specificity for H3K27me3 [85], not 
H3K9me2, and the rrp41 iRNAi/nrpe1 double mutant did not exhibit any additive or 
synergistic effect on the loss of H3K9me2 relative to respective single mutants as well, 
suggesting that the loss of H3K9me2 observed in the exosome mutants is unlikely to result 
from an unknown functional homolog of Arabidopsis HP1 simply titrating an excess of 
ncRNA off chromatin, as reported in fission yeast. 
Our results showed that the exosome depletion produced no effect on siRNAs and 
DNA methylation of solo LTR, AtSN1 and IGN5 loci, arguing that the exosome complex 
functions independently of RdDM. However, our findings also indicated that the exosome is 
involved in the silencing of these loci and does interact with the RdDM pathway, possibly 
through its functional interaction with RNA Pol V. The converging transcripts we observed in 
the rrp41-i and rrp4-i mutants in solo LTR and AtSN1 suggest that the exosome is involved 
in regulation of either processing or level of RNA from these loci (Figure 2.4 A-I, and model 
Figure 2.8). We found that production of smRNAs from the siRNA-generating A regions was 
totally abolished in rrp41/nrpd1 double mutant (Figure 2.5 A-D), ruling out a possibility for 
these transcripts to serve as a double stranded precursors for RNA Pol IV-independent 
siRNAs. We also found that the exosome physically associates with the polyadenylated 
transcripts produced from the scaffold region (region B) and exhibits synergistic derepression 
of the locus (region A) when combined with a Pol V mutant, while there was no change in the 
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derepression in rrp41/nrpd1 double mutants (Figure 2.4 B, C, H and I). Based on these 
results, we speculate that RNA polymerase V may function in gene silencing of these loci in 
two ways, the first acting in the DNA- methylation-dependent RdDM pathway, and the 
second acting independently of a DNA-methylation. Indeed, RdDM- independent roles of Pol 
V in silencing of 5S rDNA [31,86] and several other loci [83] were previously reported. A 
recent genome-wide study of Pol V-associated loci also hints at the possibility of Pol V 
having unknown functions in addition to the function it plays in the RdDM pathway [45]. The 
DNA-methylation-independent function of Pol V may then be in addition to its function in 
RdDM, and may operate in parallel to the exosome pathway. If this is the case, the depletion 
of both rrp41 and nrpd1 may not lead to synergistic derepression because it would be 
compensated by the RdDM-independent function of Pol V. However, deficiencies in exosome 
and Pol V would result in synergistic desilencing due to the loss of three different pathways. 
Both Pol II and Pol V were reported to be responsible for the transcription of scaffold RNA 
and be required for silencing [30,31], although it is not known how their activities are 
functionally integrated. It is also not known how Pol V initiation sites are chosen, but they 
appear to be promoter independent [31]. Perhaps transcription by Pol II helps maintain open 
chromatin architecture at this site, and together with the resulting noncoding RNAs facilitates 
Pol V transcription initiation. Alternative possibility is that Pol II produces two distinct pools 
of transcripts, one of which is controlled by the exosome, and the exosome functions by 
regulating the Pol II transcripts that are distinct from the transcripts that are used in RdDM 
pathway. This possibility would be very interesting to examine, particularly in light of the 
yeast exosome involvement in gene silencing through regulation of cryptic transcripts, 
 59 
transcripts originating from divergent promoters and read-through transcripts [4,57,60,61]. 
How the Arabidopsis exosome complex and the exosome controlled ncRNAs facilitate 
recruitment of chromatin modifiers in order to enforce silencing through repressive histone 
modifications remains an interesting topic of future studies. We suggest that the exosome may 
coordinate the transcriptional interplay of RNA polymerases Pol II and Pol V to achieve the 
right level of transcriptional repression of heterochromatic loci (Figure 2.8). 
  
In summary, our data suggest that the exosome likely acts in a parallel pathway to 
RdDM pathways in gene silencing, possibly affecting the transcriptional interplay of different 
RNA polymerases to modulate repression of heterochromatic sequences. The mechanisms 
that link this RNA metabolic complex, the epigenetic modification of histone methylation, 
and heterochromatic silencing in plants remain to be elucidated. Our results indicate that there 
is no one-size-fits-all pathway or mechanism that exclusively governs silencing of all loci; 
rather, different loci and different players in RdDM interact with different pathways and are 
silenced by different, likely overlapping mechanisms. The positional effects and the 
surrounding landscape most likely also play important roles in the choice of silencing 
mechanisms and the interplay between them. This may reflect the crucial importance of 
silencing in developmental gene regulation and in maintenance of genomic stability by 
suppression of invasive sequences. 
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Figure 2.8 Model for the role of the exosome complex in gene silencing at solo LTR in 
Arabidopsis. 
The process of silencing of the solo LTR locus is substantially more complex than portrayed 
here, but for simplicity only the factors examined in this study are represented. No 
modifications to the prevailing views on the roles of Pol IV, Pol V, Pol II, RDR2, DCL3, and 
AGO4 are proposed [9,28,30,31,62]. 
A. The exosome complex is not involved in the regulation of quality or quantity of siRNAs 
produced from region A. RNA Pol II (green) generates transcripts from region B of solo LTR. 
It is also possible that Pol II transcribes both A and B regions in opposite directions. Either 
Pol II transcripts or the process of transcription from region B recruits Pol V (blue), 
complexed with AGO4 and siRNA, to the scaffold-producing region B. Due to the sequence 
complementarity between siRNAs, which are derived from region A only, and the portion of 
the scaffold transcripts that partially overlaps with region A, AGO4/ siRNA RISC localizes to 
region A and recruits other components of the silencing machinery. Both Pol II and Pol V 
were implicated in producing region B scaffold transcripts [30,31]. Exosome is not involved 
in siRNA metabolism and does not contribute to DNA methylation. Exosome participates in 
controlling the amount of top transcripts emanating from the scaffold-producing region B of 
solo LTR, and thus may contribute to the repression of region A through regulating the level 
of region B transcripts. The exosome associates with transcripts emanating from the scaffold-
producing region and plays a role in locus silencing through maintaining or establishing 
chromatin structure. 
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B. More than one silencing pathway controls the solo LTR locus. The exosome associates 
with transcripts emanating from the adjacent scaffold-producing region, and plays a role in 
locus silencing through maintaining or establishing chromatin structure by affecting histone 
methylation (H3K9), in parallel to the RdDM pathway, which affects siRNAs and DNA 
methylation (“M” in red hexagons). 
 
 
 
 
MATERIALS AND METHODS 
Plant materials and growth conditions 
iRNAi lines of exosome subunits RRP4 and RRP41, RNA Pol IV 
(SALK_128428.20.10, nrpd1a-3, nrpd1-3), RNA Pol V (SALK_029919, nrpd1b-11, nrpe1-
11), RDR2  ( SAIL_1277808, rdr2-1), and DCL3 ( SALK_005512.38.70.x0, dcl3-1) mutants 
were described previously [1,27,33,87]. rrp41 iRNAi/nrpd1-3, rrp41 iRNAi/nrpe1-11, rrp4 
iRNAi/nrpd1-3,and rrp4 iRNAi/nrpe1-11 double mutants were obtained by crossing of rrp41 
iRNAi and rrp4 iRNAi with nrpd1/nrpe1-11 line. rrp41 iRNAi/dcl3-1, rrp41 iRNAi/rdr2-1 
double mutants were obtained by crossing. 
The alleles of the rrp6l2-2 and rrp6l3-1 correspond to SALK_011429 and 
SALK_122492 lines, respectively. The rrp6l1-2 allele was isolated from the University of 
Wisconsin BASTA population. The ecotype background is Col-0 for all Salk alleles and Ws 
for University of Wisconsin alleles. To induce iRNAi, seedlings were germinated and grown 
for 7 days on ½x MS plates with 8 mM 17β-estradiol, as described before [1]. 
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Library construction 
Total RNA was isolated from 7-day-old seedlings using the mirVana miRNA isolation 
kit (Ambion) according to the manufacturer’s protocol. The total RNA sample was used for 
sequencing library construction using the Small RNA sample Prep v1.5 kit and TruSeq Small 
RNA Sample Prep kit (Illumina, San Diego, CA) according to the manufacturer's instructions. 
The smRNA libraries were sequenced using the Illumina Genetic Analyzer II (by DNA Core 
Facility, University of Missouri) and Illumina HiSeq 2000 (by Biotechnology Center, 
University of Wisconsin) according to the manufacturer's instructions. HiSeq 2000 
sequencing reads were demultiplexed using Casava v 1.8 (by Bioinformatic Resource Center, 
University of Wisconsin) before further bioinformatic analysis 
 
Bioinformatic Analysis of Small RNAs 
Data processing was done using available tools and custom in-house UNIX shell 
programming [43,77,88-91]. The raw sequences in Illumina GAIIx and demultiplexed HiSeq 
2000 sequencing reads were trimmed removing adapter using “fastx_clipper” in the FASTX-
Toolkit (version 0.0.13) [92] and smRNAs with lengths between 15- and 32-nt were selected 
and mapped to the Arabidopsis genomic sequences (TAIR9 version) using BOWTIE (version 
0.12.7) [93]. Reads that failed to perfectly map to the nuclear genome with no mismatches, 
and reads present in fewer than two counts were discarded. All Arabidopsis lines used in this 
study carried iRNAi cassette transgenes used for inactivation of either RRP4 or RRP41 
exosome subunit genes [1]. These silencing cassettes generate a number of 21-, 22- and 24-nt 
silencer sequences corresponding to RRP4 or RRP41 genes (mapping to AT1G03360 and 
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AT3G61620 loci), respectively. Therefore, silencer sequences produced from iRNAi 
transgenes were filtered out from each library and libraries were analyzed separately to ensure 
accurate interpretations. The remaining smRNA reads, termed FLR for filtered reads, were 
used for further analysis.  
Each library was normalized either to the total number of mapped non-redundant reads 
or to the total number of non-redundant filtered reads (FLR), multiplied by 106 (rpm, reads per 
million). Both methods of normalizations were compared and found to produce results which 
lead to identical interpretations, therefore, only data analyzed using filtered reads are 
presented in this study.  
Classification of small RNAs was performed by BEDTools (v2.10.0) [94] and in-
house UNIX shell programming using the following databases: TAIR9 annotations for protein 
coding and non-coding features (tRNA, rRNA, ncNRA, miRNA, snRNA, snoRNA, and 
transposable elements [50]), miRBase (release 18) [51] or mature miRNA annotations. Some 
smRNAs match more than one annotation category; therefore the sum of the numbers is 
bigger than the total input number.  
The small RNA reads with 20 to 25nt length were calculated and plotted versus the 
sum of their normalized reads per million (rpm). The relative frequencies of each 5' terminal 
nucleotide of the small RNAs were calculated (Table S2.1 and S2.2) and represented 
graphically.  
Repetitive genomic features were classified using TAIR9 Tandem Repeat Finder 
(version 4.04) [95] and Inverted Repeat Finder (version 3.05) [96]. Annotation of dispersed 
repeats was done with Repeat Masker (version 3-3-0) [97]. 
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For analysis of locus-specific expression of smRNAs (solo LTR, AtSN1, IGN5, 
REG3, and REG4), the expressed normalized reads per million (rpm) were calculated for 
respective genomic locus and locus-specific datasets were plotted for comparisons. 
 
RNA analysis 
Total RNA was isolated from 7-day-old seedlings using the Trizol method. For RT-
qPCR, 1-4 µg of total RNA digested with DNase I (Fermentas) was reverse transcribed 1 hour 
either at 50°C (for oligo-dT primer) or 55°C (for specific primers) using 60-100 units 
SuperScript III Reverse Transcriptase (Invitrogen). Transcripts were quantified by RT-qPCR 
using the comparative threshold cycle method (ΔΔCt, primers listed in Table S2.4), using 
Actin2 (At3g18780) as endogenous reference. Polyacrylamide Northern Blot analyses were 
performed as described [25].  
 
Analysis of DNA methylation  
Genomic DNA was isolated from 7-day-old seedlings using a DNeasy kit (QIAGEN). 
The methylation analysis using DNA sensitive methylation enzymes was followed as 
described [27,31,78].  
 
Chromatin Immunoprecipitation (ChIP) assays 
ChIP was performed as described [98]. One gram of 7-day-old seedlings was used for 
each experiment. All ChIP experiments were reproduced at least twice on each of the two or 
more biological replicates. The normalization was done relative to input using [99]. Anti-
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RNA Pol II (ab817) and anti-H3K9me2 (ab1220) were obtained from Abcam, and anti-
H3K27me1 antibody from Upstate. An equal amount of chromatin not treated with antibody 
was used as the mock antibody control. The ChIPed DNA was purified using PCR 
purification kit (Fermentas) before being used for qPCR. The primer sets used for the PCR are 
listed in Supplemental Table S2.4. 
 
RNA Immunoprecipitation (RIP)  
RIP assays were performed by adapting an existing protocol [100]. Transgenic plants 
expressing TAP-tagged RRP41 at physiological levels [1] were used in the experiment. Two 
grams of 2-week-old seedlings were collected and fixed with 1% formaldehyde. For RRP41-
RNA complex purification, the chromatin solution was incubated overnight with prewashed 
IgG Sepharose 6 Fast Flow (GE Healthcare) at 4°C. Immunoprecipitated RNA was purified 
with phenol: chloroform and cDNA synthesis was performed using SuperScript III reverse 
transcriptase (Invitrogen) and random hexamers (Promega). The primer sets used for the PCR 
are listed in Supplemental Table S2.4. 
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SUPPORTING INFORMATION 
 
 
 
Figure S2.1 iRNAi silencer sequences produced by rrp4-i and rrp41-i cassettes in 
response to estradiol treatment. 
(A, B) 20-25 nt smRNAs corresponding RRP4 in rrp4-i (A) and corresponding and to RRP4 
in rrp41-i (B) depletion mutants profiled based on the length of the reads. 
(C, D) 20-25 nt smRNAs produced from in rrp4-i (C) and rrp4-i (D) depletion mutants 
profiled based on both their length and the terminal 5’ nucleotide. The major silencer 
sequences are 5’U and 5’A smRNA species. 
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Figure S2.2 miRNA families, miR-158a, miR-158b, miR-860, miR-823, miR-841, miR-
5561 and variations in sequence length. 
miRNA families miR-158a, miR-158b, miR-860, miR-823, miR-841, and miR-5561  and 
variations in sequence length in each family. smRNAs mapped to matching mature miR-158, 
miR-860, miR-823, miR-841, and miR-5561  sequences [51](miRBase release 18) were 
plotted versus the sum of their normalized reads per million (rpm) from smRNA libraries 
constructed from RRP4, rrp4-i ,RRP41, rrp41-i, RRP41/nrpd1, rrp41 iRNAi/nrpd1, RRP4 
iRNAi/nrpe1 and rrp41 iRNAi/nrpd1  mutants. 
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Figure S2.3 Effects of exosome deletion, RdDM, and other mutants. 
(A) Diagrams of IGN5, REG 3 and REG 4 genomic loci, based on analysis of transcription 
units by Wierzbicki et al. (2008) [1,31]. Region A corresponds to siRNA producing region, 
region B corresponds to scaffold producing region in both loci, red lines mark regions 
amplified in RT-PCR and qPCR. 
(B). 20-25 nt smRNAs produced from region A of IGN5 in rrp4-i, rrp41-i exosome depletion 
lines and RdDM mutants. All locus-specific datasets of 20-25nt smRNAs are plotted versus 
the sum of their normalized reads per million (rpm). 
(C, D) RT-PCR analysis of RRP6L1 and RRP6L mRNA expression in rrp6L1 and rrp6L2 
insertion mutants. 
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TABLE S2.1 Summary of smRNA sequence reads in the libraries of RRP4, rrp4-i, 
RRP41, and rrp41-i plants. 
 
A. Small RNA 
sequences features RRP4 rrp4-i RRP41 rrp41-i 
Raw Reads 48,848,664 41,897,506 18,217,874 30,118,453 
Genomic hitb (15-32nt) 23,222,335 20,408,013 8,912,897 17,861,373 
Filtered Reads (FLR) c 
(15-32nt) 17,896,184 16,681,585 6,840,563 13,329,388 
Filtered Reads (FLR) c 
(20-25nt) 7,995,398 7,462,442 3,373,336 5,827,569 
20nt (rpmd) 56,779 61,700 61,958 60,375 
21nt (rpmd) 149,454 155,805 169,095 156,558 
22nt (rpmd) 42,790 40,550 42,034 37,603 
23nt (rpmd) 53,225 49,405 55,146 43,083 
24nt (rpmd) 115,166 115,729 138,115 118,003 
25nt (rpmd) 29,351 24,157 26,790 21,576 
20-25nt 5'-A (rpmd) 110822.79 118685.72 129359.67 116130.84 
20-25nt 5'-U (rpmd) 167456.48 183996.42 206030.26 210829.18 
20-25nt 5'-G (rpmd) 76642.43 78219.49 75100.25 69328.39 
20-25nt 5'-C (rpmd) 91911.55 93202.23 82868.18 68293.83 
          
B. Annotation 
Classes (rpmd) RRP4 rrp4-i RRP41 rrp41-i 
Protein-coding 
featuresf         
gene 572635 (19.6%) 627475 (20%) 682069 (20.1%) 683551 (19.9%) 
CDS 15366 (0.5%) 41821 (1.3%) 18279 (0.5%) 71252 (2.1%) 
exon 595927 (20.4%) 649022 (20.7%) 705726 (20.8%) 743068 (21.6%) 
mRNA 95590 (3.3%) 126446 (4%) 118597 (3.5%) 186473 (5.4%) 
five prime UTR 1166 (0%) 1291 (0%) 1365 (0%) 3280 (0.1%) 
three prime UTR 11952 (0.4%) 12971 (0.4%) 16126 (0.5%) 13714 (0.4%) 
protein 33815 (1.2%) 62861 (2%) 43236 (1.3%) 99259 (2.9%) 
pseudogene 3435 (0.1%) 3245 (0.1%) 4164 (0.1%) 3763 (0.1%) 
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Non-coding RNAsf         
tRNA 47915 (1.6%) 48831 (1.6%) 50643 (1.5%) 52851 (1.5%) 
rRNA 100604 (3.4%) 90726 (2.9%) 89173 (2.6%) 72057 (2.1%) 
ncRNA 11809 (0.4%) 13583 (0.4%) 16371 (0.5%) 16889 (0.5%) 
miRNA 365545 (12.5%) 397568 (12.7%) 465941 (13.7%) 446439 (13%) 
snRNA 571 (0%) 509 (0%) 597 (0%) 1286 (0%) 
snoRNA 724 (0%) 937 (0%) 697 (0%) 4789 (0.1%) 
Transposable element 254064 (8.7%) 265853 (8.5%) 318542 (9.4%) 298024 (8.7%) 
Annotated Repeatsg         
Tandem repeats 88865 (3%) 85721 (2.7%) 100774 (3%) 88920 (2.6%) 
Inverted repeats 122732 (4.2%) 130538 (4.2%) 161840 (4.8%) 154009 (4.5%) 
Dispersed repeats 594212 (20.4%) 574788 (18.3%) 605038 (17.8%) 501914 (14.6%) 
Totalh 2,916,925 3,134,187 3,399,178 3,441,537 
     a7-Day plant seedlings.     
bsequences with adapter and a minimum of one perferct genomic locus 
csequences with raw seqeunce count >1, sequences expressed in respective iRNAi loci were removed. 
dsequences were normalized by the number of total read with perfect genomic matches (read per million = 
rpm) 
eReads per million (percetage against total). 
fsmall RNAs mapped to TAIR9 annotation information. 
gTandem repeats were annotated by tandem repeat finder 4.04 program, Inverted repeats were annotated by 
inverted repeat finder 3.05 program, and Dispersed repeats were annotated by RepeatMasker 3-3-0. 
hSome small RNAs can match more than one categoriesof the sequences listed so the sum of the numbers is 
bigger than the input total number. 
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TABLE S2.2 Summary of smRNA sequence reads in the libraries of RRP41/nrpd1, 
rrp41-i/nrpd1, RRP41/nrpe1, rrp41-i/nrpe1, RRP41/rdr2, rrp41-i/rdr2, RRP41/dcl3 and 
rrp41-i/dcl3 plants. 
 
A. smRNA 
sequences RRP41 x nrpd1 rrp41-i x nrpd1 RRP41 x nrpe1 rrp41-i x nrpe1 
Raw Reads 34,564,629 30,812,122 29,475,534 16,851,922 
Genomic hitb 
(15-32nt) 20,408,748 19,396,657 17,406,070 9,763,622 
Filtered Reads 
(FLR) c (15-32nt) 17,045,892 15,179,754 12,997,695 6,594,620 
Filtered Reads 
(FLR) c (20-25nt) 5,944,764 5,944,153 4,796,540 2,150,712 
20nt (rpmd) 66,828 72,918 62,621 64,257 
21nt (rpmd) 138,797 152,131 129,145 114,997 
22nt (rpmd) 44,521 49,613 44,404 41,654 
23nt (rpmd) 34,659 41,645 41,050 33,485 
24nt (rpmd) 36,108 41,167 60,854 44,208 
25nt (rpmd) 27,838 34,110 30,956 27,530 
20-25nt 5'-A 
(rpmd) 51,864.81 56,546.77 66,974.64 92,017.28 
20-25nt 5'-U 
(rpmd) 132,348.49 147,940.54 123,415.65 173,970.90 
20-25nt 5'-G 
(rpmd) 70,354.78 84,557.23 75,175.02 89,425.17 
20-25nt 5'-C 
(rpmd) 94,215.43 106,408.71 103,602.83 121,874.04 
          
B. Annotation 
Classes (rpmd) RRP41 x nrpd1 rrp41-i x nrpd1 RRP41 x nrpe1 rrp41-i x nrpe1 
Protein-coding 
featuresf         
gene 481016 (23.3%) 536265 (23.2%) 473710 (20.6%) 575026 (17.4%) 
CDS 5500 (0.3%) 13103 (0.6%) 8440 (0.4%) 274006 (8.3%) 
exon 478384 (23.2%) 535258 (23.1%) 490683 (21.4%) 708144 (21.4%) 
mRNA 20518 (1%) 34061 (1.5%) 59628 (2.6%) 349339 (10.6%) 
five prime UTR 746 (0%) 931 (0%) 787 (0%) 1533 (0%) 
three prime UTR 9269 (0.4%) 12809 (0.6%) 11526 (0.5%) 10567 (0.3%) 
protein 8845 (0.4%) 17903 (0.8%) 17917 (0.8%) 308353 (9.3%) 
pseudogene 409 (0%) 588 (0%) 1138 (0%) 788 (0%) 
Non-coding 
RNAsf         
tRNA 50872 (2.5%) 60774 (2.6%) 64203 (2.8%) 56639 (1.7%) 
rRNA 124183 (6%) 136911 (5.9%) 116455 (5.1%) 110522 (3.3%) 
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ncRNA 9036 (0.4%) 11102 (0.5%) 8827 (0.4%) 9944 (0.3%) 
miRNA 278107 (13.5%) 299029 (12.9%) 254155 (11.1%) 216095 (6.5%) 
snRNA 596 (0%) 558 (0%) 399 (0%) 851 (0%) 
snoRNA 550 (0%) 779 (0%) 438 (0%) 2356 (0.1%) 
Transposable 
element 44329 (2.1%) 49110 (2.1%) 105602 (4.6%) 81976 (2.5%) 
Annotated 
Repeatsg         
Tandem repeats 33628 (1.6%) 38214 (1.7%) 64593 (2.8%) 61281 (1.9%) 
Inverted repeats 49205 (2.4%) 48695 (2.1%) 80972 (3.5%) 68421 (2.1%) 
Dispersed 
repeats 466653 (22.6%) 517945 (22.4%) 538329 (23.4%) 474857 (14.3%) 
Totalh 2,061,845 2,314,035 2,297,803 3,310,698 
 
    C. smRNA 
sequences RRP41 x rdr2 rrp41-i x rdr2 RRP41 x dcl3 rrp41-i x dcl3 
Raw Reads 28,799,510 27,830,614 27,305,350 29,370,612 
Genomic hitb 
(15-32nt) 15,993,118 14,771,888 15,024,746 12,920,539 
Filtered Reads 
(FLR) c (15-32nt) 15,751,643 14,193,105 14,267,913 11,241,550 
Filtered Reads 
(FLR) c (20-25nt) 4,986,622 4,228,304 4,663,141 5,493,835 
20nt (rpmd) 89,110 74,720 85,838 152,010 
21nt (rpmd) 68,564 75,088 88,868 140,391 
22nt (rpmd) 47,490 47,645 52,042 65,878 
23nt (rpmd) 41,007 37,530 39,286 45,394 
24nt (rpmd) 35,794 32,937 31,358 35,752 
25nt (rpmd) 34,613 29,992 29,435 49,283 
20-25nt 5'-A 
(rpmd) 61,150.38 61,601.67 65,598.66 109,442.03 
20-25nt 5'-U 
(rpmd) 126,174.20 128,367.12 140,210.63 293,839.46 
20-25nt 5'-G 
(rpmd) 59,004.32 56,817.38 59,055.66 74,383.69 
20-25nt 5'-C 
(rpmd) 70,279.46 74,498.22 62,086.09 61,077.79 
      
D. Annotation 
Classes (rpmd) RRP41 x rdr2 rrp41-i x rdr2 RRP41 x dcl3 rrp41-i x dcl3 
Protein-coding 
featuresf         
gene 302113 (19.2%) 320029 (18.8%) 292098 (17.1%) 508485 (16.5%) 
CDS 36540 (2.3%) 81424 (4.8%) 36778 (2.2%) 149849 (4.9%) 
exon 292795 (18.7%) 334046 (19.7%) 302669 (17.7%) 585103 (19%) 
mRNA 50808 (3.2%) 96782 (5.7%) 76898 (4.5%) 251851 (8.2%) 
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five prime UTR 869 (0.1%) 963 (0.1%) 998 (0.1%) 3099 (0.1%) 
three prime UTR 3152 (0.2%) 3509 (0.2%) 3654 (0.2%) 6969 (0.2%) 
protein 45410 (2.9%) 90686 (5.3%) 47864 (2.8%) 176773 (5.7%) 
pseudogene 1044 (0.1%) 716 (0%) 1682 (0.1%) 3507 (0.1%) 
Non-coding 
RNAsf         
tRNA 87222 (5.6%) 91755 (5.4%) 89455 (5.2%) 175753 (5.7%) 
rRNA 117440 (7.5%) 110694 (6.5%) 98062 (5.7%) 99548 (3.2%) 
ncRNA 13487 (0.9%) 13963 (0.8%) 15769 (0.9%) 29282 (0.9%) 
miRNA 35566 (2.3%) 32435 (1.9%) 37277 (2.2%) 65061 (2.1%) 
snRNA 206 (0%) 240 (0%) 176 (0%) 711 (0%) 
snoRNA 123 (0%) 188 (0%) 165 (0%) 1068 (0%) 
Transposable 
element 29371 (1.9%) 29822 (1.8%) 107833 (6.3%) 220418 (7.1%) 
Annotated 
Repeatsg         
Tandem repeats 20707 (1.3%) 19135 (1.1%) 37619 (2.2%) 56283 (1.8%) 
Inverted repeats 42819 (2.7%) 46895 (2.8%) 77781 (4.6%) 136189 (4.4%) 
Dispersed 
repeats 489904 (31.2%) 425234 (25%) 478905 (28.1%) 616229 (20%) 
Totalh 2,061,845 2,314,035 2,297,803 3,310,698 
 
    a7-Day plant 
seedlings.     
bsequences with adapter and 
a minimum of one perferct 
genomic locus   
csequences with raw seqeunce count >1, sequences expressed in respective iRNAi loci were 
removed. 
dsequences were normalized by the number of total read with perfect genomic matches (read per 
million = rpm) 
eReads per million (percetage against total). 
fsmall RNAs mapped to TAIR9 annotation information. 
gTandem repeats were annotated by tandem repeat finder 4.04 program, Inverted repeats were 
annotated by inverted repeat finder 3.05 program, and Dispersed repeats were annotated by 
RepeatMasker 3-3-0. 
hSome small RNAs can match more than one categoriesof the sequences listed so the sum of 
the numbers is bigger than the input total number. 
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TABLE S2.3 Expression profiling of known mature miRNAs in the libraries of RRP4, 
rrp4-i, RRP41, and rrp41-i mutant plants. Normalized reads number (reads per million, 
rpm) of known miRNAs were listed.  
 
ID RRP4 rrp4-i RRP41 rrp41-i 
ath-miR156a 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156b 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156c 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156d 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156e 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156f 2,334.69 2,277.90 3,698.23 2,440.62 
ath-miR156g 0.89 1.14 0.44 1.43 
ath-miR156h 0.00 0.00 0.00 0.15 
ath-miR156i 0.00 0.00 0.00 0.00 
ath-miR156j 2.12 2.40 4.82 2.40 
ath-miR157a 1,672.98 2,026.49 2,750.21 3,016.04 
ath-miR157b 1,672.98 2,026.49 2,750.21 3,016.04 
ath-miR157c 1,672.98 2,026.49 2,750.21 3,016.04 
ath-miR157d 65.15 66.90 107.45 63.84 
ath-miR158a 13,419.40 18,081.38 19,940.03 23,127.39 
ath-miR158b 19.67 56.23 11.40 49.06 
ath-miR159a 4,381.05 4,693.74 6,416.14 4,646.12 
ath-miR159b 2,126.88 1,872.84 2,813.51 1,713.66 
ath-miR159c 0.84 0.90 1.75 0.23 
ath-miR160a 177.19 183.44 243.25 191.16 
ath-miR160b 177.19 183.44 243.25 191.16 
ath-miR160c 177.19 183.44 243.25 191.16 
ath-miR161.1 437.08 480.71 591.33 622.83 
ath-miR161.2 59.79 77.57 108.32 125.36 
ath-miR162a 159.59 174.62 225.57 165.50 
ath-miR162b 159.59 174.62 225.57 165.50 
ath-miR163 225.36 234.03 455.52 346.75 
ath-miR164a 4.97 7.31 6.43 8.33 
ath-miR164b 4.97 7.31 6.43 8.33 
ath-miR164c 0.89 1.14 0.73 0.68 
ath-miR165a 14,691.18 14,711.91 17,350.18 13,088.00 
ath-miR165b 14,691.18 14,711.91 17,350.18 13,088.00 
ath-miR166a 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166b 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166c 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166d 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166e 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166f 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR166g 51,296.58 55,591.72 63,727.06 62,092.72 
ath-miR167a 233.74 250.94 389.88 186.66 
ath-miR167b 233.74 250.94 389.88 186.66 
ath-miR167c 0.89 1.68 0.88 1.50 
ath-miR167d 101.64 90.16 124.26 92.35 
ath-miR168a 206.36 236.91 287.84 249.52 
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ath-miR168b 206.36 236.91 287.84 249.52 
ath-miR169a 2.46 2.64 5.99 3.38 
ath-miR169b 0.00 0.60 0.44 0.30 
ath-miR169c 0.00 0.60 0.44 0.30 
ath-miR169d 0.22 0.24 0.44 0.23 
ath-miR169e 0.22 0.24 0.44 0.23 
ath-miR169f 0.22 0.24 0.44 0.23 
ath-miR169g 0.22 0.24 0.44 0.23 
ath-miR169g* 0.00 0.00 0.00 0.00 
ath-miR169h 4.69 3.36 5.70 1.88 
ath-miR169i 4.69 3.36 5.70 1.88 
ath-miR169j 4.69 3.36 5.70 1.88 
ath-miR169k 4.69 3.36 5.70 1.88 
ath-miR169l 4.69 3.36 5.70 1.88 
ath-miR169m 4.69 3.36 5.70 1.88 
ath-miR169n 4.69 3.36 5.70 1.88 
ath-miR170 2.91 2.46 4.97 3.45 
ath-miR171a 29.95 30.93 49.85 24.38 
ath-miR171b 5.87 5.04 9.65 7.13 
ath-miR171c 5.87 5.04 9.65 7.13 
ath-miR172a 3.30 1.92 4.82 0.98 
ath-miR172b 3.30 1.92 4.82 0.98 
ath-miR172b* 1.01 0.72 2.19 0.15 
ath-miR172c 0.00 0.00 0.00 0.00 
ath-miR172d 0.00 0.00 0.00 0.00 
ath-miR172e 0.00 0.00 0.00 0.23 
ath-miR173 21.35 16.90 29.68 20.03 
ath-miR1886.1 0.61 0.78 0.88 1.35 
ath-miR1886.2 11.12 12.59 18.57 16.28 
ath-miR1886.3 0.00 0.00 0.00 0.00 
ath-miR1887 0.00 0.00 0.00 0.00 
ath-miR1888 0.61 0.36 1.02 0.68 
ath-miR1888b 0.00 0.12 0.00 0.15 
ath-miR2111a 0.61 0.54 0.44 0.38 
ath-miR2111a* 0.67 0.54 0.29 0.00 
ath-miR2111b 0.61 0.54 0.44 0.38 
ath-miR2111b* 0.22 0.30 0.58 0.23 
ath-miR2112-3p 0.00 0.00 0.00 0.15 
ath-miR2112-5p 0.22 0.00 0.44 0.23 
ath-miR2933a 0.00 0.00 0.00 0.00 
ath-miR2933b 0.00 0.00 0.00 0.00 
ath-miR2934-3p 0.00 0.00 0.00 0.00 
ath-miR2934-5p 0.11 0.00 0.00 0.68 
ath-miR2936 0.00 0.00 0.00 0.00 
ath-miR2937 0.00 0.00 0.00 0.00 
ath-miR2938 0.00 0.00 0.00 0.00 
ath-miR2939 0.00 0.00 0.00 0.00 
ath-miR319a 598.23 772.47 954.16 1,118.43 
ath-miR319b 598.23 772.47 954.16 1,118.43 
ath-miR319c 45.43 49.28 68.42 51.47 
ath-miR3434 0.22 0.00 0.00 0.15 
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ath-miR3434* 0.00 0.00 0.00 0.00 
ath-miR3440b-3p 0.00 0.00 0.00 0.00 
ath-miR3440b-5p 0.11 0.00 0.29 0.68 
ath-miR390a 161.32 168.09 253.78 201.66 
ath-miR390b 161.32 168.09 253.78 201.66 
ath-miR391 1.23 1.02 0.58 1.20 
ath-miR3932a 0.00 0.00 0.00 0.00 
ath-miR3932b 0.00 0.00 0.00 0.00 
ath-miR3933 0.00 0.00 0.00 0.00 
ath-miR393a 17.88 22.72 35.82 22.58 
ath-miR393b 17.88 22.72 35.82 22.58 
ath-miR394a 26.49 24.58 36.84 22.51 
ath-miR394b 26.49 24.58 36.84 22.51 
ath-miR395a 1.68 3.24 2.05 2.33 
ath-miR395b 2.96 5.46 3.07 3.83 
ath-miR395c 2.96 5.46 3.07 3.83 
ath-miR395d 1.68 3.24 2.05 2.33 
ath-miR395e 1.68 3.24 2.05 2.33 
ath-miR395f 2.96 5.46 3.07 3.83 
ath-miR396a 140.81 189.25 232.88 238.35 
ath-miR396b 992.67 1,108.95 1,318.90 1,165.84 
ath-miR397a 3.52 3.42 2.19 4.35 
ath-miR397b 135.78 195.54 186.39 151.69 
ath-miR398a 0.84 1.02 1.46 0.68 
ath-miR398b 6,470.26 6,172.08 8,895.61 6,219.42 
ath-miR398c 6,470.26 6,172.08 8,895.61 6,219.42 
ath-miR399a 27.77 33.33 63.45 8.93 
ath-miR399b 123.43 129.72 255.83 95.05 
ath-miR399c 123.43 129.72 255.83 95.05 
ath-miR399d 1.68 1.44 3.51 0.00 
ath-miR399e 0.00 0.00 0.00 0.00 
ath-miR399f 2.01 3.24 4.68 0.53 
ath-miR400 15.25 17.98 23.68 18.31 
ath-miR401 0.00 0.00 0.00 0.00 
ath-miR402 0.00 0.00 0.88 0.23 
ath-miR403 1,018.82 1,167.63 1,563.91 1,451.98 
ath-miR404 0.00 0.00 0.00 0.00 
ath-miR405a 0.00 0.00 0.00 0.00 
ath-miR405b 0.00 0.00 0.00 0.00 
ath-miR405d 0.00 0.00 0.00 0.00 
ath-miR406 0.00 0.00 0.00 0.00 
ath-miR407 0.00 0.00 0.00 0.00 
ath-miR408 286.82 317.96 337.55 229.12 
ath-miR413 0.00 0.00 0.00 0.00 
ath-miR414 0.00 0.00 0.00 0.00 
ath-miR415 0.00 0.00 0.00 0.00 
ath-miR416 0.00 0.00 0.00 0.00 
ath-miR417 0.00 0.00 0.00 0.00 
ath-miR418 0.00 0.00 0.00 0.00 
ath-miR419 0.00 0.00 0.00 0.00 
ath-miR420 0.00 0.00 0.00 0.00 
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ath-miR4221 0.00 0.00 0.00 0.00 
ath-miR4227 0.00 0.00 0.00 0.00 
ath-miR4228 0.00 0.00 0.00 0.00 
ath-miR4239 0.00 0.00 0.00 0.00 
ath-miR4240 0.00 0.00 0.00 0.00 
ath-miR4243 0.00 0.00 0.00 0.00 
ath-miR426 0.00 0.00 0.00 0.00 
ath-miR447a 0.84 1.02 1.46 0.23 
ath-miR447a.2 34.03 33.09 53.36 35.64 
ath-miR447b 0.84 1.02 1.46 0.23 
ath-miR447c-3p 0.00 0.00 0.00 0.00 
ath-miR447c-5p 0.00 0.00 0.00 0.00 
ath-miR472 18.33 17.02 21.20 23.03 
ath-miR5012 1.12 1.32 1.32 1.28 
ath-miR5013 0.00 0.00 0.00 0.00 
ath-miR5014-3p 0.00 0.18 0.00 0.53 
ath-miR5014-5p 0.00 0.00 0.00 0.00 
ath-miR5015a 0.00 0.00 0.00 0.00 
ath-miR5016 0.00 0.00 0.00 0.00 
ath-miR5017 0.00 0.00 0.00 0.00 
ath-miR5018 0.00 0.00 0.00 0.00 
ath-miR5019 0.00 0.00 0.00 0.00 
ath-miR5020a 0.00 0.00 0.00 0.00 
ath-miR5020b 0.00 0.00 0.00 0.00 
ath-miR5020c 0.00 0.00 0.00 0.00 
ath-miR5021 0.00 0.00 0.00 0.00 
ath-miR5022 0.00 0.00 0.00 0.00 
ath-miR5023 0.00 0.00 0.00 0.00 
ath-miR5024-3p 1.29 1.20 2.05 1.73 
ath-miR5024-5p 0.00 0.00 0.00 0.00 
ath-miR5025 0.00 0.00 0.00 0.00 
ath-miR5026 2.35 2.28 3.07 9.08 
ath-miR5027 0.00 0.00 0.00 0.53 
ath-miR5028 0.34 0.78 0.44 2.10 
ath-miR5029 0.00 0.00 0.00 0.00 
ath-miR5628 0.00 0.00 0.00 0.00 
ath-miR5629 0.00 0.00 0.00 0.00 
ath-miR5630a 0.00 0.00 0.00 0.00 
ath-miR5630b 0.00 0.00 0.00 0.00 
ath-miR5631 0.00 0.00 0.00 0.00 
ath-miR5632 0.11 0.00 0.00 0.00 
ath-miR5633 0.00 0.00 0.00 0.00 
ath-miR5634 1.23 0.90 1.90 0.00 
ath-miR5635a 0.00 0.00 0.00 0.00 
ath-miR5635b 0.00 0.00 0.00 0.00 
ath-miR5635c 0.00 0.00 0.00 0.00 
ath-miR5635d 0.00 0.00 0.00 0.00 
ath-miR5636 0.00 0.00 0.00 0.00 
ath-miR5637 0.78 0.36 1.02 0.23 
ath-miR5638a 0.00 0.00 0.00 0.00 
ath-miR5638b 0.34 0.24 0.29 0.75 
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ath-miR5639 0.00 0.00 0.00 0.00 
ath-miR5640 0.50 0.18 1.46 0.15 
ath-miR5641 0.00 0.00 0.00 0.00 
ath-miR5642a 0.45 0.30 0.29 1.43 
ath-miR5642b 0.45 0.30 0.29 1.43 
ath-miR5643a 0.00 0.00 0.00 0.15 
ath-miR5643b 0.00 0.00 0.00 0.15 
ath-miR5644 0.00 0.00 0.00 0.00 
ath-miR5645a 0.00 0.00 0.00 0.00 
ath-miR5645b 0.00 0.00 0.00 0.00 
ath-miR5645c 0.00 0.00 0.00 0.00 
ath-miR5645d 0.00 0.00 0.00 0.00 
ath-miR5645e 0.00 0.00 0.00 0.00 
ath-miR5645f 0.00 0.00 0.00 0.00 
ath-miR5646 0.00 0.00 0.00 0.00 
ath-miR5647 0.00 0.00 0.00 0.00 
ath-miR5648-3p 0.11 0.00 0.00 0.00 
ath-miR5648-5p 0.22 0.12 0.29 0.00 
ath-miR5649a 0.00 0.12 0.00 0.00 
ath-miR5649b 0.00 0.12 0.00 0.00 
ath-miR5650 0.28 0.36 0.29 1.50 
ath-miR5651 18.55 42.56 33.62 100.98 
ath-miR5652 0.22 0.42 0.00 0.45 
ath-miR5653 0.45 0.36 0.44 0.30 
ath-miR5654 0.95 0.66 0.44 0.15 
ath-miR5655 0.00 0.00 0.00 0.00 
ath-miR5656 0.00 0.00 0.44 0.15 
ath-miR5657 0.00 0.00 0.00 0.00 
ath-miR5658 0.00 0.00 0.00 0.00 
ath-miR5659 0.11 0.00 0.44 0.30 
ath-miR5660 0.00 0.00 0.00 0.00 
ath-miR5661 0.00 0.00 0.00 0.00 
ath-miR5662 0.00 0.00 0.00 0.00 
ath-miR5663 0.22 0.54 0.00 0.60 
ath-miR5664 0.00 0.00 0.00 0.00 
ath-miR5665 0.00 0.00 0.00 0.00 
ath-miR5666 0.00 0.00 0.00 0.00 
ath-miR771 0.00 0.00 0.00 0.00 
ath-miR773 0.00 0.00 0.00 0.60 
ath-miR773b 0.00 0.00 0.00 0.00 
ath-miR773b* 0.00 0.00 0.00 0.00 
ath-miR774 0.00 0.00 0.00 0.23 
ath-miR774b 0.00 0.00 0.00 0.00 
ath-miR774b* 0.00 0.00 0.00 0.00 
ath-miR775 21.40 20.08 25.44 27.83 
ath-miR776 0.00 0.00 0.00 0.00 
ath-miR777 3.80 3.78 6.72 5.55 
ath-miR778 0.00 0.00 0.00 0.00 
ath-miR779.1 0.00 0.00 0.00 0.00 
ath-miR779.2 20.79 22.42 26.02 30.01 
ath-miR780.1 0.00 0.00 0.00 0.00 
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ath-miR780.2 0.00 0.00 0.00 0.15 
ath-miR781 9.61 13.73 18.57 25.73 
ath-miR781b 9.61 13.73 18.57 25.73 
ath-miR782 0.00 0.00 0.00 0.00 
ath-miR783 0.00 0.00 0.00 0.00 
ath-miR822 43.70 50.47 55.84 56.87 
ath-miR823 9.00 11.93 9.36 27.91 
ath-miR824 11.90 16.37 22.22 23.93 
ath-miR825 4.25 4.26 6.72 4.28 
ath-miR826 0.00 0.00 0.00 0.00 
ath-miR827 176.13 153.28 207.15 43.74 
ath-miR828 0.17 0.00 0.00 1.20 
ath-miR829.1 5.31 11.69 3.51 9.23 
ath-miR829.2 0.11 0.12 0.29 0.90 
ath-miR830 0.00 0.12 0.00 0.00 
ath-miR830* 2.01 2.28 4.53 2.48 
ath-miR831 0.00 0.12 0.00 0.00 
ath-miR832-3p 0.00 0.00 0.00 0.00 
ath-miR832-5p 0.00 0.00 0.00 0.00 
ath-miR833-3p 0.00 0.00 0.00 0.00 
ath-miR833-5p 0.89 0.54 0.44 1.05 
ath-miR833b 0.00 0.00 0.00 0.15 
ath-miR834 0.00 0.00 0.00 0.00 
ath-miR835-3p 0.00 0.00 0.00 0.00 
ath-miR835-5p 0.00 0.00 0.00 0.38 
ath-miR836 0.00 0.00 0.00 0.00 
ath-miR837-3p 0.00 0.00 0.00 0.00 
ath-miR837-5p 0.22 0.12 0.00 0.00 
ath-miR838 1.79 1.38 2.19 1.58 
ath-miR839 2.18 1.20 2.19 2.25 
ath-miR840 2.85 2.16 2.19 1.95 
ath-miR841 12.80 16.07 11.40 33.61 
ath-miR841b 1.29 1.80 1.46 2.70 
ath-miR841b* 0.00 0.00 0.00 0.15 
ath-miR842 1.23 1.44 1.61 2.48 
ath-miR843 1.51 2.52 3.07 3.53 
ath-miR844 0.00 0.12 0.29 0.15 
ath-miR844* 1.79 3.18 3.51 1.88 
ath-miR845a 0.78 0.60 1.02 1.73 
ath-miR845b 0.00 0.00 0.00 0.00 
ath-miR846 64.65 101.55 68.12 106.38 
ath-miR847 2.57 2.10 3.51 1.20 
ath-miR848 0.84 1.68 1.46 1.80 
ath-miR849 0.00 0.00 0.00 0.00 
ath-miR850 2.91 2.82 2.78 4.80 
ath-miR851-3p 0.00 0.00 0.00 0.00 
ath-miR851-5p 0.11 0.24 0.00 0.00 
ath-miR852 0.78 1.02 1.61 1.43 
ath-miR853 0.22 0.24 0.29 0.38 
ath-miR854a 0.00 0.00 0.00 0.00 
ath-miR854b 0.00 0.00 0.00 0.00 
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ath-miR854c 0.00 0.00 0.00 0.00 
ath-miR854d 0.00 0.00 0.00 0.00 
ath-miR854e 0.00 0.00 0.00 0.00 
ath-miR855 0.00 0.00 0.00 0.00 
ath-miR856 0.00 0.00 0.00 0.00 
ath-miR857 1.40 1.56 2.34 2.33 
ath-miR858 6.37 6.89 8.33 19.88 
ath-miR858b 2.18 3.00 3.51 9.08 
ath-miR859 0.11 0.18 0.00 0.53 
ath-miR860 2.46 4.02 5.12 22.96 
ath-miR861-3p 9.05 9.83 12.72 7.05 
ath-miR861-5p 0.00 0.00 0.00 0.00 
ath-miR862-3p 0.00 0.00 0.00 0.00 
ath-miR862-5p 0.11 0.00 0.29 0.60 
ath-miR863-3p 1.29 2.28 0.73 4.05 
ath-miR863-5p 0.00 0.18 0.00 0.68 
ath-miR864-3p 0.00 0.00 0.00 0.00 
ath-miR864-5p 0.00 0.12 0.29 0.15 
ath-miR865-3p 0.00 0.00 0.00 0.00 
ath-miR865-5p 0.11 0.18 0.29 0.68 
ath-miR866-3p 0.00 0.00 0.00 0.23 
ath-miR866-5p 0.00 0.00 0.00 0.00 
ath-miR867 0.00 0.00 0.00 0.00 
ath-miR868-3p 0.00 0.00 0.00 0.00 
ath-miR868-5p 0.00 0.00 0.00 0.00 
ath-miR869.1 0.00 0.00 0.00 0.00 
ath-miR869.2 8.83 22.30 10.96 16.05 
ath-miR870 0.00 0.00 0.29 0.00 
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TABLE S2.4 Oligonucleotides used in this study. 
Oligo 
number Sequences (5' to 3') 
Oligomer 
name Application Size Reference 
o1725 AAAAGCTGGGGTTTTATGAATGG   
Actin2 RT-PCR & qPCR 190 bp Chekanova et al (2007) o1726 TGGGACTAAAACGCAAAACG 
o2585 ACCAACGTGCTGTTGGCCCAGTGGTAAATC ATS15-AtSN1(A)  RT-PCR region A 
and chop PCR 240bp 
Wierzbicki et al 
(2008) o2586 AAAATAAGTGGTGGTTGTACAAGC AtSN1-F4-AtSN1(A)  
o2587 TGAGAGATTTACCACTGGGCCAACA A205-AtSN1(B)  RT-PCR of region 
B 180bp 
Wierzbicki et al 
(2008) o2588 TGAGGAGCTCAACACATAAATGGCAATA A206-AtSN1(B)  
o2591 CCAGAAATTCATCTTCTTTGGAAAAG  A122-AtSN1  
qPCR of region A 85 bp Wierzbicki et al (2008) o2592 GCCCAGTGGTAAATCTCTCAGATAGA  A123-AtSN1 
o2720 ACTTAATTAGCACTCAAATTAAACAAAATAAGT  AtSN1-F   
Chop PCR 322 bp Onodera et al (2005) o2721 TTTAAACATAAGAAGAAGTTCCTTTTTCATCTAC  AtSN1-R  
o2669 ATCAATTATTATGTCATGTTAAAACCGATTG solo LTR A221  RT-PCR of region 
A 203bp 
Wierzbicki et al 
(2008) o2670 TGTTTCGAGTTTTATTCTCTCTAGTCTTCATT solo LTR A222  
o2671 CATATAACCGAAGCCGAAGGATGTGAAA solo LTR A217  RT-PCR of region 
B 282bp 
Wierzbicki et al 
(2008) o2672 CAGAAACCTAAGGAACCATTACACGCTAAACC solo LTR A218  
o2827 GGATAGAGATGAATGATGGATAATGACA  solo LTR-F A142 qPCR of region A 73 bp Wierzbicki et al (2008) o2828 TTATTTTGATCAGTGTTATAAACCGGATA  solo LTR-R A143 
o3859 CCTCTCAATCTCCGTTTCTTATGTA solo LTR-F 
qPCR of region B 82 bp This study. o3860 ACCATTACACGCTAAACCAACTAGA solo LTR-R  
o3133 ATAAAACTCGAAACAAGAGTTTTCTTATTGCTTTC 
solo LTR C-
A211  Chop PCR 351 bp Wierzbicki et al (2008) o3134 TAATGGTATTATTTTGATCAGTGTTATAAACCGGA 
solo LTR C-
A212 
o3129 AATGCATTACAAAAACCTTCTGA Solo LTR-F   
Chop PCR 446 bp This study. o3130 GGATTCACGATTAGAGAACGTAGA Solo LTR-R  
o2675 CGCAGCGGAATTGACATCCTATC IGN5 A293  RT-PCR & q-PCR 
of region A 190bp 
Wierzbicki et al 
(2008) o2676 TCGGAAAGAGACTCTCCGCTAGAAA IGN5 A294 
o2736 AAGCCCAAACCATACACTAATAATCTAAT IGN5-F A193 
qPCR of region B 58 bp Wierzbicki et al (2008) o2737 CCGAATAACAGCAAGTCCTTTTAATA IGN5-R A194  
o2897 TTGCCCTCCTCCAATTCAT  No3-F  
qPCR of ChIP 79 bp This study. o2898 ATGAAAATAATGAGGATGCAGAG No3-R 
o2901 TGATATATTTTTCTCAACGATTCC  No4-F  
qPCR of ChIP 92 bp This study. o2902 ATCTTCGATCCAAACTTGAAAT No4-R 
o1027 TAGAGCTCCCTTCAATCCAAA miR-159a miRNA Nothern Blot   
Chekanova et al 
(2007) 
o1029 TAGATCATGCTGGCAGCTTCA miR-167a miRNA Nothern Blot   
Chekanova et al 
(2007) 
o1030 GTGATTTCTCTCTGCAAGCGAA miR-173a miRNA Nothern Blot   
Chekanova et al 
(2007) 
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CHAPTER 3 
CHARACTERIZATION OF THE SUB-GROUP OF SMRNAS PRODUCING GENOMIC 
LOCI AFFECTED BY THE DEFECT IN ARABIDOPSIS EXOSOME COMPLEX  
 
Keywords: Arabidopsis; exosome; smRNAs; transposons; RdDM; heterochromatin silencing  
 
ABSTRACT 
The exosome complex regulates a broad range of RNA species in eukaryotes and also 
functions in transcriptional gene silencing in a sequence- and locus-specific manner. 
However, the evidence addressing the relationship between the exosome complex and 
smRNAs that maintain heterochromatic state remains limited. To uncover the possible subset 
of smRNA-generating genomic loci that could be regulated by the Arabidopsis exosome 
complex, we utilized a different computational approach to re-examine our previously 
sequenced smRNA populations in the mutants of the exosome core complex subunits, 
AtRRP4 and AtRRP41.  
Indeed, we uncovered the previously undetected subset of smRNA-generating loci that 
are regulated by the Arabidopsis exosome complex. Although this subset of genomic loci 
accounted for a very small proportion of all genomic loci, their location was specific to the 
certain genomic regions. We found that RRP41-downregulated clusters area highly enriched 
in pericentromeric regions. In contrast, RRP41-upregulated clusters were dispersed across the 
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entire chromosomes length. While we observed that the majority of the RRP41-
downregulated smRNA-generating loci also exhibited dependence on the components in the 
RdDM pathway in smRNA production, we isolated a small proportion of the loci that were 
independent of RNA Pol IV and Pol V activities. When we analyzed these smRNA-
generating loci, which were independent of RNA Pol IV and Pol V activities and were down-
regulated in AtRRP41 mutant only, we found that many of these loci harbor specific types of 
transposons, such as DNA/MuDR and LTR/Gypsy elements.  
Our data suggest that while the exosome complex does not appear to control the 
expression of smRNA level in Arabidopsis, in accord with our previous observations (Chapter 
2), the exosome complex may play a role in providing an additional layer of control of 
smRNAs expression from specific limited subset of genomic regions and thus allow precise 
and dynamic management of smRNAs level necessary for proper activity in heterochromatin 
silencing in these regions 
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  RESULTS 
Identification of small group of smRNA-generating TE (3-4%) regulated by the exosome 
using features specific analysis 
Previously, using whole-genome tiling array analysis we found that the majority of 
transcripts upregulated in the depletion mutants of the core subunits of Arabidopsis exosome, 
RRP4 and RRP41, originate from the repeats, intergenic, and siRNA generating regions 
known to be regulated by smRNAs through RdDM pathway [1]. When we analyzed several 
known heterochromatic loci regulated by RdDM and combined our analysis with profiling 
genome-wide populations of smRNAs in the Arabidopsis exosome depletion mutants [2],we 
found that, to our surprise, the Arabidopsis exosome complex was not involved in smRNA 
metabolism on a global scale, unlike it had been reported in fission yeast [3]. However, 
epigenetic mechanisms and smRNA pathways are known to function not only in the 
sequence-specific but also in the locus-specific manner. Therefore, we could not exclude the 
possibility that the Arabidopsis exosome may control a small number of smRNA precursor 
transcripts at a few specific loci, which would have been missed in our previous studies where 
we used features- specific and sequence-specific approaches.  
To investigate a possible subset of loci that could be controlled by the Arabidopsis 
exosome complex, we analyzed the previously sequenced smRNA populations in the 
inducible RNAi (iRNAi) mutants of the Arabidopsis exosome complex, RRP4, rrp4-i, 
RRP41, rrp41-i, RRP41/nrpd1, rrp41-i/nrpd1, RRP41/nrpe1, rrp41-i/nrpe1. Two core 
subunits of Arabidopsis exosome complex were examined in this report, including RRP4 and 
RRP41 (RRP4 and RRP41 correspond to the iRNAi lines grown without estradiol and rrp4-i 
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and rrp41-i correspond to lines grown on estradiol-containing medium). The smRNA libraries 
were generated and sequenced as previously described, and the raw sequences were processed 
and normalized using the same method [2]. 
Majority of functional/mature smRNAs in Arabidopsis are 20-25nt in length. To first 
visualize the mature population of smRNAs (20-25nt) in a non-bias fashion globally as a 
function of expression level and genomic coordinates, the Arabidopsis chromosomes were 
binned into non-overlapping 5kb clusters and quantified an expression of 20-25nt smRNAs in 
each cluster. Expression of smRNAs in each cluster was plotted as a heatmap on all five 
chromosomes and compared between mutants (Figure 3.1). RRP4 and RRP41 correspond to 
the iRNAi lines grown without estradiol; rrp4-i and rrp41-i correspond to iRNAi mutants 
grown on estradiol-containing medium to induce the RNAi-mediated knockdown of RRP4 
and RRP41, respectively; nrpd1 and nrpe1 were mutants of the RNA Pol IV and RNA Pol V, 
respectively. RRP41/nrpd1 and RRP41/nrpe1 were double mutants grown without estradiol, 
thus correspond to nrpd1 and nrpe1 single mutants, where rrp41-i/nrpd1 and rrp41-1/nrpe1 
were double mutants grown on estradiol-containing medium to induce the RNAi-mediated 
knockdown of RRP41. The outer annotation track (in red) highlights the position of coding 
genes and the track next to it (in green) highlights the position of transposons (TEs) along the 
Arabidopsis chromosomes (Figure 3.1).  
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Figure 3.1 Heatmap representation of smRNA expression. Expression of 20-25 nt 
smRNA in the mutants of the exosome complex components and RdDM mutants. 
Arabidopsis chromosomes were binned into non-overlapping 5kb clusters and an expression 
of 20-25nt smRNAs was quantified in each cluster. Expression of smRNAs in each cluster 
was plotted as a heatmap on all five chromosomes and compared between mutants. RRP4 and 
RRP41 correspond to the iRNAi lines grown without estradiol. rrp4-i and rrp41-i correspond 
to iRNAi mutants grown on estradiol-containing medium to induce the RNAi-mediated 
knockdown of RRP4 and RRP41, respectively. nrpd1 and nrpe1 are mutants of the RNA Pol 
IV and  RNA Pol V, respectively. RRP41/nrpd1 and RRP41/nrpe1 are double mutants grown 
without estradiol, thus correspond to nrpd1 and nrpe1 single mutants. rrp41-i/nrpd1 and 
rrp41-i/nrpe1 are double mutants grown on estradiol-containing medium to induce the RNAi-
mediated knockdown of RRP41. The outer annotation track (in red) highlights the position of 
coding genes along the Arabidopsis chromosomes. The track next to it (in green) highlights 
the position of transposons (TEs).  
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Majority of smRNAs are highly expressed from the centromeric and pericentromeric 
regions. The RNA Pol IV is known to be responsible for producing >90% of 24nt siRNAs in 
Arabidopsis [4,5]. In accord with it, we observed that smRNAs are highly expressed from the 
centromeric and pericentromeric regions of all libraries except for RRP41/nrpd1 and rrp41-
i/nrpd1 (Figure 3.1). The largest subunit, NRPD1, of RNA Pol IV is silenced in nrpd1 mutant 
lines; therefore, the significant repression of smRNAs originating from the centromeric 
regions was observed there, as shown in the tracks of both the single and double mutant of Pol 
IV (labeled on the tracks as RRP41/nrpd1 and rrp41-i/nrpd1, respectively). Similar to our 
previous observations, we found that exosome defects (rrp4-i, rrp41-i) do not lead to global 
changes in smRNA population on a genome-wide scale when compared to corresponding 
controls (RRP4 and RRP41).  
Majority of smRNAs in Arabidopsis originate from transposable elements (TEs) and 
repeats. Therefore, we reasoned that, if Arabidopsis exosome subunits, RRP4 and RRP41, 
regulate a small group of smRNAs, these smRNAs will likely be originated from TEs. We 
allowed the smRNAs to be mapped at maximum capacity in the genome since TE are largely 
composed of repetitive sequences. Then, we specifically quantified the smRNAs expression in 
each individual TE there was identified in Arabidopsis Information Resource (TAIR9). As 
expected, we found that the majority of TEs exhibited from no to insignificant changes within 
2 fold (96-97% of total TE loci) in smRNA expression when comparing exosome mutants, 
rrp4-i and rrp41-i, to the corresponding controls (Figure 3.2 A and B). However, we found 
that a small subset of smRNA-generating TEs was affected upon exosome depletion. The 4% 
of total TEs were significantly up- or down-regulated upon RRP4 depletion and 3% of total 
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TEs were significantly up- or down-regulated upon RRP41 depletion, which were not 
detected in our previous analysis (Figure 3.2 A and B). Therefore, using different approach 
we were able to find out that there is a small subset of smRNAs that could be regulated by the 
exosome complex. 
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Figure 3.2  The efect of exosome depletion in smRNA generating transposable 
elements (TE) and genomic clusters. 
(A-B) TE: (A) Number of TE loci impacted upon depletion of the exosome subunit RRP4. (B) 
Number of TE loci impacted upon depletion of the exosome subunit RRP41.  
(C-H) Genomic clusters. (C, E, G) Number of genomic clusters impacted upon depletion of 
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the exosome subunit RRP4; (D, F, H) Number of genomic clusters impacted upon depletion 
of the exosome subunit RRP41. (C, D) represent the 15-32nt smRNA-generating clusters; (E, 
F) represent the 24nt smRNA-generating clusters; and (G, H) represent the 21nt smRNA-
generating clusters. 
 
The number of impacted loci is based on the ratio of summed smRNA abundances per locus. 
For each loci/cluster, we compared the number of smRNA reads per million (RPM) of RRP4 
(or RRP41) to the number of smRNA RPM of rrp4-i (or rrp41-i). The ratio of rrp4-i vs. 
RRP4 (or rrp41-i vs. RRP41) is used to present up-regulated loci when the RPM of rrp4-i (or 
rrp41-i) libraries is greater than that in RRP4 (or RRP41) libraries (shown as positive values). 
The ratio of RRP4 vs. rrp4-i (or RRP41 vs. rrp41-i) is used to present down-regulated loci 
when the RPM of RRP4 or RRP41 is greater than that in rrp4-i or rrp41-i libraries 
respectively (shown as negative values).  
 
 
 
 
 
Identification of a small subset of smRNA-regenerating loci affected upon RRP4 and 
RRP41 depletion using proximity-base algorithm   
Next we set out to investigate the smRNA-generating clusters that are affected upon 
exosome subunits, RRP4 and RRP41, depletion on the genome-wide scale. To isolate the 
‘hidden’ subset of smRNA loci potentially regulated by the Arabidopsis exosome complex, 
we adapted a different method build based on a proximity-based algorithm [6], termed 
“clustering analysis” and combined it with the previously utilized genomic features specific 
method [2]. The feature-specific method summed and normalized all the smRNA mapped to a 
genomic region based on its genomic feature (as the described above in Figure 3.2A and B). 
These features could be transposons, repeats, coding genes, etc. Specifically, the feature-
specific method provided the advantages of dissecting complex genomic data based on the 
already known functional genomic features, which usually represent different functional 
characteristics. In contrast, the clustering method quantifies the smRNA expression within 
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individual genomic regions without considering the genomic characteristics of each region in 
an unbiased fashion. 
Using each method independently provides practical ways to compare the genomic 
regions across different libraries. However, combining these methods in a step-wise matter, as 
a hybrid approach, allowed us to (i) first identify the smRNA-generating genomic regions that 
are specifically regulated by the Arabidopsis exosome complex on the genome-wide level 
without having any bias towards genomic features, and (ii) to cross compare the identified 
genomic clusters with the known genomic features, such as TEs on the second step, thus 
allowing us to dissect the characteristics of the genomic clusters that are regulated by the 
Arabidopsis exosome complex.  
Based on the result of the clustering analysis, we found that smRNA expression was 
insignificantly affected in majority of the genomic clusters in response to exosome depletion 
in all three smRNA size groups (15-32nt, 21nt and 24nt) (Table 3.1 and Figure 3.2 C to H), 
and this result was consistent with our previous report [2]. However, we also identified a 
small subset of genomic loci, which their smRNA expression is affected in the absence of 
Arabidopsis exosome complex, RRP4 and RRP41 (Table 3.1, Figure 3.2 C to H). As shown 
in Figure 3.2C to H, majority of the 15-32nt small RNA-generating loci were not impacted in 
exosome depletion, with 93-96% of the clusters showing less than 2-fold differences to the 
control. Reciprocally, 2.2-4.2% of total small RNA-generating loci were upregulated and 1.7-
2.8% of clusters were downregulated upon depletion of exosome rrp4 and rrp41 (≥ 3 fold 
changes). We obtained the similar results when we applied the same analysis to 21nt and 24nt 
smRNA- generating clusters (Table 3.1 and Figure 3.2C to H).  
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Table 3.1 Summary of smRNA-generating clusters upon depletion of exosome subunits, RRP4 
and RRP41.   
(A) 
15-32nt smRNAs 24nt smRNAs 21nt smRNAs 
RRP4 RRP41 RRP4 RRP41 RRP4 RRP41 
“smRNA-generating loci” 
Number of clusters with minimal smRNA 
expression requirement (Both control and 
exosome depletion have ≥ 5 raw counts) =  
50,008 41,595 43,661 35,663 6,223 4,100 
“Exosome-independent clusters” 
Numbers of clusters that shows minimal 
changes between control and exosome 
depletion (within 1-2 fold changes) 
48,026 
(96.0%) 
38,705 
(93.1%) 
37,652 
(86.2%) 
27,412 
(76.9%) 
5,758 
(92.5%) 
3,547 
(86.5%) 
“Exosome downregulated clusters” 
Numbers of clusters that shows 
downregualtion upon exosome depletion (≥ 3 
fold) 
863 
(1.7%) 
1,154 
(2.8%) 
2,784 
(6.4%) 
4,687 
(13.1%) 
123 
(2.2%) 
208 
(5.1%) 
“Exosome upregulated clusters” 
Numbers of clusters that shows upregualtion 
upon exosome depletion (≥ 3 fold) 
1,119 
(2.2%) 
1,736 
(4.2%) 
3,225 
(7.4%) 
3,564 
(10.0%) 
329 
(5.3%) 
345 
(8.4%) 
        
(B) The number of impacted loci is based on 
the ratio of summed smRNA abundances per 
locus 
15-32nt smRNAs 24nt smRNAs 21nt smRNAs 
RRP4 RRP41 RRP4 RRP41 RRP4 RRP41 
D
ow
n-
re
gu
la
te
d 
-10* 19 42 517 780 6 16 
-9 6 6 117 121 4 3 
-8 10 10 141 169 0 3 
-7 9 16 183 203 2 8 
-6 18 39 210 323 7 4 
-5 62 55 278 482 7 11 
-4 155 214 493 747 18 31 
-3 584 772 845 1,862 92 132 
-2 4,612 5,628 3,375 7,121 756 614 
-1 15,594 14,990 11,835 10,046 1,703 1,086 
U
p-
re
gu
la
te
d 
1 21,818 12,021 17,485 6,524 2,066 1,147 
2 6,002 6,066 4,957 3,721 1,233 700 
3 840 1,127 1,050 1,268 206 174 
4 162 313 474 750 50 41 
5 43 123 313 463 21 29 
6 26 57 253 318 12 11 
7 11 41 170 186 5 18 
8 2 15 177 109 2 12 
9 5 3 109 86 3 6 
10* 30 57 679 384 30 54 
Note: Percentage in total smRNA-generating clusters (satisfy min smRNA expression per clusters).  
* Indicate the significantly up- or down- regulated clusters (≥ 10 fold changes in RPM).   
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The genomic distribution of smRNAs producing clusters that are affected upon RRP41 
depletion 
We previously identified the Arabidopsis cores subunit, AtRRP41, have the catalytic 
activity in vitro [1,7], and this feature is specific to the Arabidopsis exosome complex in 
comparison to what was shown in other system. Therefore, we were interested in 
characterizing the genomic distribution of smRNA-generating loci that were affected upon 
depletion of RRP41, which represent less than 13% of all the smRNA generating in the 
Arabidopsis genome (Table 3.1 and Figure 3.2E and F). We focused on 24nt smRNA 
generating clusters since the group of 24nt smRNAs contains the majority of all functional 
siRNAs in Arabidopsis. Also, we observed a clear preference toward regulating 24nt smRNA-
generating cluster in the exosome depletion line rrp41-i (Figure 3.2F and Table 3.1B). For 
the purpose of the analysis, we separated the genomic clusters that satisfied the minimal 
smRNA expression requirement into three categories: RRP41-independent clusters, RRP41-
upregualted clusters, and RRP41-downregulated clusters. First, we defined 27,412 clusters, 
which showed insignificant (within 2 fold difference in RPM) changes in smRNA expression 
between control (RRP41) and iRNAi (rrp41-i) mutant, as ‘RRP41-independent’ clusters. 
Second, we defined 3,564 clusters, which showed an increase in smRNA accumulation at 
least 3-fold or more in depletion of RRP41 as ‘RRP41-upregulated’ clusters. Third, we 
defined 4,687 clusters as ‘RRP41-downregulated’, since their 24nt smRNA accumulation 
was reduced at least 3-fold or more in depletion of RRP41.  
We found that the RRP41-independent clusters exhibit strong pericentromeric 
localizations and smoothly fanned out into both arms of the chromosomes (Figure 3.3A), 
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similar to the typical genomic distribution of smRNAs in wild type Arabidopsis plants. 
Second, we plotted the RRP41-downregualted and RRP41-upregulated clusters individually 
as a function of chromosomal location and fold differences of smRNA expression per clusters 
between control (RRP41) and the inducible mutant of RRP41 (rrp41-i) (Figure 3.3 B and C). 
We also overlaid the distribution of RRP41-independent clusters (shown on Figure 3.3A) on 
background to highlight the differences between exosome independent clusters and the 
clusters that are affected in exosome depletion mutant. We found that in contrast to RRP41-
independent clusters, majority of the RRP41-downregulated clusters were highly enriched 
precisely at the centromeric regions, especially on chromosome 3 (Figure 3.3C). 
Interestingly, there were a significant number of RRP41- downregulated clusters concentrated 
in the heterochromatin-dense regions near the centromeres and the pericentromeric regions, 
and a very small number of them located in the chromosomes arms (Figure 3.3C). In 
contrast, the distribution of RRP41-upregulated clusters exhibited somewhat different pattern 
compared to the other categories of clusters. For example, with exception in chromosome 2, 
the RRP41-upregulated clusters were no longer highly enriched around the centromeric 
regions; instead, the clusters dispersed across the genome almost equally well along the entire 
chromosome (Figure 3.3B). The genomic distribution pattern we observed for all three 
categories have similar result for clusters originated both from the Watson or Crick strands.  
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Figure 3.3 Genomic distribution of 20-25nt smRNA expressing regions significantly 
afected by depletion of RRP41 subunit.  
(A) Genomic distribution of smRNA expressing clusters that are not significantly efected in 
smRNA production by depletion of RRP41; (B) Genomic distribution of smRNA expressing 
clusters that are significantly up-regulated by depletion of RRP41; (C) Genomic distribution 
of smRNA expressing clusters that are significantly down-regulated by depletion of RRP41. 
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However, it is important to note that consistent with our previous report, a large 
number of 24nt-generating clusters are not generally regulated by the exosome complex [2]. 
Also, the RRP41-independent clusters exhibited a wide-range of genomic distribution 
compared to other two groups of clusters. The smRNAs generating from these clusters may be 
regulated by components in the smRNA pathway, independent of the exosome function. 
Together, these data suggested that although the Arabidopsis exosome complex has a minor 
effect in smRNA metabolism genome-wide, the exosome regulate smRNAs originate from 
specific subset of genomic loci differently. We speculate that the “correct” genomic 
localization might be necessary to define how these smRNAs are regulated by the exosome. 
In this minor subset of genomic locations, the exosome might provide an additional layer to 
regulate smRNA productions in addition to the known mechanisms.  
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MATERIAL AND METHODS 
Plant materials and growth conditions 
The inducible RNAi lines of exosome subunits RRP4 and RRP41, RNA Pol IV 
(SALK_128428.20.10, nrpd1a-3, nrpd1-3), RNA Pol V (SALK_029919, nrpd1b-11, nrpe1-
11), RDR2 (SAIL_1277808, rdr2-1), and DCL3 (SALK_005512.38.70.x0, dcl3-1) single 
mutants were described previously [1,2,8-10]. rrp41 iRNAi/nrpd1-3 and rrp41 iRNAi/nrpe1-
11 double mutants were obtained by crossing of rrp41 iRNAi with nrpd1/nrpe1-11 line. For 
iRNAi, seedlings were germinated and grown for 7 days on ½ MS plates with 8mM 17b-
estradiol, as described before.  
 
SmRNA data generation and analysis 
Small RNA libraries were constructed as described before [2], and the smRNA 
libraries were sequenced using the Illumina Genetic Analyzer II (by DNA Core Facility, 
University of Missouri) and Illumina HiSeq 2000 (by Biotechnology Center, University of 
Wisconsin) according to the manufacturer’s instructions. Data processing was done using 
available tools and custom in-house UNIX shell programming as described previously [2]. 
The raw sequences in Illumina GAIIx sequencing reads were trimmed removing adapter using 
“fastx_clipper” in the FASTX-Toolkit (version 0.0.13) [11] and smRNAs with lengths 
between 15 and 40 nt were selected and mapped to the Arabidopsis genomic sequences 
(TAIR9 version) using BOWTIE (version 0.12.7) [12]. Reads that failed to perfectly map to 
the nuclear genome with no mismatches were discarded and the reads produced from iRNAi 
silencer cassette were filtered out from each library. The remaining smRNA reads was 
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normalized to the total number of mapped reads multiplied by 106 (rpm, reads per million). 
Repetitive genomic features were annotated as described before for TAIR9 genomic 
sequences [2]. The repetitive genomic features were classified using Tandem Repeat Finder 
(version 4.04) [13], Inverted Repeat Finder (version 3.05) [14] and Repeat Masker (version 3-
3-0) [15].  
The analysis of smRNA producing genomic clusters was done using custom in-house 
UNIX shell programming. The data of smRNA transcriptomes were plotted as heatmap on all 
five chromosomes (total of ten smRNA transcriptome libraries). The circular heat map 
visualization of smRNA transcriptome was drawn using Circos [16]. SmRNA expression is 
represented in 10 kb blocks and the maximum value of the heat map is calibrated to the un-
estradiol treated iRNAi line of RRP41 (function as WT). For clustering analysis, Arabidopsis 
chromosomes were binned into non- overlapping 1kb clusters and an expression of 15-32nt, 
21nt and 24nt smRNAs were quantified separately in each cluster [6]. Arabidopsis TAIR9 
genome consists of 119,149 non-overlapping fixed size 1kb clusters in each DNA strand, a 
total of 238,298 clusters covering the complete nuclear genome (both Watson and Crick 
strands). Only the smRNA reads with a minimum of five raw counts were considered for 
further analysis. The expression of 15-32nt, 21nt and 24nt smRNAs mapped to each 1kb 
genomic cluster was normalized to the total number of mapped reads multiplied by 106(rpm, 
reads per million) and expression of smRNAs (in RPMs) produced from each individual 1kb 
cluster was then cross-compared between different mutant plants.  
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CHAPTER 4 
STRESS-INDUCED ENDOGENOUS SIRNAS TARGETING REGULATORY INTRON 
SEQUENCES IN BRACHYPODIUM 
 
Running head: siRNAs targeting regulatory intron sequences 
Keywords: smRNAs; abiotic stresses; splicing; splicing regulation; Brachypodium 
 
ABSTRACT 
Exposure to abiotic stresses triggers global changes in the expression of thousands of 
eukaryotic genes at the transcriptional and post-transcriptional levels. Small RNA (smRNA) 
pathways and splicing both function as crucial mechanisms regulating stress-responsive gene 
expression. However, examples of smRNAs regulating gene expression remain largely 
limited to effects on mRNA stability, translation, and epigenetic regulation. Also, our 
understanding of the networks controlling plant gene expression in response to environmental 
changes, and examples of these regulatory pathways intersecting, remain limited. 
Here, to investigate the role of smRNAs in stress responses we examined smRNA 
transcriptomes of Brachypodium distachyon plants subjected to various abiotic stresses. We 
found that exposure to different abiotic stresses specifically induced a group of novel, 
endogenous small interfering RNAs (stress-induced, UTR-derived siRNAs, or sutr-siRNAs) 
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that originate from the 3’UTRs of a subset of coding genes. Our bioinformatics analyses 
predicted that sutr-siRNAs have potential regulatory functions and that over 90% of sutr-
siRNAs target intronic regions of many mRNAs in trans. Importantly, a subgroup of these 
sutr-siRNAs target the important intron regulatory regions, such as branch point sequences, 
that could affect splicing.  
Our study indicates that in Brachypodium, sutr-siRNAs may affect splicing by 
masking or changing accessibility of specific cis-elements through base-pairing interactions to 
mediate gene expression in response to stresses. We hypothesize that this mode of regulation 
of gene expression may also serve as a general mechanism for regulation of gene expression 
in plants and potentially in other eukaryotes. 
 
INTRODUCTION 
Plants have evolved sophisticated mechanisms to adapt to environmental stresses, and 
abiotic stresses, such as heat, cold, and salinity, trigger changes in the expression of thousands 
of genes, with regulation at both the transcriptional and post-transcriptional levels [1-5]. 
However, our understanding of the interactions among the regulatory networks that control 
plant gene expression in response to environmental changes remains limited. 
One mechanism by which plants respond to environmental stress is by modifying gene 
expression through the activity of small RNAs (smRNAs) [3,6,7], including microRNAs 
(miRNAs) and small interfering RNAs (siRNAs), which differ in their biogenesis [8-11]. All 
smRNAs are incorporated into Argonaute (AGO) proteins; in the AGO complex, miRNAs 
repress their targets at primarily post-transcriptional levels through cleavage or translational 
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inhibition of their target RNAs [8-11] and siRNAs affect translation and cleavage of target 
RNAs similarly to miRNAs, but can also affect DNA methylation and histone modification of 
their targets [12-14]. 
Studies in Arabidopsis and other plants showed that miRNAs and siRNAs function in 
the responses to many different abiotic stresses [6,7,15-17]. In Brachypodium, miRNAs also 
function in the response to cold, dehydration, and pathogen infections, supporting the idea 
that smRNAs play a general role in protecting the plant from stresses [18,19]. Recent work 
also described a large and diverse population of stress-responsive nat-siRNAs derived from 
cis-natural antisense transcripts (cis-NATs) of biotic and abiotic stress-challenged rice, 
suggesting that nat- siRNAs may contribute to plant responses to environmental stresses 
[3,15,16,20]. In addition to regulating gene expression through RNA degradation and 
translational repression, the most prominent role of plant siRNAs is their function in siRNA-
dependent DNA methylation [12-14]. It was reported that abiotic stresses also induce changes 
in DNA methylation in various plant species [21-23], suggesting a link between responses to 
stresses and chromatin modifications in plants. More recently, 21 nt siRNAs induced in 
response to infection of Arabidopsis with the bacterial pathogen Pseudomonas syringae were 
implicated in triggering dynamic changes in DNA methylation [23], suggesting that stress-
triggered siRNAs could also possibly regulate gene expression by affecting chromatin 
compaction. 
Eukaryotes also regulate gene expression by regulating splicing of pre-mRNAs. 
Regulation of splicing (and smRNA pathways) in response to environmental stresses is 
particularly important since stresses trigger rapid, global changes in transcriptomes leading to 
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dramatic reprogramming of gene expression on many different levels and these post- 
transcriptional mechanisms can provide the rapid responses vital for survival of stresses 
[4,5,24,25]. Splicing, removal of introns and ligation of exons, is executed by the 
spliceosome, which consists of five small nuclear RNAs (snRNAs) and over 180 proteins, and 
pre- mRNA splicing is among the most highly-regulated processes in eukaryotes [26,27]. 
Most eukaryotic genes also undergo alternative splicing (AS), in which the spliceosome 
selects different pairs of splice sites in a pre-mRNA transcript to produce different mRNAs 
[28]. Indeed, recent high-throughput studies demonstrated that at least 95% of multi-exon 
genes in human, over 60% of intron-containing genes in Arabidopsis and over 40% of genes 
in rice produce alternatively spliced mRNAs [29-33]. A study of the transcriptome of 
Brachypodium plants detected only a few alternatively-spliced transcripts [34], but this 
number will most likely increase as more studies add data. Assembly of the spliceosome on 
pre-mRNAs occurs via step-wise recognition of the short sequences at the exon/intron 
boundaries by snRNAs through base-pairing interactions. While the three minimal core 
splicing motifs, the 5’ splice site (5’ss), the 3’ splice site (3’ss), and the branch point (BP) are 
present in every intron and are required for the splicing reaction, they are degenerate and lack 
sufficient information to determine the correct 5’ and 3’ pairs [26-28]. The additional 
information necessary for fidelity and efficiency of splicing process is also provided by 
numerous additional exonic/intronic cis- regulatory elements on the pre-mRNA molecule. 
These cis elements, collectively termed the ‘‘splicing code’’, are recognized by trans-acting 
regulatory proteins, which promote or repress splice site selection depending on their binding 
location and the surrounding sequence context [35-38]. RNA secondary structure also 
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contributes to regulate splicing by affecting splice site accessibility [39,40]. In addition to 
authentic constitutive and alternative splice sites, eukaryotic genes also contain cryptic splice 
sites not normally used for splicing and a large excess of so called “decoy” splice sites, the 
sequences that match the consensus splice site motifs as good as authentic sites, yet are rarely 
or never used in splicing [41,42]. Despite the large potential for errors due to (i) the 
degeneracy and variability of splice signals, (ii) the myriad possibilities for alternative 
splicing, (iii) the huge variety of positional and context-dependent regulatory cis elements 
governing recognition of splice sites, and (iv) the presence of numerous cryptic and decoy 
splice sites, the splicing process appears to occur with very high fidelity. Therefore, the 
splicing machinery must be able to distinguish authentic splice sites and also respond to 
regulatory cues that affect splicing. 
There is also an extensive crosstalk between splicing and other gene regulatory 
mechanisms [26,43]. Recent evidence suggests that the fidelity of splice site selection is 
governed not only by the interaction of snRNPs and non-snRNP factors with pre-mRNA but 
also by the factors associated with chromatin and the transcriptional machinery [26]. For 
example, chromatin features, such as DNA and chromatin modifications that alter chromatin 
compaction, also regulate splicing by affecting RNA Polymerase II elongation rate, thus 
modulating the binding of effector proteins, which in turn affects splicing [44-46]. DNA 
modifications and chromatin compaction are regulated through smRNA pathways in many 
eukaryotes [10,12,14]. The crucial functions of splicing and smRNA pathways in regulation 
of gene expression in eukaryotes indicate that these pathways may connect; however, 
examples of these two pathways intersecting remain limited. A few cases of regulation of 
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splicing by RNAi components have been reported in Drosophila and mammalian cells 
[44,47,48]. Ago proteins were also found to bind throughout the length of pre- mRNA 
transcripts in both smRNA-independent and smRNA-dependent manners, suggesting a 
connection between these two processes [48-50]. In addition, the RNAi machinery and 
siRNAs were also shown to be involved in regulation of alternative splicing through 
epigenetic mechanisms [43,44,47] and human RNAi components AGO1 and AGO2 were 
reported to affect alternative splicing by linking chromatin modifiers with the splicing 
machinery [44,46,47]. 
Although work in animal systems has provided intriguing hints on the potential roles 
of smRNAs in splicing, our understanding of their role in plants remains unclear. Recent work 
reported the presence of miRNA binding sites within introns of Arabidopsis and rice genes, 
suggesting that these miRNAs could participate in cleavage of pre-mRNAs [51]. 
Reciprocally, expression of miRNAs was shown to be affected by alternative splicing of the 
transcripts that serve as precursors of these miRNAs in Arabidopsis [52,53]. In two cases, 
heat stress and abscisic acid triggered changes in miRNA expression through AS [52,53]. 
However, there is no evidence so far suggesting that small regulatory RNAs, such as miRNAs 
or siRNAs, can directly regulate splicing in plants. 
Here, to investigate the role of smRNAs in stress responses, we examined the smRNA 
transcriptomes in Brachypodium plants challenged by various abiotic stresses. We found that 
a specific group of Brachypodium stress- responsive genes gives rise to a novel group of 24 nt 
smRNAs from their 3’UTRs and that these smRNAs have potential regulatory functions. 
Furthermore, our bioinformatics analyses indicate that over 90% of these smRNAs target 
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regulatory regions within introns, including branch point sequences that may affect splice-site 
selection and fidelity of splicing. 
 
RESULT 
Analysis of smRNA transcriptomes in Brachypodium plants under abiotic stress 
To profile the populations of smRNAs in the model monocot Brachypodium 
distachyon and examine their regulation in response to abiotic stresses, we conducted high-
throughput sequencing of smRNAs from plants exposed to four different abiotic stress 
conditions, cold, heat (air), heat (water immersion), and salt, in the wild type Brachypodium 
cultivar Bd21. For our experiments we used information from the literature to select two time-
points for stress durations, short and long, which differed for each stress: cold (6 and 24 
hours), heat-air (1 and 3 hours), heat-water (1 and 3 hours), and salt (48 hours) [54-56]. We 
generated small RNA libraries for Illumina sequencing from the leaves of Brachypodium 
plants subjected to stresses (Supplemental file 1: Table S4.1) and selected smRNAs between 
15 and 40 nt in length, which we mapped to the Brachypodium genome [57-59]. 
To characterize these smRNAs, we first analyzed and compared the genomic regions 
producing smRNAs in response to various stresses (Supplemental file 2: Supplementary 
information; Supplemental file 3 and 4: Figure S4.1 and S4.2). We then plotted the 
smRNA expression data as a heatmap on all five chromosomes, compared the stressed 
smRNA expression dataset with the smRNA expression from unstressed Bd21 plants (Figure 
4.1). This is the first graphical representation of stress-induced smRNA expression, on a 
whole-genome scale in Brachypodium plants. As expected, we observed that in both 
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unstressed and stressed Bd21 plants smRNAs are highly expressed from the centromeric and 
pericentromeric regions, which are known to be silenced through smRNA-dependent DNA 
methylation in plants. Also, consistent with previously published data, we found that 
smRNAs are highly expressed specifically from the telomeric region on chromosome 5 [58]. 
We then classified the smRNAs based on their size, level of expression, and genomic 
features. The majority of functional smRNAs in plants ranged from 20 to 25 nt. We found that 
the response to all stresses primarily affected the 20 nt and 24 nt smRNAs (Figure 4.2A). We 
also observed a similar trend when we examined smRNAs that correspond to predicted 
Brachypodium coding genes (Figure 4.2B). To further investigate the origin of smRNAs 
corresponding to coding genes, we examined the smRNAs that map to 5’UTRs and 3’UTRs 
of Brachypodium coding genes. We found that, for all the stress conditions used in our study, 
the exposure to stress led to a significant decrease in 20 nt smRNAs that map to 5’UTRs 
(Figure 4.2C), and a significant increase in smRNAs of all sizes that map to 3’UTRs of 
coding genes, with 24 nt smRNAs being the most abundant affected group (Figure 4.2D). We 
next examined the populations of smRNAs that map to 5’UTRs and analyzed the 5’UTR loci 
that exhibit significant decreases in production of 20 nt smRNAs. However, we found that 
only a few 5’UTRs showed this trend and the majority of affected 20 nt smRNAs correspond 
to Bradi1g05790, an unknown gene that shows sequence similarity only to putative 
chloroplast proteins in rice or maize and thus is likely specific to grasses. 
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Figure 4.1 Heat map representation of smRNA expression in response to stresses.  
Bd21, unstressed Brachypodium plants; Ss-48 salt stress; Cs-6 or Cs-24 cold stress, 6 or 24 
hours; HsA-1 or HsA-3 heat stress by air incubation, 1 or 3 hours; HsW-1or HsW-3 heat 
stress by water immersion, 1 or 3 hours. The outer track highlights the position of coding 
genes along the Brachypodium chromosomes. 3’UTRs track correspond to the positions of 
genes (along the chromosomes) that express sutr-siRNAs from their 3’UTRs. The target genes 
track corresponds to the positions of genes (along the chromosomes) that are targeted by sutr-
siRNAs. 
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Figure 4.2 Effect of abiotic stresses on Brachypodium smRNA populations. 
The distribution of smRNAs based on their length and expression level (RPM, reads per 
million). A. The expression of Brachypodium smRNAs in response to various stresses; B. The 
distribution of smRNAs mapped to Brachypodium coding genes; C. The distribution of 
smRNAs mapped to 5’UTRs of Brachypodium coding genes; D. The distribution of smRNAs 
mapped to 3’UTRs of Brachypodium coding genes. Bd21, unstressed Brachypodium plants; 
Cs, 6 or 24 hours of cold stress; HsA 1 or 3 hours of heat stress by air incubation; HsW, 1 or 3 
hours of heat stress by water immersion; Ss-48, salt stress. 
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smRNAs produced from 3’UTRs of stress-responsive coding genes 
We then decided to focus on smRNAs originating from the 3’UTRs of coding genes 
and the nature of the coding genes that give rise to them. To further examine the genes that 
show induction of smRNAs from their 3’UTRs in response to stresses, we used gene ontology 
(GO) classification, and chose for further, detailed analysis several specific loci that produce 
smRNAs in response to all the stresses used in this study (Supplemental file 1: Table S4.4). 
One of the examined loci was Bradi2g25050, a previously uncharacterized locus that encodes 
a member of the AP2-EREBP (ethylene-responsive element binding proteins) family of plant-
specific transcription factors, which regulate development and abiotic stress responses in 
Arabidopsis [60]. To characterize the smRNAs produced from the Bradi2g25050 3’UTR, we 
mapped these smRNAs at 2 nt resolution to the coding region of Bradi2g25050 (Figure 4.3A-
D), including an additional 2.5 kb of up- and down-stream sequences (Figure 4.3E-H). We 
found that all the smRNAs come from a short stretch of the Bradi2g25050 3’UTR. These 
smRNAs were produced only from the plus strand and were collinear with the Bradi2g25050 
transcript. Notably, all four different stress conditions used in our study triggered an identical 
pattern of smRNA production from the Bradi2g25050 3’UTR (Figure 4.3A-H). 
To examine the pattern of smRNA production from the 3’UTRs of other genes, we 
analyzed in detail the 3’UTRs of several additional genes that give rise to smRNAs in 
response to all applied stresses, Bradi4g11670, Bradi1g62460, Bradi1g20200 (Figure 4.4A-
D). All unique smRNAs originating from the 3’UTRs of these genes were mapped at 2 nt 
resolution to the 3’UTRs of their origin. We found that, similar to Bradi2g25050, all smRNAs 
originated only from a short stretch of each examined 3’UTR, 25 nt for the Bradi2g25050 
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3’UTR. Similarly, all smRNAs were produced only from the plus strand and were the same 
polarity as their predicted precursor transcripts (Figure 4.4A-D). When we analyzed smRNAs 
originating from these four 3’UTRs, we found that vast majority of them are 24 nt in length. 
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Figure 4.3 The pattern of smRNA production from the 3’UTR of Bradi2g25050 in 
response to various stresses. 
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(A-H) The region of Bradi2g25050 3’UTR that gives rise to smRNAs triggered by various 
stresses. (A-D) smRNAs produced from the Bradi2g25050 locus were mapped to its coding 
region. The peak in 3’UTR corresponds to the position of smRNAs that are triggered by 
various stresses. (E-H) smRNAs produced from the Bradi2g25050 region were mapped at a 
lower resolution to the genomic region comprising the coding region and additional 2.5kb up- 
and down-stream sequences. (A and E) Salt stress; (B and F) Cold stress, 6 hours and 24 
hours; (C and G) Heat stress air, 1 hour and 3 hours; (D and H) Heat stress by immersion in 
water, 1 hour and 3 hours. These plots show the smRNAs are produced from Bradi2g25050 in 
response to all applied stresses, and the pattern of smRNA production is identical for all 
stresses used in this study. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Characteristics of the smRNAs originating from the 3’UTRs of various genes 
in response to salt stress. 
(A) Bradi2g25050, (B) Bradi4g11670, (C) Bradi1g62460 and (D) Bradi1g20200. All unique 
smRNAs are shown mapped to 3’UTRs at 2nt resolution. All unique smRNAs triggered by 
salt stress are displayed according to their location along their respective 3’UTRs. The 
position of smRNAs relative to each respective 3’UTR is indicated on the x-axis. The level of 
each smRNA expression (in RPM) in response to salt stress is indicated on the y-axis. The 
light blue dotted line corresponds to the position and expression of smRNAs found in 
unstressed Bd21 plants. The dark blue dotted line corresponds to the position and the level of 
expression of smRNAs triggered by high salinity. 
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3’UTR-derived smRNAs with predicted targets 
Using Bradi2g25050 and the other genes described above as examples, we set out to 
isolate all 3’UTRs genome-wide that serve as precursors to smRNAs and also exhibit the 
same pattern of smRNA production in response to stresses as these four genes. To that end, 
we first isolated all 3’UTRs that could give rise to smRNAs in a collinear fashion with their 
precursor transcripts. Since the majority of smRNAs found to be triggered by stresses from 
the 3’UTRs of the four example genes are 24 nt in length, we then calculated the abundance 
of 24 nt smRNAs from each individual 3’UTR. For the subsequent analysis, we retained only 
the 3’UTRs that produce 24 nt smRNAs both in response to stresses and in the unstressed 
Bd21 plants. Next, we compared the smRNA expression triggered by individual stresses from 
each 3’UTR with smRNA expression (from identical 3’UTRs) in unstressed Bd21 plants and 
retained only the 3’UTRs that exhibit at least a 3-fold increase in production of 24 nt 
smRNAs in response to each stress. We then reasoned that, if these stress-induced smRNAs 
are functional, they should have targets within genes elsewhere in the genome. Therefore, we 
searched for their potential targets on the basis of sequence complementarity. Using this logic, 
we isolated the group of 3’UTRs that produce smRNAs with perfect complementarity to 
transcripts of other genes. 
Applying the algorithm written based on the set of rules outlined above to the whole 
genome, we identified a group of genes that, in response to stresses, can produce 24 nt 
smRNAs collinear with their precursor transcripts, and these 24 nt smRNAs have the potential 
to target products of other genes in trans (Figure 4.5A; Supplemental file 1: Table S4.5-11). 
Our analysis indicates that some stress-induced, 3’UTR-derived 24 nt smRNAs do not have 
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complementary targets. As an example, salt stress triggers production of 24 nt smRNAs from 
171 individual 3’UTRs of coding genes, but only 85 of these give rise to smRNAs with 
perfect complementarity to predicted targets elsewhere in the genome. We observed a very 
similar percentage for all stresses used in this study. Notably, in all stress treatments, the 
majority of 3’UTRs that satisfied the stringent parameters used to isolate them exhibit sharp 
increases, more than 10-fold, in induction of 24 nt smRNAs in response to stresses in 
comparison to unstressed plants (Figure 4.5B and Supplemental file 5: Figure S4.3). 
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Figure 4.5 Analysis of 3’UTRs of coding genes that give rise to smRNAs with predicted 
trans-targets. 
(A) Summary of the group of stress-responsive 3’UTRs that give rise to smRNAs with 
predicted trans-targets (see text for description of parameters). For example 85 salt stress-
responsive UTRs give rise to 24 nt smRNAs that are predicted to target the products of other 
coding genes in trans. (B) Fold difference in expression of smRNAs from 3’UTRs in 
response to salt stress; C-F. Cross-comparison of loci that show significant increase in 24 nt 
smRNAs with predicted targets in response to various stresses. Venn diagram demonstrates 
the number of smRNA generating 3’UTRs that are either stress-specific or common among 
different stress treatments. The comparison was done separately for short (C and E) or long 
(D and F) stress treatment. 
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Functional analysis of the genes producing smRNAs from their 3’UTRs 
To obtain more information on the pathways that govern the plant responses to 
different stresses, we used the groups of 3’UTRs that satisfied all of the above criteria (from 
mRNAs that increase in response to stress and produce smRNAs from their 3’ UTRs) in 
response to each individual stress and compared them between different stresses (Figure 
4.5C-F). This comparison was done separately for short (C and D) or long (E and F) stress 
time points. As a result we isolated a set of genes that have an increase in smRNA levels in 
response to all stresses, the sets of genes that overlap between different individual stresses, 
and the sets of genes that are specific to one individual type of stress (Figure 4.5C and E; 
Supplemental file 1: Table S4.12). The overlap between affected 3’UTRs (Figure 4.5D and 
F), suggests that similar smRNA pathways could be activated in response to different abiotic 
stresses (Figure 4.5D and F). The overall trend was very similar for short or long stress 
treatments. 
To obtain more information on the networks that govern the plant responses to stresses 
we also carried out the functional analysis of the genes producing smRNAs from their 
3’UTRs in response to different stresses. To this end, we subjected the genes producing 
smRNAs from their 3’UTRs to GO analysis. This analysis was performed independently for 
each individual stress and stress duration. The resultant GO terms were then examined to find 
which GO terms were enriched, and the results were visualized using REVIGO and 
Cytoscape applications (Figure 4.6, Supplemental Files 6: Figure S4.4 and Supplemental 
Files 1: Table S4.4) [61,62]. In the case of salt stress (Ss-48), a total of 171 coding genes 
were subjected to GO term analysis and 116 GO terms were used for the GO term enrichment 
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(Figure 4.6). The GO analysis of the genes producing smRNAs from their 3’UTRs indicated 
that similar biological processes are enriched among all stress conditions and in early and late 
stress durations (Figure 4.6, Supplemental Files 6: Figure S4.4 and Supplemental Files 1: 
Table S4.4). The enriched biological processes include various binding activities and, in 
particular, protein, DNA, RNA, chromatin and ATP binding. In addition to binding activities, 
the comparison of GO term enrichment between different kind of stresses indicates that RNA 
polymerase II activity and various membrane channel activity were enriched among all stress 
conditions (Figure 4.6, Supplemental Files 6: Figure S4.4 and Supplemental Files 1: 
Table S4.4). Interestingly, we found that H3K9 specific histone methyltransferase activity 
was specifically enriched only following heat stress by water immersion (Supplemental Files 
6: Figure S4.4 E and F). These results suggested that genes producing smRNAs from their 
3’UTRs are associated with functionally important protein coding genes and these genes may 
be part of an important mechanism regulating plant stress responses. 
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Figure 4.6 Enriched biological processes among genes producing smRNAs from their 
3’UTRs in salt stress (Ss- 48). 
The genes harboring smRNAs producing 3’UTRs were subjected to GO-term enrichment and 
the analysis was performed separately for each stress condition and duration of stress. The 
figure represents the enriched GO terms for genes that produce smRNAs in response to salt 
stress (Ss-48). A total of 171 3’UTR loci and 116 GO-terms were used for the analysis. 
Similar functional categories were clustered together and connected within the same network 
using REVIGO and Cytoscape. Nodes (green circles) reflect the GO-terms, and edges (blue 
lines) connect similar functional categories. The node color indicates the frequency of the GO 
terms and corresponds to the color scale indicated on the figure. 
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3’UTR-derived smRNAs with predicted trans-targets are uniformly 24 nt long  
Our initial analysis of all stress-induced smRNAs that map to 3’UTRs indicated that 
the set of 24 nt smRNAs is the predominant group of smRNAs triggered by all stresses; 
however, smRNAs of other sizes also increased in abundance (Figure 4.2D). In addition, 
while analyzing the smRNAs produced from 3’UTRs of genes, including Bradi2g25050, 
Bradi4g11670, Bradi1g62460 and Bradi1g20200 (Figure 4.4A-D), we also observed a few 
smRNAs of other sizes. 
Although we used 3-fold ratio in increase of 24 nt smRNA production in response to 
stresses as one of the criteria to isolate this subset of 3’UTRs, the calculations we applied did 
not discriminate against 3’UTRs that generate smRNAs of sizes other than 24 nt. Thus, our 
analysis can also identify smRNAs of various sizes that are produced from this subset of 
3’UTRs. To gain more insight into the nature of smRNAs triggered by stresses and how they 
may be produced from their precursor transcripts, we analyzed in detail the entire population 
of smRNAs of all sizes originating from the group of 3’UTRs isolated using the stringent 
criteria described above (Figure 4.5A; Supplemental file 1: Table S4.5-S4.11). Therefore, 
we used the entire population of smRNAs triggered from these 3’UTRs by each stress and 
profiled these smRNAs by size and expression level. To our surprise, we found that the 
smRNAs originating from this group of 3’UTRs are almost uniformly 24 nt long and 
dramatically increase in their abundance under all stress conditions (Figure 4.7A-G). The 
only other group of smRNAs that had a very minor increase in abundance was a group of 21 
nt smRNAs. We observed the same pattern in the response to all stresses used in our study. 
We also inspected all smRNAs triggered from each individual 3’UTR and found that 
 133 
smRNAs that differ in size from 24 nt were expressed only from a few loci. For example, in 
the case of salt stress, only three loci (Bradi2g04380, Bradi3g45010, and Bradi3g53300) 
from the total set of 85 isolated 3’UTRs (<4%), give rise to smRNAs of different sizes, while 
all other loci produce only 24 nt smRNAs in response to salt stress. This observation suggests 
that a small number of 3’UTRs that produce smRNAs of all sizes could lead to a visual 
distortion of the size distribution of the total population of smRNAs mapped to 3’UTRs, and 
thus could also explain the increase in abundance of 3’UTR-derived smRNAs of different 
sizes observed in Figure 2D. The observation that smRNAs originating from this group of 
3’UTRs are exclusively 24 nt in length also argues that these smRNAs are not the products of 
nonspecific mRNA degradation, and supports our hypothesis that these smRNAs have 
regulatory potential. Profiling these smRNAs by their first nucleotide revealed that the 
majority of them start with a 5’A, with 5’U being the second largest group (Figure 4.8), 
suggesting that if these smRNAs participate in RNAi pathways they could preferentially be 
loaded into Brachypodium homologs of the Ago2 and Ago4 complexes to silence their targets 
[63]. 
To shed more light on the nature of smRNAs produced from the group of identified 
3’UTRs and whether they could be miRNAs, we used mfold tools to examine the possible 
RNA secondary structures that could be formed by RNA corresponding to the 3’UTRs of 
these genes [64]. We used the 3’UTRs of genes responsive to salt stress in this analysis and 
found that the RNA secondary structures predicted using bioinformatics RNA folding tools 
suggested that these loci are unlikely to be miRNA precursors (see Materials and Methods). 
Thus, we isolated a set of stress-responsive genes that produce a novel group of 
 134 
smRNAs from short stretches of their 3’UTRs. These smRNAs are generated in collinear 
manner to their precursor transcripts, are almost exclusively 24 nt in length and have perfect 
complementarity to transcripts of other Brachypodium coding genes. Since these 24 nt 
smRNAs triggered by stresses from these 3’UTR loci are predicted to target transcripts of 
other Brachypodium coding genes and thus have a potential to be functional, we termed them 
sutr-siRNAs (for stress-induced, UTR-derived siRNAs) and focused our analysis on their 
predicted targets. 
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Figure 4.7 Characterization of 
smRNAs originating from 3’UTRs in 
response to stresses. 
(A-G) Size distribution and expression 
of smRNAs originating from the group 
of 3’UTRs isolated using set of 
parameters described in text. This group 
of 3’UTRs produces smRNAs that are 
predicted to target other coding genes in 
trans. The numbers of 3’UTRs used to 
profile smRNAs originating from them 
are listed on Figure 5A. For example, 85 
salt-stress responsive 3’UTRs, 120 cold-
stress responsive UTRs, etc, were used 
to profile smRNAs originating from 
them. 
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Figure 4.8. The relative frequency of each 5' terminal nucleotide among sutr-siRNAs. 
Frequency distribution of the 5’ terminal nucleotide for sutr-siRNAs originating in different 
stress conditions, Ss-48, salt stress; Cs, 6 or 24 hours of cold stress; HsA 1 or 3 hours of heat 
stress by air incubation; HsW, 1 or 3 hours of heat stress by water immersion. 
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Predicted targets of sutr-siRNAs 
To isolate the genes that could be targeted by sutr-siRNAs, we used the sequence of 
each unique sutr-siRNA to search genome-wide for all Brachypodium coding genes that 
harbor sequences with reverse complementarity, allowing no mismatches. This identified a 
group of coding genes predicted to be targeted by various sutr-siRNAs in response to stresses 
(Table 4.1; Supplemental file 1: Table S4.5-S4.11). As an example, we found that salt stress 
triggers the induction of 232 unique sutr-siRNAs that have perfect complementarity to the 
transcripts of 363 Brachypodium coding genes (Table 4.1 and Supplemental file 1: Table 
S4.5). 
To obtain more functional information on the networks that govern plant responses to 
different abiotic stresses, we carried out functional analysis of the genes targeted by sutr-
siRNAs using GO classification. As for the 3’ UTRs, GO classification was conducted 
separately for each individual stress and duration of stress and the resultant GO-terms for the 
sutr-siRNA target genes were then subjected to enrichment analysis and visualized using 
REVIGO and Cytoscape (Figure 4.9, Supplemental Files 7: Figure S4.5 and Supplemental 
Files 1: Table S4.13) [61,62]. For example, in salt stress, (Ss-48), 363 trans-targeted coding 
genes were subjected to GO-term analysis and 480 GO-terms were used for the GO-term 
enrichment analysis (Ss-48) (Figure 4.9). Similar to enrichment of GO terms of the genes that 
produce sutr-siRNAs, GO classification of the genes targeted by sutr-siRNAs suggested that 
sutr- siRNAs target a broad spectrum of genes involved in different biological processes, 
although the majority of the GO- terms of genes targeted by sutr-siRNAs indicate that these 
target genes also involved in binding activities (Figure 4.9, Supplemental Files 7: Figure 
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S4.5 and Supplemental Files 1: Table S4.13). Early and late time points of stress duration 
were very similar within each stress. Importantly, we found that many enriched GO-terms 
were involved in transcriptional activities and were enriched in all stresses. These results 
suggest that sutr-siRNAs potentially target functionally important coding genes, which further 
indicates the importance of sutr-siRNAs in the plant response to abiotic stresses. 
 
 
 
Table 4.1 Summary of sutr-siRNAs and their predicted target genes. 
    Ss-48 Cs-6 Cs-24 HsA-1 HsA-3 HsS-1 HsS-3 
A
. s
ut
r-
si
R
N
A
s 
The number of unique 
24nt smRNA 
sequences with perfect 
complementarity to 
other genes 
232 488 496 224 269 203 160 
The number of unique 
24nt smRNAs 
targeting sequences 
within introns 
204 439 445 196 241 179 138 
Percentage of unique 
24nt smRNAs 
targeting sequences 
within introns 
88% 90% 90% 88% 90% 88% 86% 
B
. T
ar
ge
t g
en
es
 
The number of genes 
predicted to be 
targeted by sutr-
siRNAs in trans 
363 685 653 390 401 336 268 
The number of genes 
predicted to be 
targeted by sutr-
siRNAs within introns 
333 633 605 359 358 311 244 
Percentage of 
predicted target genes 
that are targeted within 
introns 
92% 92% 93% 92% 89% 93% 91% 
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Figure 4.9 Enriched biological processes among genes targeted in trans by sutr-siRNAs 
in response to salt stress. 
The genes targeted by sutr-siRNA in trans were subjected to GO-term enrichment and the 
analysis was performed separately/independently for each stress condition and duration. The 
figure represent the GO-terms enriched in targeted coding genes in salt stress 48 hours (Ss-48) 
condition and a total 363 coding genes and 480 GO-terms were used for the analysis. Similar 
functional categories clustered together and connected within the same network using 
REVIGO and Cytoscape. Nodes (green circles) reflect the GO-terms, and edges (blue lines) 
connect the similar functional categories. The node color indicates the frequency of the GO 
terms and corresponds to the color scale indicated on the figure.  
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Potential targeting mechanisms of sutr-siRNAs 
Mechanistically, known smRNAs regulate gene expression by sequence-specific 
transcript degradation, translational inhibition or transcriptional repression [8,10,11]. As a 
first step towards elucidating the mechanism of sutr-siRNA action, we examined their 
predicted target sites. We found that sutr-siRNA target sites fall into two main categories. 
Some sutr-siRNAs (fewer than 10% of total) have their predicted target sites located almost 
exclusively within the 3’UTRs of their target genes (Supplemental file 1: Table S4.14). This 
observation suggests that these sutr-siRNAs could participate in RNAi pathways and regulate 
the expression of their targets through translational repression or mRNA degradation, 
consistent with a function in trans-acting gene regulation. By contrast, and much to our 
surprise, we found that over 90% of all genes predicted to be targeted by sutr-siRNAs have 
the target site located within one of their introns. This trend was almost identical in all types 
of stresses used in our study (Table 4.1B). Reciprocally, about 90% of all sutr-siRNA 
sequences have complementarity to intronic sequences (Table 4.1A). 
Since these sutr-siRNAs are predicted to target introns, and thus pre-mRNAs, we 
reasoned that they function in the nucleus and thus could be involved in the degradation of 
pre-mRNAs, in epigenetic regulation or in pre-mRNA processing. Therefore, we set out to 
investigate the features of the sutr-siRNAs that are predicted to target introns and chose the 
group of sutr-siRNAs triggered by salt stress for detailed analysis. The number of intronic 
target sites is higher than the number of sutr-siRNAs predicted to target them; therefore, we 
first examined whether different sutr- siRNAs carry common motifs or have other common 
features. We did not identify a specific common consensus motif shared by all of the sutr-
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siRNAs, but we found that sutr-siRNAs were uniformly purine rich, indicating that they target 
pyrimidine-rich regions. Pyrimidine and polypyrimidine rich tracts are located between 
important regulatory regions within introns, such as the branch point and 3’splice site [25]. 
The branch point sequence in plants is located about 17-40 nt upstream of the 3’splice site, 
and the branch point and downstream 3’ splice site are essential signals for efficient 
recognition of the 3’splice site [25,65]. 
To investigate whether sutr-siRNAs can target any conserved intronic cis elements 
that are required for splicing, we used the population of sutr-siRNAs triggered by salt stress 
for detailed analysis. The branch point sequence, with its conserved A residue, which is 
required for the catalysis in the first trans-esterification reaction in the first step of splicing, is 
among the most identifiable regulatory cis elements within introns. In vertebrates, the branch 
point region is variable but has a more-identifiable consensus sequence, CURAY [35]. 
However, in plants the same branch point consensus sequence is not obvious and the 
sequences defining splice sites are degenerate [25,65]. Therefore, we used a database of 
Arabidopsis and rice branch point sequence motifs, which were predicted on the basis of 
training sets compiled using experimental data [66], to interrogate the population of sutr-
siRNAs that have target sites within introns. 
Interestingly, we found that 30% of intron targeting sutr-siRNAs carry sequences that 
are complementary to the predicted plant branch point sequences (Figure 4.10A). We also 
identified the branch point motif that is favored by this group of sutr-siRNAs (Figure 4.10B). 
The position of the branch point site relative to the polypyrimidine tract and the 3’ splice site 
downstream of it are essential for it to function as a branch point in splicing reaction.  
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In order to find out whether the predicted intron branch point sequences targeted by 
these sutr-siRNAs could indeed be considered as functional branch points, we examined gene 
structures of a subset of target genes using the gene models available from Brachypodium 
databases. In plants, the branch point (BP) sequences are located upstream of the 
polypyrimidine tracts and usually about 17-40 nt upstream of 3’ splice site [25,65].While 
some of the predicted BP sequences targeted by sutr-siRNAs did not have a clearly 
identifiable 3’ splice site consensus downstream of the BP sequences targeted by sutr-
siRNAs, other BP sequences were found positioned next to the polypyrimidine tract and the 
3’ splice site downstream.  
We then chose several sutr-siRNA target genes, Bradi4g09040, Bradi2g06430, 
Bradi2g54840 and Bradi1g05660 for detailed analysis (Figure 4.10C-F). In these genes, 
branch point sequences targeted by sutr-siRNAs are located within 16-31 nt upstream of the 
potential 3’ splice sites (Figure 4.10C-F). Based on the protein domain sequence alignment 
and GO analysis Bradi4g09040, Bradi2g06430, Bradi2g54840 and Bradi1g05660 encode 
Cytochrome P450 (the ortholog of Arabidopsis AT2G26170), DNA polymerase subunit 
Cdc27 (the ortholog of Arabidopsis AT1G78650), a putative methyltransferase (the ortholog 
of Arabidopsis AT2G39750), and 3’-5’ exoribonuclease XRN4 (the ortholog of Arabidopsis 
AT1G54490), respectively. 
We then examined the structures of these genes, using the gene models available from 
Brachypodium databases. When we examined the intron regions in the vicinity of the sutr-
siRNAs target sites in these target genes in detail and compared them with the annotated gene 
structures, we found that additional splice sites could be predicted in these regions. These 
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additional predicted splice sites have high similarity to the known consensus splice sites in 
human and Drosophila and in all cases sutr-siRNAs targeted the BP of the splice site located 
upstream of the annotated splice site (Figure 4.10C-F). Bioinformatics analysis suggests that 
the selection of the splice sites predicted to be targeted by sutr-siRNAs in the examined genes 
would result in the introduction of a premature stop codon downstream of this 3’ splice site; 
this stop codon can activate nonsense-mediated mRNA decay (NMD) and thus down-regulate 
the expression of the affected gene [67]. 
The Brachypodium consortium has annotated the structure of these genes based on 
EST and RNA-seq data [57-59]. To determine whether alternatively spliced transcripts of 
these four genes were identified experimentally, we examined the annotated gene structures 
from the Brachypodium consortium and the expression data and found that no alternatively 
spliced transcripts of these genes were identified experimentally in Brachypodium plants 
grown under normal conditions, nor in plants challenged by various abiotic stresses [58,68]. A 
recent genome-wide study of the alternative splicing landscape experimentally identified 
many novel splice junctions Arabidopsis [30]. Thus, we used the information from this study 
and TAIR 9 to cross-examine the splicing pattern of the closest orthologs of these 
Brachypodium genes in Arabidopsis. Similarly, we did not find isoforms that were spliced at 
the 3’ splice site targeted by the sutr-siRNAs. The position of the sutr-siRNAs targeted 3’ 
splice sites upstream of the annotated major splice site in these genes also suggests that these 
splice sites could fall into the category of “decoy” splice sites, sequences that have similar 
degrees of similarity to consensus sequences as authentic splice sites, but that are rarely or 
never spliced [41,42]. Thus, the selection of the 3’ splice sites targeted by sutr-siRNAs in the 
 144 
examined genes will most likely result in an aberrant PTC- containing transcript that could be 
turned over by NMD. The base-paring interactions between sutr-siRNAs and BP sequences 
targeted by sutr-siRNAs may potentially prevent the 3’splice sites downstream of them from 
being recognized as the authentic splice sites. 
Perhaps the most intriguing gene predicted to be targeted by sutr-siRNAs is 
Bradi1g05660, the Brachypodium ortholog of Arabidopsis XRN4, the functional homologue 
of the yeast XRN1 [69,70]. XRN4 is a 5'-3' exoribonuclease that degrades uncapped mRNAs 
and in Arabidopsis is known to act as silencing suppressor and a regulator of developmental 
and biotic stress response pathways [16,70-73]. XRN4 also plays an important role in the 
heat-sensing pathway in Arabidopsis [74]. The heat shock response triggers the quick and 
global reprogramming of gene expression on many different levels and 25% of the 
Arabidopsis transcriptome undergoes rapid XRN4-dependent degradation in response to heat 
shock. Thus, the function of XRN4 is required for the thermotolerance of plants to long 
exposure to high temperatures, with xrn4 mutant plants losing their ability to adapt to and 
survive heat stress. 
We hypothesize that under stress conditions, the broader role of sutr-siRNAs could be 
to increase the fidelity of the splicing reaction, by masking or changing accessibility to 
specific cryptic, decoy, or alternative splice sites through base-pairing interactions, or by 
affecting the overall secondary structure of pre-mRNAs. Therefore, sutr-siRNAs could ensure 
that plants under stress conditions use the authentic splice site and produce functional protein 
to allow the plant to defend against abiotic stress conditions. 
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Figure 4.10 Sutr-siRNAs that are predicted to target branch point sequences and gene 
structure of their targets. 
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A. Predicted intron branch point sequences that are complementary to sutr-siRNAs. 
B. The features of BP sequences predicted to be targeted by the sutr-siRNAs. A position 
weight matrix for the branch point consensus in sutr-siRNAs. The height of each letter 
represents its frequency of occurrence. 
 
C-D. Gene structure of sutr-siRNA target genes. 
C. The structure of Bradi4g09040, encoding Cytochrome P450. The target site of the sutr-
siRNA is located in intron 2 of the cytochrome P450 transcript. 
D. The structure of Bradi2g06430, encoding DNA polymerase subunit Cdc27. The target site 
of sutr-siRNA is located in intron 1 of the Cdc27 transcript. 
E. The structure of Bradi2g54840, encoding a putative methyltransferase. The target site of 
sutr-siRNA is located in intron 3 of the Bradi2g54840 transcript. 
F. The structure of Bradi1g05660, encoding 5’-3’ exoribonuclease XRN4. The target site of 
the sutr-siRNA is located in intron 9 of the XRN4 transcript. 
 
The annotated/authentic 3’ splice site (3’SS) is the splice site used to produce full-length 
protein. Additional 3’SS is the splice site that could be used if the alternative branch point 
complementary to sutr-siRNA is chosen in splicing. In these examples the choice of 
alternative splice site would introduce a premature stop codon downstream of the splice site, 
resulting in either a short isoform or producing RNA substrate for nonsense-mediated 
degradation. 
 
* XRN4 and putative methyltransferase gene exon/intron numbering follows the genomic 
sequence annotation of the Brachypodium Sequence Consortium (International Brachypodium 
Initiative 2010), where the exon numbering is based not on the gene/transcript orientation, but 
on the DNA direction from 5’ to 3’. Therefore, for genes encoded on the sense strand, the first 
exon (closest to the 5’ end of the transcript) is “exon 1”. For genes encoded on the antisense 
strand, however, the last exon (closest to the 3’ end of the transcript) is “exon 1”. 
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DISCUSSION 
Plants use a sophisticated array of mechanisms to respond to the changes in their 
environments upon exposure to different abiotic stresses. These mechanisms involve 
coordinated induction of various signals that trigger alterations in gene expression networks, 
which, together, allow plants to survive in a variety of environmental conditions [2,4,5]. 
Various smRNAs regulate many of these processes [8]. Here, we used Brachypodium plants 
as a model system to investigate how the smRNA transcriptome responds to various abiotic 
stresses. 
We isolated the specific group of Brachypodium stress-responsive genes that respond 
to stresses by giving rise, from their 3’UTRs, to a novel group of smRNAs with regulatory 
potential (Figure 4.5A). Some of these genes generate smRNAs in response to all stresses or 
in response to more than one stress (Figure 4.5C-F). The identical response of some genes to 
different stresses suggests that similar smRNA pathways could be activated in response to 
these abiotic stresses. Other genes responded only to a specific stress, suggestive of stress-
specific smRNA pathways (Figure 4.5C-F). Importantly, over half of these isolated 3’UTRs 
exhibit more than a 10-fold increase in levels of smRNAs in response to stress (Figure 4.5B; 
Supplemental file 5: Figure S4.3A-F). 
Our analyses also demonstrated that production of these 24 nt smRNAs from 3’UTRs 
of stress-responsive genes follows a specific, striking pattern. These smRNAs originate only 
from a very short stretch of each 3’UTR and are collinear with their precursor transcripts 
(Figure 4.5 and 4.4). Also, all of these smRNAs have predicted targets within transcripts of 
other coding genes (Figure 4.5A; Table 4.1). Although smRNAs of the same polarity as their 
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precursor transcripts might arise as degradation products of their precursor RNAs, our data 
suggest that sutr-siRNAs do not fall into this category. First, for non-specific degradation 
products, we would expect smRNAs originating from the entire mRNA, but the sutr-siRNAs 
are produced only from a specific, very short stretch of 25-30 nt of each 3’UTR (Figure 4.3 
and 4.4). Second, for nonspecific degradation products, we would expect to observe smRNAs 
of various sizes. However, with the exception of a few 21 nt smRNAs, we observed only 24 
nt sutr-siRNAs from these selected 3’UTRs (Figure 4.7A-G). Therefore, this specific group 
of stress-responsive 3’UTRs identified here serves as precursors to only one type of smRNAs, 
which we termed sutr-siRNAs. 
 
Possible mechanisms of sutr-siRNA biogenesis 
Plants have large and diverse endogenous smRNA populations in two main categories, 
miRNAs and siRNAs, based on the structures of their precursors and their biogenesis 
[9,11,75]. miRNAs originate from miRNA precursors that form imperfect RNA stem-loops. 
The very diverse populations of plant siRNAs originate from perfect double-stranded RNA 
(dsRNA) precursors that can be formed by various mechanisms [75]. To shed more light on a 
possible mechanism of sutr-siRNAs biogenesis, we used the set of all salt- stress responsive 
genes to analyze possible RNA secondary structures that could be formed by their transcripts. 
However, none of the secondary structures predicted using bioinformatics RNA folding tools 
met the parameters required for being considered as miRNA precursors [76] (see Material and 
Methods). Although we are aware of the limitations of mfold, our data suggest that these loci 
are unlikely to be miRNA precursors. The sutr- siRNAs are 24 nt long and in Arabidopsis 
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DCL3 generates the majority of 24 nt siRNAs [75], suggesting that if this extends to 
Brachypodium, the biogenesis of sutr-siRNAs might require the Brachypodium homolog of 
DCL3, encoded by Bradi3g29290. Inverted repeats could be one of the sources of dsRNA 
serving as precursor for DCL proteins to generate smRNAs. However, when we analyzed the 
regions in the vicinity of sutr-siRNA producing sites, we found no DNA sequences nearby 
that could be considered reverse complementary to the sutr-siRNAs, indicating that sutr-
siRNAs are unlikely to be produced from the dsRNA precursors formed by inverted repeats. 
In addition, based on the Brachypodium genome annotation, no cis-NAT pairs could be 
predicted in locations giving rise to sutr-siRNAs. Therefore, dsRNA precursors for sutr-
siRNAs must originate through different mechanisms. Most sutr-siRNAs start with a 5’A 
(Figure 4.8), suggesting that if these smRNAs participate in RNAi pathways they could 
preferentially be loaded into Brachypodium homologs of Ago2 and Ago4 complexes, encoded 
by Bradi5g21800 and Bradi2g10370, to silence their targets [63]. Further experimental work 
and the use of different experimental approaches will be needed to determine the mechanism 
of sutr-siRNA biogenesis. 
 
sutr-siRNA targets 
We also identified the group of genes predicted to be targeted by sutr-siRNAs. GO 
classification of the predicted target genes suggested that sutr-siRNAs target a broad spectrum 
of genes involved in different processes (Figure 4.9, Supplemental file 7: Figure S4.5, 
Supplemental file 1: Table S4.13). To our surprise, over 90% of the target genes are 
predicted to have the target site located in one of their introns (Table 4.1). The bioinformatics 
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analysis of intron-targeting sutr-siRNAs indicated that they are complementary to intronic 
polypyrimidine tracts and a third of them carry sequences that are complementary to plant 
branch point sequences, which are among the most important intronic cis elements 
determining the choice of splice site. When we analyzed the structures of the predicted target 
genes, we found that these sutr-siRNAs were targeting not the major annotated splice sites, 
but rather the additional potential splice sites located upstream of the annotated major splice 
sites in the target introns (Figure 4.10C-F). Our bioinformatics analysis also indicates that the 
choice of the splice sites targeted by the sutr-siRNAs could potentially lead to short, 
alternatively-spliced transcripts and result in the introduction of a stop codon downstream of 
these sutr- siRNAs targeted 3’ splice sites, which could make these transcripts substrates for 
nonsense-mediated decay [67]. The fact that most of the sutr-siRNAs are complementary to 
intronic regulatory regions suggests that they may play a role in the regulation of splicing 
under stress conditions. 
Both pre-mRNA splicing and smRNA pathways in plants are powerful mechanisms 
involved in regulation of gene expression in all conditions, including abiotic stresses [4,6,77]. 
However, a direct link between pre-mRNA splicing and small RNA pathways has so far 
remained elusive. The possible connection between splicing and RNAi pathways has been 
explored in other organisms and several examples of a regulation of alternative splicing 
through smRNAs in other eukaryotes have been reported recently [44,46,47]. Among the 
most direct connections between RNAi machinery and splicing was the finding that human 
RNAi components AGO1 and AGO2 can link chromatin modifiers with the splicing 
machinery [44,46,47]. In this case Ago proteins were shown to facilitate spliceosome 
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recruitment by modulating the elongation rate of RNA polymerase II, thereby affecting 
alternative splicing. Recent work also demonstrated that Drosophila Ago-2 protein binds G-
rich regions within introns, suggesting that it also may be involved in regulation of splicing of 
specific transcripts, providing another possible link between components of RNAi machinery 
and splicing [48]. These examples suggest that siRNAs and the RNAi pathway are involved in 
splicing and alternative splicing in these organisms, thus connecting splicing with epigenetic 
modifications. 
 
Potential mechanism of action of sutr-siRNAs that target introns 
Similar to other smRNAs, sutr-siRNAs could function in sequence-specific transcript 
degradation or participate in epigenetic regulation of gene expression by modulating DNA 
methylation in response to stresses [8,23]. The approaches used in our study differ from the 
approaches used to link Drosophila and mammalian RNAi pathways in alternative-splicing 
decisions by connecting splicing with epigenetic modifications. Thus, we cannot rule out the 
possibility that sutr-siRNAs are involved in connecting splicing with epigenetic modifications 
or in degradation of pre-mRNAs. The use of different experimental approaches will be needed 
to distinguish among all possibilities. However, the fact that many sutr-siRNAs appear to 
target splice sites that are potentially cryptic or decoy splice sites argues that these sutr-
siRNAs may function in either masking these splice sites or preventing other splicing cis 
determinants from being recognized by the splicing machinery. 
The main splicing signals for pre-mRNA processing are degenerate and numerous 
additional intronic and exonic cis- regulatory elements function as recruiters for trans-acting 
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splicing factors that recognize these cis-signals on pre- mRNAs [35,36,65,78]. The 
recognition of the correct splice sites is critical and the commitment to splice at a particular 
splice site is believed to occur during the step-wise co-transcriptional assembly of the 
spliceosomal machinery on the pre-mRNA. The formation of the commitment and pre-
splicing complexes appears to be reversible and accumulating evidence also indicates that 
these steps could be subject to regulation more often than other steps [27,79]. It is intriguing 
to speculate that stress-triggered sutr-siRNAs with complementarity to regulatory cis elements 
within introns may function in a manner that differs from the canonical roles of smRNAs in 
transcript degradation or epigenetic regulation of gene expression. The splice sites targeted by 
sutr-siRNAs could potentially produce either alternatively spliced RNAs or aberrant 
transcripts that become possible substrates for nonsense-mediated decay (Figure 4.10C-F) 
and thus down-regulate the expression of the genes. Therefore, the base-pairing of sutr-
siRNAs to alternative branch point sequences or other cis elements could prevent them from 
being recognized by the splicing machinery through inhibiting the first steps of splicing at the 
target splice site and ensuring that the machinery choses the correct splice site. Indeed, one of 
the sutr-siRNA targets encodes 5’-3’ exoribonuclease XRN4, one of the key regulators in 
plant stress responses. Therefore, in this case, sutr-siRNAs could ensure that plants under 
stress conditions use the correct splice site and produce functional XRN4 protein to allow the 
plant to survive abiotic stress conditions. 
Redirecting of splicing events through the use of single-stranded oligomers has been 
explored widely in therapeutic and experimental settings [80-83]. Synthesized splice-
switching oligonucleotides can direct pre-mRNA splicing by binding to intronic elements and 
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blocking access to the transcript by the spliceosome and other splicing factors [80,81]. In 
another example, the endogenous snoRNA HBII-52 and the smRNAs processed from it were 
reported to function in regulation of alternative splice-site selection through base-pairing-
dependent RNA-RNA interactions in human and mouse tissue cultures [84,85], providing 
evidence that endogenous smRNAs also can modulate splicing. Thus, one could also envision 
the existence of other endogenous smRNAs that bind to either cryptic splice sequences or 
other cis-regulatory elements to ensure the preferential use of one splice site relative to other 
splice sites, thereby ensuring the fidelity of splicing reaction, which may become particularly 
important under stress conditions. In this case, smRNAs would be expected to have an 
advantage over proteins due to their complementarity to specific RNA targets. 
Based on our observations, we favor the hypothesis that under stress conditions, sutr-
siRNAs may affect the selection of splice sites by either masking cis determinants of specific 
cryptic or alternative splice sites, or by affecting pre- mRNA overall secondary structure, 
which can also affect the accessibility of cis elements and splice sites [39]. To our knowledge, 
our finding represents the first genome-wide identification of smRNAs that have a potential to 
regulate splicing of pre-mRNAs in response to abiotic stresses. Production of sutr-siRNAs in 
our study was triggered specifically by various abiotic stresses. Why would sutr-siRNAs be 
needed during stress conditions? Stresses trigger global reprogramming of gene expression on 
different levels and many protein factors are also sequestered by chaperone proteins to protect 
them from mis-folding or degradation during stresses [2]. Therefore, it is possible that during 
stress it becomes more important to rely on base-pairing interactions through smRNAs. It is 
worth noting that one of the parameters we applied for isolating the specific group of 3’UTRs 
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producing sutr-siRNAs was the condition that they express 24 nt smRNAs both in response to 
stresses and in unstressed plants. Indeed, 24 nt smRNAs were expressed in unstressed plants 
(Figure 4.7A-G), suggesting that sutr-siRNAs may function in plants grown under normal 
conditions as well as in stress responses. 
It remains to be determined if a similar group of smRNAs exists in different plant 
species or other organisms, and further experimental work will be needed to determine the 
significance of this observation. Also, to fully understand the mechanism of sutr-siRNA 
action, the splice isoforms of the sutr-siRNA target genes produced in wild-type plants will 
need to be compared with the splice isoforms produced in the organisms that do not express 
sutr-siRNAs during stress treatments. To address these questions requires an experimental 
system permitting elimination of sutr-siRNA during stress treatment. This can be 
accomplished through either use of mutants that eliminate or suppress the expression of a 
specific sutr-siRNA, or by using a different experimental system, such as mammalian or 
Drosophila cells, where experiments can be conducted in vitro in splicing extracts (by 
eliminating sutr-siRNAs with the anti-sense oligonucleotides that titrate the sutr-siRNAs). 
Our study, conducted in Brachypodium, provides a framework for researchers studying 
mechanisms of splicing regulation in other eukaryotes. 
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MATERIALS AND METHODS  
Plant material and abiotic stress conditions  
A community standard diploid inbred line of Brachypodium distachyon, Bd21, was 
used for all experimental treatments. The palea and lemma were carefully peeled off from the 
mature seeds with fine forceps. The stripped seeds were sterilized by soaking in a solution of 
0.615% sodium hypochlorite supplemented with 0.1% Tween 20 for 10 min with occasional 
rocking. The sterilized seeds were thoroughly rinsed three times with sterile double-distilled 
water and placed on Murashige and Skoog (1/2 MS)-agar plates (1/2 MS-agar plates 
hereafter) (4.3 g/l MS salts with vitamins, 3% sucrose, pH 5.8, and 0.4% phytagel). The 
seeds/plates were cold-treated at 4°C for 2 days to synchronize germination, followed by 
germination in a light incubator at 22°C with a daily photoperiodic cycle of 16 h light and 8 h 
dark. Germinated seedlings were transplanted into soil and grown in a light incubator at 22°C 
with a daily photoperiodic cycle of 16 h light and 8 h dark. For heat stress treatments, plants 
were either incubated at 42°C for 1 or 3 hours in the temperature and light controlled growth 
chamber, or immersed in 42°C water for 1 or 3 hours. For cold stress treatment, plants were 
incubated at 4°C for 6 or 24 hours. For the salt stress treatment, the soil of plants was soaked 
with 300 mM NaCl until saturation and plants were grown for 48 hours in a light incubator. 
The leaves of unstressed and stress treated plants were collected and frozen in liquid nitrogen 
before RNA extraction. 
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Library construction and smRNA sequencing 
Total RNA was isolated from the leaves of unstressed and stress treated plants using 
TRIzol (Life Technologies) according to the manufacturer’s protocol. The RNA samples were 
used for sequencing library construction using the Small RNA sample Prep v1.5 kit and 
TruSeq Small RNA Sample Prep kit (Illumina, San Diego, CA) according to the 
manufacturer’s instructions, as described previously [86]. The smRNA libraries were 
sequenced using the Illumina Genome Analyzer II (by DNA Core Facility, University of 
Missouri- Columbia) according to the manufacturer’s instructions. The smRNA sequencing 
data have been deposited to the Gene Expression Omnibus (GEO accession number 
GSE55217). 
 
smRNA data analysis 
Data processing was done using available tools and custom in-house UNIX shell 
programming as described previously [63,86]. The raw sequences in Illumina GAIIx 
sequencing reads were trimmed removing adapter using “fastx_clipper” in the FASTX-
Toolkit (version 0.0.13) and smRNAs with lengths between 15 and 40 nt were selected and 
mapped to the Brachypodium genomic sequences (Bd v1.0 version) [58] using BOWTIE 
(version 0.12.7) [87]. Reads that failed to perfectly map to the nuclear genome with no 
mismatches were discarded. Each library was normalized to the total number of mapped reads 
multiplied by 106 (rpm, reads per million). 
Classification of small RNAs was performed by BEDTools (v2.10.0) [88] and in-
house UNIX shell programming using the following databases: Bd v1.0 annotations for 
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protein coding features downloading from www.Brachypodium.org, miRBase (release 18) 
[89] for mature miRNA annotations. Some smRNAs match more than one annotation 
category; therefore the sum of the numbers is bigger than the total input number. The small 
RNA reads of 15 to 40 nt length were calculated and plotted versus the sum of their 
normalized reads per million (rpm). 
The data of smRNA transcriptomes under various abiotic stresses challenges were 
plotted as heatmap on all five chromosomes (total of eight smRNA transcriptome libraries). 
The circular heat map visualization of smRNA transcriptome was drawn using Circos [90]. 
smRNA expression is represented in 10 kb blocks and the maximum value of the heat map is 
calibrated to the Bd21 (un-stress treated library). The outer annotation track highlights the 
position of coding genes (Genes). In addition to the smRNA transcriptomes, the genomic 
locations of 3’UTRs that serve as precursors to stress induced sutr-siRNAs and the targeted 
genes of sutr-siRNAs were displayed on all five chromosomes in the same circular map. 
 
The analysis of smRNA producing genomic clusters was done using custom in-house 
UNIX shell programming. For clustering analysis, Brachypodium chromosomes were binned 
into non-overlapping 500 nt clusters and an expression of 20-25 nt smRNAs was quantified in 
each cluster [91]. Brachypodium consists of 1,084,598 non- overlapping fixed size 500 bp 
clusters covering the complete nuclear genome (Chromosome 1 to 5). The expression of 20-
25 nt smRNAs mapped to each 500 nt genomic cluster was normalized to the total number of 
mapped reads multiplied by 106 (rpm, reads per million) and expression of smRNAs (in 
RPMs) produced from each individual 500 bp cluster was then cross-compared between 
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unstressed plants and plants subjected to stresses. 
 
Calculation for genome-wide isolation of 3’UTRs that produce sutr-siRNAs was done 
using custom in-house UNIX shell programming applying the following rules: First, isolate 
all 3’UTRs that could give rise to smRNAs in a collinear fashion with their precursor 
transcripts. Second, calculate the abundance of 24 nt smRNAs in each individual 3’UTR and 
retain only the group of 3’UTRs that exhibit 24 nt smRNA expression both in response to 
stresses and in unstressed Bd21 plants. Third, retain only 3’UTRs that exhibit at least a 3-fold 
increase in expression of 24 nt smRNAs in response to stress. Fourth, isolate the group of 
3’UTRs that produce smRNAs with perfect complementarity to transcripts of other genes. 
 
The analysis of RNA secondary structure of sutr-siRNAs producing 3’UTRs was done 
using mfold [64]. The loci that were found to harbor any tandem or inverted repeat sequences 
were excluded from further analysis according to the criteria for annotating plant miRNAs 
[76]. For the 3’UTR loci that did not contain any repetitive sequences, the flanking regions 
(300 bp upstream and 20 bp downstream, 150 bp upstream and 20 bp downstream, 150 bp 
upstream and 150 bp downstream, 20 bp upstream and 150 bp downstream, and 20 bp 
upstream and 300 bp downstream) of the sutr-siRNA producing sites were subjected to RNA 
secondary structure folding analysis [92]. The flanking sequences were extracted from Bd21 
v1.0 genomic sequences [58] and RNA folded using mfold using the default parameters [64]. 
The two lowest folding energies for each secondary structure were then inspected manually. 
The folds were discarded as putative pri-miRNA if the secondary structure revealed the 
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miRNA/miRNA* duplex had more than four mismatches, showed asymmetric bulges with 
more than two bases or present more than one time, a free energy of > -23kcal/mole, or the 
miRNA/miRNA* duplex being located >10 bases from the terminal loop [76,93].  
 
Isolation and analysis of sutr-siRNA targets  
The Brachypodium genome annotations (v1.0 and v1.2) were used to classify the 
genomic features of sutr-siRNA targeting sites [58] and the analysis was performed by 
BEDTools (v2.10.0) [88] and in-house UNIX shell programming. The predicted branch point 
sequences for both Arabidopsis thaliana and Oryza sativa (brach_download.gz) were 
downloaded from Database of Plant Splice Sites and Splicing Signals 
(http://lemur.amu.edu.pl/share/ERISdb/home.html) [66]. NCBI BLASTN was used to search 
for sequences complementary to the 24 nt sutr-siRNAs smRNA sequences. The nucleotide 
frequency of branch point sequences was calculated and graphically displayed using Web 
Logo [94]. 
 
Gene ontology analyses 
The brachy_v1.0 GO terms library was downloaded from the Munich information 
center for protein sequence (MIPS) (http://mips.helmholtz-muenchen.de/) [58]. GO terms 
were retrieved for both stress-induced 3’UTR loci and the trans-target coding genes, and the 
complete list of GO terms is available in Supplemental file 1: Table S4.4 and S4.13. The 
GO terms were further analyzed using simple clustering algorithm provided by REVIGO with 
standard parameters [61], which the REVIGO software is used to summarize the GO-terms in 
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all stress conditions separately. 
For each stress condition dataset, the enriched biological processes are analyzed using 
REVIGO software and the resultant network generated by REVIGO was uploaded into 
Cytoscape [61,62] for further editing and visualization modifications before the images are 
exported as final enrichment maps. The colors of the circles represent the various levels of 
GO-term enrichment, where the darker shade represents more represented GO-terms in 
specific datasets than the lighter one. 
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SUPPORTING INFORMATION 
Supplemental file 1:  
Table S4.1. Summary of smRNA processing.  
Table S4.2. Expression of mature miRNAs in response to stresses.  
Table S4.3. Summary of comparison of genomic clusters producing smRNAs. 
Table S4.4. Gene Ontology analysis of stresses responsive genes producing smRNAs from 
their 3'UTRs. 
Table S4.5. Salt stress 48 hour (SS48): 3'UTRs of salt stress responsive genes, the 24nt 
smRNA sequence and target genes.  
Table S4.6. Cold stress 6 hour (CS6): 3'UTRs of cold stress responsive genes, the 24nt 
smRNA sequence and target genes.  
Table S4.7. Cold stress 24 hour (CS24): 3'UTRs of cold stress responsive genes, the 24nt 
smRNA sequence and target genes.  
Table S4.8. Heat stress air 1 hour (HSA1): 3'UTRs of heat stress responsive genes, the 24nt 
smRNA sequence and target genes.  
Table S4.9. Heat stress air 3 hour (HSA3): 3'UTRs of heat stress responsive genes, the 24nt 
smRNA sequence and target genes.  
Table S4.10. Heat stress by immersion in water 1 hour (HSW1): 3'UTRs of heat stress 
responsive genes, the 24nt smRNA sequence and target genes.  
Table S4.11. Heat stress by immersion in water 3 hour (HSW3): 3'UTRs of heat stress 
responsive genes, the 24nt smRNA sequence and target genes.  
Table S4.12. The list of smRNA-generating 3’UTRs that are either stress-specific or common 
among different stress treatments.  
Table S4.13. Gene Ontology analysis of genes predicted to be targeted by sutr-siRNAs.  
Table S4.14. Target genes with the target site predicted to be located in their 3' UTRs. 
  
 162 
Table S4.1. Summary of smRNA processing 
 
  
A. Non-stressed 
condition
E. Salt Stress
Bd21 Cs-6 Cs-24 Ss-48
Raw reads 7,987,052 13,008,585 12,141,227 5,982,196
High qualitya 7,322,138 11,387,661 10,524,598 5,433,962
Clipped reads 6,845,670 10,918,262 9,880,290 5,258,971
Genomic Hitb 5,843,356 9,503,576 8,725,960 4,259,528
Unique sRNA 516,066 2,961,085 2,974,349 1,114,256
HsA-1 HsA-3 HsW-1 HsW-3
Raw reads 12,656,200 13,994,745 4,390,670 10,473,702
High qualitya 10,659,005 11,922,348 4,033,711 8,581,075
Clipped reads 10,325,864 11,591,935 3,908,621 8,112,507
Genomic Hitb 9,407,611 10,521,567 3,105,953 7,342,098
Unique sRNA 2,028,894 2,421,454 823,449 1,576,534
aSeq <15nt removed during the process.
b15-40nt Sequeces with perfect genomic matches to Bd21 draft genome as well as scaffolds. 
These are also the values used for normalization.
B. Cold Stress
C. Heat Stress by air incubation D. Heat Stress by water immersion
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Table S4.2. Expression of mature miRNAs in response to stresses 
           Bd21 Cs-6 Cs-24 HsA-1 HsA-3 HsW-1 HsW-3 Ss-48 
         bdi-miR1122 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR1135 0.51 0.21 0.46 0.11 0.19 0.32 0.27 0.47 
bdi-miR1139 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR156 6.16 2.84 7.11 3.51 10.83 5.80 6.13 3.05 
bdi-miR156b 2778.88 2964.99 6210.66 3484.84 12136.50 2189.67 6201.91 3345.21 
bdi-miR156c 2778.88 2964.99 6210.66 3484.84 12136.50 2189.67 6201.91 3345.21 
bdi-miR156d 2778.88 2964.99 6210.66 3484.84 12136.50 2189.67 6201.91 3345.21 
bdi-miR159 8.21 31.46 241.35 19.24 75.56 33.81 39.50 381.26 
bdi-miR160a 1.03 7.79 21.89 8.93 11.22 28.65 20.16 13.62 
bdi-miR160b 1.03 7.79 21.89 8.93 11.22 28.65 20.16 13.62 
bdi-miR160c 1.03 7.79 21.89 8.93 11.22 28.65 20.16 13.62 
bdi-miR160d 1.03 7.79 21.89 8.93 11.22 28.65 20.16 13.62 
bdi-miR160e 10.44 36.20 68.76 19.56 33.46 30.26 47.40 38.50 
bdi-miR162 0.00 0.21 0.11 0.00 0.00 0.00 0.14 1.17 
bdi-miR164a 10.44 81.44 205.14 78.02 160.62 119.13 144.24 135.93 
bdi-miR164b 10.44 81.44 205.14 78.02 160.62 119.13 144.24 135.93 
bdi-miR164c 2.57 13.89 25.21 14.67 28.61 12.88 19.48 15.26 
bdi-miR164e 10.44 81.44 205.14 78.02 160.62 119.13 144.24 135.93 
bdi-miR164f 0.17 1.68 1.49 1.38 3.14 0.97 3.54 0.94 
bdi-miR166a 58.87 287.68 775.50 188.25 353.56 392.15 398.25 426.81 
bdi-miR166b 58.87 287.68 775.50 188.25 353.56 392.15 398.25 426.81 
bdi-miR166c 58.87 287.68 775.50 188.25 353.56 392.15 398.25 426.81 
bdi-miR166d 58.87 287.68 775.50 188.25 353.56 392.15 398.25 426.81 
bdi-miR166e 8.90 28.94 68.30 20.73 36.69 40.57 48.22 43.90 
bdi-miR166f 2.74 18.41 62.57 17.96 36.78 41.21 43.72 34.51 
bdi-miR167a 2.05 27.15 53.40 11.69 15.59 23.83 28.06 33.10 
bdi-miR167b 2.05 27.15 53.40 11.69 15.59 23.83 28.06 33.10 
bdi-miR167c 96.18 524.96 1199.41 328.99 766.81 320.67 943.46 394.64 
bdi-miR167d 96.18 524.96 1199.41 328.99 766.81 320.67 943.46 394.64 
bdi-miR168 964.34 2938.05 5923.59 1247.82 700.18 885.07 1634.68 1068.19 
bdi-miR169a 0.34 5.79 2.29 3.19 0.48 3.22 1.36 0.00 
bdi-miR169b 1.71 7.16 5.04 3.93 0.67 1.29 2.32 0.47 
bdi-miR169c 18.48 95.02 50.54 51.77 7.98 45.72 39.36 5.16 
bdi-miR169d 0.17 0.11 0.11 0.00 0.00 0.00 0.00 0.00 
bdi-miR169e 1.54 2.74 1.49 2.02 0.29 2.25 0.95 0.47 
bdi-miR169f 18.48 95.02 50.54 51.77 7.98 45.72 39.36 5.16 
bdi-miR169g 1.54 2.74 1.49 2.02 0.29 2.25 0.95 0.47 
bdi-miR169h 1.20 1.05 0.46 1.06 0.10 0.64 0.41 0.00 
bdi-miR169i 0.00 0.42 0.00 0.11 0.00 0.32 0.00 0.00 
bdi-miR169j 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 
bdi-miR169k 0.51 1.37 0.00 0.64 0.00 0.64 0.00 0.00 
bdi-miR171a 0.17 0.00 0.00 0.00 0.00 0.32 0.14 0.00 
bdi-miR171b 5.31 19.15 39.54 11.48 12.83 7.41 14.16 11.97 
bdi-miR171c 5.31 19.15 39.54 11.48 12.83 7.41 14.16 11.97 
bdi-miR171d 5.31 19.15 39.54 11.48 12.83 7.41 14.16 11.97 
bdi-miR172a 4.28 15.15 34.15 7.12 5.80 11.59 5.18 21.13 
bdi-miR172b 0.34 2.84 5.50 0.43 0.29 0.64 0.14 1.88 
bdi-miR172d 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR1878 0.51 6.42 7.33 2.34 1.62 4.83 1.91 1.64 
bdi-miR319 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 
bdi-miR319b 1.54 202.13 646.92 204.94 421.80 224.41 301.00 553.58 
bdi-miR390 0.34 8.21 9.28 4.57 2.09 3.54 3.54 3.52 
bdi-miR393a 2.22 10.00 16.73 4.78 4.66 4.51 3.00 10.33 
bdi-miR393b 2.22 10.00 16.73 4.78 4.66 4.51 3.00 10.33 
bdi-miR394 1.71 27.99 75.29 39.01 30.79 34.77 59.52 36.15 
bdi-miR395a 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395b 14.72 25.67 34.72 0.85 3.23 0.64 0.68 18.55 
bdi-miR395c 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395d 24.30 20.73 64.86 1.49 5.04 0.00 0.00 24.18 
bdi-miR395e 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395f 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395g 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
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bdi-miR395h 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395j 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395k 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395l 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR395m 14.72 25.67 34.72 0.85 3.23 0.64 0.68 18.78 
bdi-miR395n 14.72 25.78 34.84 0.85 3.23 0.64 0.68 18.78 
bdi-miR396a 63.49 588.20 1337.85 439.96 612.84 665.17 687.27 911.37 
bdi-miR396b 63.49 588.20 1337.85 439.96 612.84 665.17 687.27 911.37 
bdi-miR396c 0.00 3.05 9.28 2.76 3.42 4.51 3.54 7.28 
bdi-miR396d 0.00 3.05 9.28 2.76 3.42 4.51 3.54 7.28 
bdi-miR396e 0.34 12.31 22.12 8.72 12.17 16.74 15.12 14.56 
bdi-miR397a 0.00 0.00 0.11 0.00 0.00 0.32 0.14 0.00 
bdi-miR398a 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.00 
bdi-miR398b 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR399 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR399b 0.00 0.00 0.46 0.21 0.00 0.00 0.00 0.00 
bdi-miR408 0.00 0.53 0.34 7.44 1.05 1.93 1.77 0.94 
bdi-miR437 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5054 22.08 0.00 0.23 3.30 1.33 0.32 7.08 0.00 
bdi-miR5055 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5056 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5057 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5058 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5059 0.00 0.42 0.23 0.32 0.10 0.00 0.68 0.47 
bdi-miR5061 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5062a 0.00 0.00 0.23 0.00 0.00 0.00 0.00 0.00 
bdi-miR5063 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5064 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5065 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5066 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5067 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5068 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 
bdi-miR5069 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5070 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5163 7.70 14.73 51.80 23.70 41.34 111.72 43.18 109.64 
bdi-miR5164 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5165 0.17 0.63 0.11 0.11 0.10 0.32 0.27 0.47 
bdi-miR5166 0.00 0.00 0.00 0.00 0.10 0.00 0.00 0.00 
bdi-miR5167 1.03 0.84 0.80 0.43 0.19 0.64 0.68 0.47 
bdi-miR5168 161.89 191.82 306.67 214.51 319.82 228.92 416.37 226.32 
bdi-miR5169 7.19 12.00 14.55 8.50 8.55 15.13 11.58 15.96 
bdi-miR5170 0.00 0.32 0.11 0.00 0.10 0.00 0.27 0.70 
bdi-miR5171 0.00 0.00 0.11 0.11 0.00 0.00 0.00 0.00 
bdi-miR5172 0.00 0.42 0.92 0.32 0.19 0.32 0.68 0.47 
bdi-miR5173 2.22 5.47 6.88 3.83 1.62 2.25 2.45 2.58 
bdi-miR5174 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5175a 0.51 101.23 0.00 41.77 0.00 1.61 0.00 0.23 
bdi-miR5175b 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5176-3p 0.17 0.84 2.29 0.74 1.90 0.64 1.77 0.94 
bdi-miR5176-5p 0.00 0.74 0.57 0.21 0.29 1.93 0.68 2.35 
bdi-miR5177 0.51 2.10 3.90 1.28 1.81 0.32 0.95 0.70 
bdi-miR5178 0.34 0.53 0.92 0.74 0.38 0.32 0.54 0.70 
bdi-miR5179 0.34 0.95 3.09 0.32 0.86 0.32 1.23 0.00 
bdi-miR5180a 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.00 
bdi-miR5180b 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5181a 0.86 4.42 5.73 1.28 0.57 1.29 1.63 3.29 
bdi-miR5181b 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 
bdi-miR5182 58.19 52.09 49.28 42.09 33.74 28.01 63.06 40.61 
bdi-miR5183 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
bdi-miR5184 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 
bdi-miR5185a 0.00 0.11 0.00 0.00 0.00 0.64 0.00 0.23 
bdi-miR5185b 0.00 0.11 0.00 0.00 0.00 0.64 0.00 0.23 
bdi-miR5198 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.23 
bdi-miR5199 0.00 0.53 0.46 0.00 0.10 0.32 0.41 0.70 
bdi-miR5200 0.00 0.21 0.00 0.00 0.10 0.64 0.00 0.23 
bdi-miR5201 0.17 2.95 1.83 0.32 0.95 0.97 0.82 1.41 
bdi-miR5202 0.00 0.21 0.23 0.11 0.10 0.00 0.00 0.47 
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bdi-miR5203 0.86 1.89 1.15 0.11 0.00 0.32 0.14 0.00 
bdi-miR528 163.60 313.78 333.83 389.05 772.70 125.24 569.46 206.83 
bdi-miR529 8.90 8.63 12.61 5.10 6.27 21.57 2.86 15.26 
bdi-miR827 0.00 0.53 0.80 0.32 0.38 0.32 0.41 1.41 
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Table S4.3. Summary of comparison of clusters producing smRNAs 
 
  
Cs-6 Cs-24 HsA-1 HsA-3 HsW-1 HsW-3 Ss-48
Total Number of 500bp clusters 1084598 1084598 1084598 1084598 1084598 1084598 1084598
Number of clusters exhibiting 
increase in smRNA production
236931 233331 177913 211646 51849 132118 82518
Percentage of clusters exhibiting 
increase in smRNA production
21.8% 21.5% 16.4% 19.5% 4.8% 12.2% 7.6%
Number of clusters exhibiting 
decrease in smRNA production
479 603 1541 1036 11841 3099 7109
Percentage of clusters exhibiting 
decrease in smRNA production
0.0% 0.1% 0.1% 0.1% 1.1% 0.3% 0.7%
Number of clusters with no 
change in smRNA production
847188 850664 905144 871916 1020908 949381 994971
Percentage of clusters with no 
change in smRNA production
78.1% 78.4% 83.5% 80.4% 94.1% 87.5% 91.7%
Table S3. Summary of comparison of clusters producing smRNAs
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Table S4.4. Gene ontology analysis of stress responsive genes producing smRNAs from 
their 3’UTRs (*Please enlarge the table electronically or refer to the RNA journal 
publication website).  
 
 
 
  
Go term Go term functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR loci Go term
Go term 
functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR 
loci
Go term Go term functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR loci Go term
Go term 
functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR 
loci
Go term Go term functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR loci Go term
Go term 
functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR loci Go term
Go term 
functions
Total 
number of 
3'UTR loci 
Percentage of 
total 3'UTR loci
GO:0005515 protein_binding 21 8.02% GO:0005515 protein_binding 39 10.51% GO:0005515 protein_binding 55 13.00% GO:0005515 protein_binding 26 13.20% GO:0005515 protein_binding 36 11.39% GO:0005515 protein_binding 20 7.97% GO:0005515 protein_binding 18 8.78%
GO:0005524 ATP_binding 14 5.34% GO:0005524 ATP_binding 13 3.50% GO:0003677 DNA_binding 15 3.55% GO:0008134 transcription_factor_binding 6 3.05% GO:0005524 ATP_binding 14 4.43% GO:0005524 ATP_binding 9 3.59% GO:0020037 heme_binding 5 2.44%
GO:0004713 protein_tyrosine_kinase_activity7 2.67% GO:0003677 DNA_binding 12 3.23% GO:0005524 ATP_binding 12 2.84% GO:0005524 ATP_binding 6 3.05% GO:0003677 DNA_binding 12 3.80% GO:0020037 heme_binding 6 2.39% GO:0003713 transcription_coactivator_activity5 2.44%
GO:0003677 DNA_binding 7 2.67% GO:0042802 identical_protein_binding 9 2.43% GO:0003824 catalytic_activity 12 2.84% GO:0003779 actin_binding 6 3.05% GO:0003824 catalytic_activity 11 3.48% GO:0003702 RNA_polymerase_II_transcription_factor_activity5 1.99% GO:0042803 protein_homodimerization_activity4 1.95%
GO:0042803 protein_homodimerization_activity6 2.29% GO:0005488 binding 7 1.89% GO:0042802 identical_protein_binding 11 2.60% GO:0020037 heme_binding 5 2.54% GO:0019901 protein_kinase_binding 6 1.90% GO:0003682 chromatin_binding 5 1.99% GO:0042802 identical_protein_binding 4 1.95%
GO:0042802 identical_protein_binding 6 2.29% GO:0019904 protein_domain_specific_binding6 1.62% GO:0008134 transcription_factor_binding 9 2.13% GO:0008270 zinc_ion_binding 5 2.54% GO:0004713 protein_tyrosine_kinase_activity6 1.90% GO:0003677 DNA_binding 5 1.99% GO:0019904 protein_domain_specific_binding4 1.95%
GO:0005488 binding 6 2.29% GO:0016563 transcription_activator_activity6 1.62% GO:0003702 RNA_polymerase_II_transcription_factor_activity8 1.89% GO:0003824 catalytic_activity 5 2.54% GO:0003779 actin_binding 6 1.90% GO:0042803 protein_homodimerization_activity4 1.59% GO:0016491 oxidoreductase_activity 4 1.95%
GO:0003779 actin_binding 6 2.29% GO:0008270 zinc_ion_binding 6 1.62% GO:0003682 chromatin_binding 8 1.89% GO:0003677 DNA_binding 5 2.54% GO:0019904 protein_domain_specific_binding5 1.58% GO:0016563 transcription_activator_activity4 1.59% GO:0009055 electron_carrier_activity 4 1.95%
GO:0003774 motor_activity 6 2.29% GO:0008134 transcription_factor_binding 6 1.62% GO:0043565 sequence-specific_DNA_binding6 1.42% GO:0032559 adenyl_ribonucleotide_binding4 2.03% GO:0005488 binding 5 1.58% GO:0009055 electron_carrier_activity 4 1.59% GO:0008270 zinc_ion_binding 4 1.95%
GO:0000287 magnesium_ion_binding 6 2.29% GO:0003824 catalytic_activity 6 1.62% GO:0019904 protein_domain_specific_binding6 1.42% GO:0019904 protein_domain_specific_binding4 2.03% GO:0000287 magnesium_ion_binding 5 1.58% GO:0005488 binding 4 1.59% GO:0004300 enoyl-CoA_hydratase_activity4 1.95%
GO:0019901 protein_kinase_binding 5 1.91% GO:0003682 chromatin_binding 6 1.62% GO:0016563 transcription_activator_activity6 1.42% GO:0008017 microtubule_binding 4 2.03% GO:0042803 protein_homodimerization_activity4 1.27% GO:0004300 enoyl-CoA_hydratase_activity4 1.59% GO:0003723 RNA_binding 4 1.95%
GO:0008134 transcription_factor_binding 5 1.91% GO:0043565 sequence-specific_DNA_binding5 1.35% GO:0008270 zinc_ion_binding 6 1.42% GO:0003774 motor_activity 4 2.03% GO:0042802 identical_protein_binding 4 1.27% GO:0003824 catalytic_activity 4 1.59% GO:0046974 histone_methyltransferase_activity_(H3-K9_specific)3 1.46%
GO:0032559 adenyl_ribonucleotide_binding4 1.53% GO:0020037 heme_binding 5 1.35% GO:0005488 binding 6 1.42% GO:0046983 protein_dimerization_activity3 1.52% GO:0032093 SAM_domain_binding 4 1.27% GO:0003723 RNA_binding 4 1.59% GO:0043565 sequence-specific_DNA_binding3 1.46%
GO:0032093 SAM_domain_binding 4 1.53% GO:0008092 cytoskeletal_protein_binding5 1.35% GO:0003779 actin_binding 6 1.42% GO:0042802 identical_protein_binding 3 1.52% GO:0008656 caspase_activator_activity 4 1.27% GO:0003713 transcription_coactivator_activity4 1.59% GO:0042800 histone_methyltransferase_activity_(H3-K4_specific)3 1.46%
GO:0019904 protein_domain_specific_binding4 1.53% GO:0003779 actin_binding 5 1.35% GO:0003774 motor_activity 6 1.42% GO:0042623 ATPase_activity,_coupled 3 1.52% GO:0008134 transcription_factor_binding 4 1.27% GO:0046974 histone_methyltransferase_activity_(H3-K9_specific)3 1.20% GO:0035257 nuclear_hormone_receptor_binding3 1.46%
GO:0016563 transcription_activator_activity4 1.53% GO:0003723 RNA_binding 5 1.35% GO:0003713 transcription_coactivator_activity6 1.42% GO:0016563 transcription_activator_activity3 1.52% GO:0004709 MAP_kinase_kinase_kinase_activity4 1.27% GO:0043565 sequence-specific_DNA_binding3 1.20% GO:0019900 kinase_binding 3 1.46%
GO:0008656 caspase_activator_activity 4 1.53% GO:0003702 RNA_polymerase_II_transcription_factor_activity5 1.35% GO:0020037 heme_binding 5 1.18% GO:0008094 DNA-dependent_ATPase_activity3 1.52% GO:0004300 enoyl-CoA_hydratase_activity4 1.27% GO:0042802 identical_protein_binding 3 1.20% GO:0016508 long-chain-enoyl-CoA_hydratase_activity3 1.46%
GO:0008017 microtubule_binding 4 1.53% GO:0003700 transcription_factor_activity 5 1.35% GO:0003723 RNA_binding 5 1.18% GO:0005488 binding 3 1.52% GO:0003682 chromatin_binding 4 1.27% GO:0042800 histone_methyltransferase_activity_(H3-K4_specific)3 1.20% GO:0005524 ATP_binding 3 1.46%
GO:0004709 MAP_kinase_kinase_kinase_activity4 1.53% GO:0046982 protein_heterodimerization_activity4 1.08% GO:0003700 transcription_factor_activity 5 1.18% GO:0004130 cytochrome-c_peroxidase_activity3 1.52% GO:0046983 protein_dimerization_activity3 0.95% GO:0035257 nuclear_hormone_receptor_binding3 1.20% GO:0005488 binding 3 1.46%
GO:0003824 catalytic_activity 4 1.53% GO:0005198 structural_molecule_activity 4 1.08% GO:0042803 protein_homodimerization_activity4 0.95% GO:0003723 RNA_binding 3 1.52% GO:0042623 ATPase_activity,_coupled 3 0.95% GO:0019904 protein_domain_specific_binding3 1.20% GO:0004130 cytochrome-c_peroxidase_activity3 1.46%
GO:0046983 protein_dimerization_activity3 1.15% GO:0004674 protein_serine/threonine_kinase_activity4 1.08% GO:0032559 adenyl_ribonucleotide_binding4 0.95% GO:0003702 RNA_polymerase_II_transcription_factor_activity3 1.52% GO:0032559 adenyl_ribonucleotide_binding3 0.95% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen3 1.20% GO:0003857 3-hydroxyacyl-CoA_dehydrogenase_activity3 1.46%
GO:0046982 protein_heterodimerization_activity3 1.15% GO:0004300 enoyl-CoA_hydratase_activity4 1.08% GO:0019900 kinase_binding 4 0.95% GO:0003682 chromatin_binding 3 1.52% GO:0016563 transcription_activator_activity3 0.95% GO:0016508 long-chain-enoyl-CoA_hydratase_activity3 1.20% GO:0003779 actin_binding 3 1.46%
GO:0042623 ATPase_activity,_coupled 3 1.15% GO:0003774 motor_activity 4 1.08% GO:0016491 oxidoreductase_activity 4 0.95% GO:0003678 DNA_helicase_activity 3 1.52% GO:0016508 long-chain-enoyl-CoA_hydratase_activity3 0.95% GO:0005509 calcium_ion_binding 3 1.20% GO:0003702 RNA_polymerase_II_transcription_factor_activity3 1.46%
GO:0009055 electron_carrier_activity 3 1.15% GO:0051082 unfolded_protein_binding 3 0.81% GO:0009055 electron_carrier_activity 4 0.95% GO:0046790 virion_binding 2 1.02% GO:0008270 zinc_ion_binding 3 0.95% GO:0004130 cytochrome-c_peroxidase_activity3 1.20% GO:0003682 chromatin_binding 3 1.46%
GO:0008395 steroid_hydroxylase_activity3 1.15% GO:0019901 protein_kinase_binding 3 0.81% GO:0008092 cytoskeletal_protein_binding4 0.95% GO:0042393 histone_binding 2 1.02% GO:0008094 DNA-dependent_ATPase_activity3 0.95% GO:0003857 3-hydroxyacyl-CoA_dehydrogenase_activity3 1.20% GO:0051287 NAD_binding 2 0.98%
GO:0008092 cytoskeletal_protein_binding3 1.15% GO:0016508 long-chain-enoyl-CoA_hydratase_activity3 0.81% GO:0008017 microtubule_binding 4 0.95% GO:0030276 clathrin_binding 2 1.02% GO:0008017 microtubule_binding 3 0.95% GO:0003779 actin_binding 3 1.20% GO:0050660 FAD_binding 2 0.98%
GO:0005149 interleukin-1_receptor_binding3 1.15% GO:0009055 electron_carrier_activity 3 0.81% GO:0004842 ubiquitin-protein_ligase_activity4 0.95% GO:0019901 protein_kinase_binding 2 1.02% GO:0005509 calcium_ion_binding 3 0.95% GO:0051287 NAD_binding 2 0.80% GO:0046976 histone_methyltransferase_activity_(H3-K27_specific)2 0.98%
GO:0004674 protein_serine/threonine_kinase_activity3 1.15% GO:0008375 acetylglucosaminyltransferase_activity3 0.81% GO:0004300 enoyl-CoA_hydratase_activity4 0.95% GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 1.02% GO:0004842 ubiquitin-protein_ligase_activity3 0.95% GO:0046982 protein_heterodimerization_activity2 0.80% GO:0018812 3-hydroxyacyl-CoA_dehydratase_activity2 0.98%
GO:0003723 RNA_binding 3 1.15% GO:0008094 DNA-dependent_ATPase_activity3 0.81% GO:0046983 protein_dimerization_activity3 0.71% GO:0016410 N-acyltransferase_activity 2 1.02% GO:0004674 protein_serine/threonine_kinase_activity3 0.95% GO:0046976 histone_methyltransferase_activity_(H3-K27_specific)2 0.80% GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 0.98%
GO:0003682 chromatin_binding 3 1.15% GO:0005509 calcium_ion_binding 3 0.81% GO:0046974 histone_methyltransferase_activity_(H3-K9_specific)3 0.71% GO:0016407 acetyltransferase_activity 2 1.02% GO:0003857 3-hydroxyacyl-CoA_dehydrogenase_activity3 0.95% GO:0046790 virion_binding 2 0.80% GO:0016565 general_transcriptional_repressor_activity2 0.98%
GO:0051082 unfolded_protein_binding 2 0.76% GO:0005149 interleukin-1_receptor_binding3 0.81% GO:0042800 histone_methyltransferase_activity_(H3-K4_specific)3 0.71% GO:0015250 water_channel_activity 2 1.02% GO:0003774 motor_activity 3 0.95% GO:0042393 histone_binding 2 0.80% GO:0016509 long-chain-3-hydroxyacyl-CoA_dehydrogenase_activity2 0.98%
GO:0046790 virion_binding 2 0.76% GO:0004713 protein_tyrosine_kinase_activity3 0.81% GO:0042623 ATPase_activity,_coupled 3 0.71% GO:0009055 electron_carrier_activity 2 1.02% GO:0003678 DNA_helicase_activity 3 0.95% GO:0030276 clathrin_binding 2 0.80% GO:0015250 water_channel_activity 2 0.98%
GO:0042393 histone_binding 2 0.76% GO:0004130 cytochrome-c_peroxidase_activity3 0.81% GO:0035257 nuclear_hormone_receptor_binding3 0.71% GO:0008565 protein_transporter_activity 2 1.02% GO:0051287 NAD_binding 2 0.63% GO:0019900 kinase_binding 2 0.80% GO:0008692 3-hydroxybutyryl-CoA_epimerase_activity2 0.98%
GO:0031072 heat_shock_protein_binding2 0.76% GO:0003857 3-hydroxyacyl-CoA_dehydrogenase_activity3 0.81% GO:0016508 long-chain-enoyl-CoA_hydratase_activity3 0.71% GO:0008320 protein_transmembrane_transporter_activity2 1.02% GO:0046982 protein_heterodimerization_activity2 0.63% GO:0018812 3-hydroxyacyl-CoA_dehydratase_activity2 0.80% GO:0008375 acetylglucosaminyltransferase_activity2 0.98%
GO:0020037 heme_binding 2 0.76% GO:0003713 transcription_coactivator_activity3 0.81% GO:0008094 DNA-dependent_ATPase_activity3 0.71% GO:0008159 positive_transcription_elongation_factor_activity2 1.02% GO:0046790 virion_binding 2 0.63% GO:0016509 long-chain-3-hydroxyacyl-CoA_dehydrogenase_activity2 0.80% GO:0008320 protein_transmembrane_transporter_activity2 0.98%
GO:0019900 kinase_binding 2 0.76% GO:0003678 DNA_helicase_activity 3 0.81% GO:0005149 interleukin-1_receptor_binding3 0.71% GO:0008139 nuclear_localization_sequence_binding2 1.02% GO:0042393 histone_binding 2 0.63% GO:0016491 oxidoreductase_activity 2 0.80% GO:0008199 ferric_iron_binding 2 0.98%
GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 0.76% GO:0051287 NAD_binding 2 0.54% GO:0004713 protein_tyrosine_kinase_activity3 0.71% GO:0005149 interleukin-1_receptor_binding2 1.02% GO:0019900 kinase_binding 2 0.63% GO:0016410 N-acyltransferase_activity 2 0.80% GO:0008198 ferrous_iron_binding 2 0.98%
GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen2 0.76% GO:0046790 v rion_binding 2 0.54% GO:0004674 protein_serine/threonine_kinase_activity3 0.71% GO:0004713 protein_tyrosine_kinase_activity2 1.02% GO:0018812 3-hydroxyacyl-CoA_dehydratase_activity2 0.63% GO:0016407 acetyltransferase_activity 2 0.80% GO:0008159 positive_transcription_elongation_factor_activity2 0.98%
GO:0016491 oxidoreductase_activity 2 0.76% GO:0042393 histone_binding 2 0.54% GO:0004130 cytochrome-c_peroxidase_activity3 0.71% GO:0004674 protein_serine/threonine_kinase_activity2 1.02% GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 0.63% GO:0015250 water_channel_activity 2 0.80% GO:0008139 nuclear_localization_sequence_binding2 0.98%
GO:0015250 water_channel_activity 2 0.76% GO:0032559 adenyl_ribonucleotide_binding2 0.54% GO:0003857 3-hydroxyacyl-CoA_dehydrogenase_activity3 0.71% GO:0004003 ATP-dependent_DNA_helicase_activity2 1.02% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen2 0.63% GO:0008692 3-hydroxybutyryl-C A_epimer se_activity2 0.80% GO:0005149 interleukin-1_receptor_binding2 0.98%
GO:0008391 arachidonic_acid_monooxygenase_activity2 0.76% GO:0031072 heat_shock_protein_binding2 0.54% GO:0003678 DNA_helicase_activity 3 0.71% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.51% GO:0016565 general_transcriptional_repressor_activity2 0.63% GO:0008270 zinc_ion_binding 2 0.80% GO:0004713 protein_tyrosine_kinase_activity2 0.98%
GO:0008270 zinc_ion_binding 2 0.76% GO:0019900 kinase_binding 2 0.54% GO:0003676 nucleic_acid_binding 3 0.71% GO:0051427 hormone_receptor_binding 1 0.51% GO:0016509 long-chain-3-hydroxyacyl-CoA_dehydrogenase_activity2 0.63% GO:0008134 transcription_factor_binding 2 0.80% GO:0004674 protein_serine/threonine_kinase_activity2 0.98%
GO:0008159 positive_transcription_elongation_factor_activity2 0.76% GO:0018812 3-hydroxyacyl-CoA_dehydratase_activity2 0.54% GO:0051287 NAD_binding 2 0.47% GO:0047800 cysteamine_dioxygenase_activity1 0.51% GO:0016491 oxidoreductase_activity 2 0.63% GO:0008094 DNA-dependent_ATPase_activity2 0.80% GO:0004322 ferroxidase_activity 2 0.98%
GO:0008094 DNA-dependent_ATPase_activity2 0.76% GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 0.54% GO:0050660 FAD_binding 2 0.47% GO:0046982 protein_heterodimerization_activity1 0.51% GO:0016410 N-acyltransferase_activity 2 0.63% GO:0008092 cytoskeletal_protein_binding2 0.80% GO:0004165 dodecenoyl-CoA_delta-isomerase_activity2 0.98%
GO:0005509 calcium_ion_binding 2 0.76% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen2 0.54% GO:0046982 protein_het rodimerization_a tivity2 0.47% GO:0045296 cadherin_binding 1 0.51% GO:0016407 acetyltransferase_activity 2 0.63% GO:0005261 cation_channel_activity 2 0.80% GO:0003988 acetyl-CoA_C-acyltransferase_activity2 0.98%
GO:0005261 cation_channel_activity 2 0.76% GO:0016565 general_transcriptional_repressor_activity2 0.54% GO:0046976 histone_methyltransferase_activity_(H3-K27_specific)2 0.47% GO:0045295 gamma-catenin_binding 1 0.51% GO:0015250 water_channel_activity 2 0.63% GO:0005198 structural_molecule_activity 2 0.80% GO:0003677 DNA_binding 2 0.98%
GO:0004197 cysteine-type_endopeptidase_activity2 0.76% GO:0016509 long-chain-3-hydroxyacyl-CoA_dehydrogenase_activity2 0.54% GO:0046790 virion_binding 2 0.47% GO:0045174 glutathione_dehydrogenase_(ascorbate)_activity1 0.51% GO:0009055 electron_carrier_activity 2 0.63% GO:0005149 interleukin-1_receptor_binding2 0.80% GO:0003676 nucleic_acid_binding 2 0.98%
GO:0003702 RNA_polymerase_II_transcription_factor_activity2 0.76% GO:0016491 oxidoreductase_activity 2 0.54% GO:0042393 histone_binding 2 0.47% GO:0043565 sequence-specific_DNA_binding1 0.51% GO:0008692 3-hydroxybutyryl-CoA_epimerase_activity2 0.63% GO:0004713 protein_tyrosine_kinase_activity2 0.80% GO:0000062 acyl-CoA_binding 2 0.98%
GO:0003678 DNA_helicase_activity 2 0.76% GO:0016410 N-acyltransferase_activity 2 0.54% GO:0030276 clathrin_binding 2 0.47% GO:0042803 protein_homodimerization_activity1 0.51% GO:0008375 acetylglucosaminyltransferase_activity2 0.63% GO:0004674 protein_serine/threonine_kinase_activity2 0.80% GO:0070006 metalloaminopeptidase_activity1 0.49%
GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.38% GO:0016407 acetyltransferase_activity 2 0.54% GO:0019901 protein_kinase_binding 2 0.47% GO:0030145 manganese_ion_binding 1 0.51% GO:0008320 protein_transmembrane_transporter_activity2 0.63% GO:0004497 monooxygenase_activity 2 0.80% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.49%
GO:0051427 hormone_receptor_binding 1 0.38% GO:0015250 water_channel_activity 2 0.54% GO:0018812 3-hydroxyacyl-CoA_dehydratase_activity2 0.47% GO:0019900 kinase_binding 1 0.51% GO:0008159 positive_transcription_elongation_factor_activity2 0.63% GO:0004165 dodecenoyl-CoA_delta-isomerase_activity2 0.80% GO:0051427 hormone_receptor_binding 1 0.49%
GO:0048365 Rac_GTPase_binding 1 0.38% GO:0008692 3-hydroxybutyryl-CoA_epimerase_activity2 0.54% GO:0016944 RNA_polymerase_II_transcription_elongation_factor_activity2 0.47% GO:0017137 Rab_GTPase_binding 1 0.51% GO:0008139 nuclear_localization_sequence_binding2 0.63% GO:0004003 ATP-dependent_DNA_helicase_activity2 0.80% GO:0050662 coenzyme_binding 1 0.49%
GO:0048306 calcium-dependent_protein_binding1 0.38% GO:0008320 protein_transmembrane_transporter_activity2 0.54% GO:0016565 general_transcriptional_repressor_activity2 0.47% GO:0016782 transferase_activity,_transferring_sulfur-containing_groups1 0.51% GO:0008092 cytoskeletal_protein_binding2 0.63% GO:0003988 acetyl-CoA_C-acyltransferase_activity2 0.80% GO:0050660 flavin_adenine_dinucleotide_binding1 0.49%
GO:0047800 cysteamine_dioxygenase_activity1 0.38% GO:0008159 positive_transcription_elongation_factor_activity2 0.54% GO:0016509 long-chain-3-hydroxyacyl-CoA_dehydrogenase_activity2 0.47% GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.51% GO:0005261 c tion_channel_activity 2 0.63% GO:0003678 DNA_helicase_activity 2 0.80% GO:0047800 cysteamine_dioxygenase_activity1 0.49%
GO:0047485 protein_N-terminus_binding 1 0.38% GO:0008139 nuclear_localization_sequence_binding2 0.54% GO:0016410 N-acyltransferase_activity 2 0.47% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.51% GO:0005149 interleukin-1_receptor_binding2 0.63% GO:0003676 nucleic_acid_binding 2 0.80% GO:0046982 protein_heterodimerization_activity1 0.49%
GO:0045296 cadherin_binding 1 0.38% GO:0008026 ATP-dependent_helicase_activity2 0.54% GO:0016407 acetyltransferase_activity 2 0.47% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen1 0.51% GO:0004165 dodecenoyl-CoA_delta-isomerase activity2 0.63% GO:0000062 acyl-CoA_binding 2 0.80% GO:0045296 cadherin_binding 1 0.49%
GO:0045295 gamma-catenin_binding 1 0.38% GO:0005261 cation_channel_activity 2 0.54% GO:0015250 water_channel_activity 2 0.47% GO:0016688 L-ascorbate_peroxidase_activity1 0.51% GO:0004003 ATP-dependent_DNA_helicase_activity2 0.63% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.40% GO:0045295 gamma-catenin_binding 1 0.49%
GO:0043565 sequence-specific_DNA_binding1 0.38% GO:0004165 dodecenoyl-CoA_delta-isomerase_activity2 0.54% GO:0008692 3-hydroxybutyryl-CoA_epimerase_activity2 0.47% GO:0016491 oxidoreductase_activity 1 0.51% GO:0003988 acetyl-CoA_C-acyltransferase_activity2 0.63% GO:0051427 hormone_receptor_binding 1 0.40% GO:0042054 histone_methyltransferase_activity1 0.49%
GO:0042277 peptide_binding 1 0.38% GO:0004003 ATP-dependent_DNA_helicase_activity2 0.54% GO:0008565 protein_transporter_activity 2 0.47% GO:0016301 kinase_activity 1 0.51% GO:0003723 RNA_binding 2 0.63% GO:0050662 coenzyme_binding 1 0.40% GO:0032559 adenyl_ribonucleotide_binding1 0.49%
GO:0031434 mitogen-activated_protein_kinase_kinase_binding1 0.38% GO:0003988 acetyl-CoA_C-acyltransferase_activity2 0.54% GO:0008375 acetylglucosaminyltransferase_activity2 0.47% GO:0015288 porin_activity 1 0.51% GO:0003713 transcription_coactivator_activity2 0.63% GO:0048306 calcium-dependent_protein_binding1 0.40% GO:0030276 clathrin_binding 1 0.49%
GO:0030984 kininogen_binding 1 0.38% GO:0003735 structural_constituent_of_ribosome2 0.54% GO:0008320 protein_transmembrane_transporter_activity2 0.47% GO:0015205 nucleobase_transmembrane_transporter_activity1 0.51% GO:0003702 RNA_polymerase_II_transcription_factor_activity2 0.63% GO:0047958 glycine:2-oxoglutarate_aminotransferase_activity1 0.40% GO:0030145 manganese_ion_binding 1 0.49%
GO:0030528 transcription_regulator_activity1 0.38% GO:0003729 mRNA_binding 2 0.54% GO:0008199 ferric_iron_binding 2 0.47% GO:0015112 nitrate_transmembrane_transporter_activity1 0.51% GO:0003700 transcription_factor_activity 2 0.63% GO:0047800 cysteamine_dioxygenase_activity1 0.40% GO:0019901 protein_kinase_binding 1 0.49%
GO:0030276 clathrin_binding 1 0.38% GO:0003712 transcription_cofactor_activity2 0.54% GO:0008198 ferrous_iron_binding 2 0.47% GO:0008395 steroid_hydroxylase_activity1 0.51% GO:0000062 acyl-CoA_binding 2 0.63% GO:0047485 protein_N-terminus_binding 1 0.40% GO:0018024 histone-lysine_N-methyltransferase_activity1 0.49%
GO:0030145 manganese_ion_binding 1 0.38% GO:0003700 sequence-specific_DNA_binding_transcription_factor_activity2 0.54% GO:0008159 positive_transcription_elongation_factor_activity2 0.47% GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.51% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.32% GO:0046914 transition_metal_ion_binding1 0.40% GO:0017137 Rab_GTPase_binding 1 0.49%
GO:0017137 Rab_GTPase_binding 1 0.38% GO:0000287 magnesium_ion_binding 2 0.54% GO:0008139 nuclear_localization_sequence_binding2 0.47% GO:0008391 arachidonic_acid_monooxygenase_activity1 0.51% GO:0051427 hormone_receptor_binding 1 0.32% GO:0046872 metal_ion_binding 1 0.40% GO:0017046 peptide_hormone_binding 1 0.49%
GO:0017111 nucleoside-triphosphatase_activity1 0.38% GO:0000062 acyl-CoA_binding 2 0.54% GO:0005507 copper_ion_binding 2 0.47% GO:0008092 cytoskeletal_protein_binding1 0.51% GO:0050662 coenzyme_binding 1 0.32% GO:0043499 eukaryotic_cell_surface_binding1 0.40% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.49%
GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.38% GO:0051787 misfolded_protein_binding 1 0.27% GO:0005261 cation_channel_activity 2 0.47% GO:0008026 ATP-dependent_helicase_activity1 0.51% GO:0048306 calcium-dependent_protein_binding1 0.32% GO:0042054 histone_methyltransferase_activity1 0.40% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen1 0.49%
GO:0016709 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_NADH_or_NADPH_as_one_donor,_and_incorporation_of_one_atom_of_oxygen1 0.38% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase activity1 0.27% GO:0004322 ferroxi ase_activity 2 0.47% GO:0005545 phosphatidylinositol_binding1 0.51% GO:0047958 glycine:2-oxoglutarate_aminotransferase_activity1 0.32% GO:0032559 adenyl_ribonucleotide_binding1 0.40% GO:0016688 L-ascorbate_peroxidase_activity1 0.49%
GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.38% GO:0051427 h rm ne_receptor_binding 1 0.27% GO:0004165 dodecenoyl-CoA_delta-is merase_activity2 0.47% GO:0005545 1-phosphatidylinositol_binding1 0.51% GO:0047800 cysteamine_dioxygenase_activity1 0.32% GO:0030971 receptor_tyrosine_kinase_binding1 0.40% GO:0016563 transcription_activator_activity1 0.49%
GO:0016566 specific_transcriptional_repressor_activity1 0.38% GO:0051087 chaperone_binding 1 0.27% GO:0004003 ATP-dependent_DNA_helicase_activity2 0.47% GO:0005539 glycosaminoglycan_binding 1 0.51% GO:0047485 protein_N-terminus_binding 1 0.32% GO:0030674 protein_binding,_bridging 1 0.40% GO:0016301 kinase_activity 1 0.49%
GO:0016301 kinase_activity 1 0.38% GO:0050662 coenzyme_binding 1 0.27% GO:0003988 acetyl-CoA_C-acyltransferase_activity2 0.47% GO:0005529 sugar_binding 1 0.51% GO:0046914 transition_metal_ion_binding1 0.32% GO:0030528 transcription_regulator_activity1 0.40% GO:0015288 porin_activity 1 0.49%
GO:0015459 potassium_channel_regulator_activity1 0.38% GO:0048306 calcium-dependent_protein_binding1 0.27% GO:0003735 structural_constituent_of_ribosome2 0.47% GO:0005525 GTP_binding 1 0.51% GO:0046872 metal_ion_binding 1 0.32% GO:0030170 pyridoxal_phosphate_binding1 0.40% GO:0015234 thiamin_transmembrane_transporter_activity1 0.49%
GO:0015288 porin_activity 1 0.38% GO:0047800 cysteamine_dioxygenase_activity1 0.27% GO:0003729 mRNA_binding 2 0.47% GO:0005261 cation_channel_activity 1 0.51% GO:0045296 cadherin_binding 1 0.32% GO:0019899 enzyme_binding 1 0.40% GO:0015228 coenzyme_A_transmembrane_transporter_activity1 0.49%
GO:0015234 thiamin_transmembrane_transporter_activity1 0.38% GO:0047485 protein_N-terminus_binding 1 0.27% GO:0003700 sequence-specific_DNA_binding_transcription_factor_activity2 0.47% GO:0005212 structural_constituent_of_eye_lens1 0.51% GO:0045295 gamma-catenin_binding 1 0.32% GO:0019834 phospholipase_A2_inhibitor_activity1 0.40% GO:0015205 nucleobase_transmembrane_transporter_activity1 0.49%
GO:0015228 coenzyme_A_transmembrane_transporter_activity1 0.38% GO:0047274 galactinol-sucrose_galactosyltransferase_activity1 0.27% GO:0000287 magnesium_ion_binding 2 0.47% GO:0005198 structural_molecule_activity 1 0.51% GO:0043565 sequence-specific_DNA_binding1 0.32% GO:0019199 transmembrane_receptor_protein_kinase_activity1 0.40% GO:0015112 nitrate_transmembrane_transporter_activity1 0.49%
GO:0015205 nucleobase_transmembrane_transporter_activity1 0.38% GO:0047268 galactinol-raffinose_galactosyltransferase_activity1 0.27% GO:0000062 acyl-CoA_binding 2 0.47% GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.51% GO:0043499 eukaryotic_cell_surface_binding1 0.32% GO:0018024 histone-lysine_N-methyltransferase_activity1 0.40% GO:0008565 protein_transporter_activity 1 0.49%
GO:0015112 nitrate_transmembrane_transporter_activity1 0.38% GO:0046983 protein_dimerization_activity1 0.27% GO:0051750 delta3,5-delta2,4-dienoyl-CoA_isomerase_activity1 0.24% GO:0005057 receptor_signaling_protein_activity1 0.51% GO:0030971 receptor_tyrosine_kinase_binding1 0.32% GO:0016847 1-aminocyclopropane-1-carboxylate_synthase_activity1 0.40% GO:0008395 steroid_hydroxylase_activity1 0.49%
GO:0015066 alpha-amylase_inhibitor_activity1 0.38% GO:0046914 transition_metal_ion_binding1 0.27% GO:0051427 hormone_receptor_binding 1 0.24% GO:0005003 ephrin_receptor_activity 1 0.51% GO:0030674 protein_binding,_bridging 1 0.32% GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.40% GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.49%
GO:0008415 acyltransferase_activity 1 0.38% GO:0046872 metal_ion_binding 1 0.27% GO:0050662 coenzyme_binding 1 0.24% GO:0004734 pyrimidodiazepine_synthase_activity1 0.51% GO:0030234 enzyme_regulator_activity 1 0.32% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.40% GO:0008391 arachidonic_acid_mono xygenase_activity1 0.49%
GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.38% GO:0046332 SMAD_binding 1 0.27% GO:0050660 flavin_adenine_dinucleotide_binding1 0.24% GO:0004722 protein_serine/threonine_phosphatase_activity1 0.51% GO:0030170 pyridoxal_phosphate_binding1 0.32% GO:0016688 L-ascorbate_peroxidase_activity1 0.40% GO:0008236 serine-type_peptidase_activity1 0.49%
GO:0008048 calcium_sensitive_guanylate_cyclase_activator_activity1 0.38% GO:0045296 cadherin_binding 1 0.27% GO:0048306 calcium-dependent_protein_binding1 0.24% GO:0004693 cyclin-dependent_protein_kinase_activity1 0.51% GO:0030145 manganese_ion_binding 1 0.32% GO:0016566 specific_transcriptional_repressor_activity1 0.40% GO:0008134 transcription_factor_binding 1 0.49%
GO:0008026 ATP-dependent_helicase_activity1 0.38% GO:0045295 gamma-catenin_binding 1 0.27% GO:0047800 cysteamine_dioxygenase_activity1 0.24% GO:0004601 peroxidase_activity 1 0.51% GO:0020037 heme_binding 1 0.32% GO:0016565 general_transcriptional_repressor_activity1 0.40% GO:0008017 microtubule_binding 1 0.49%
GO:0008022 protein_C-terminus_binding 1 0.38% GO:0043559 insulin_binding 1 0.27% GO:0047485 protein_N-terminus_binding 1 0.24% GO:0004386 helicase_activity 1 0.51% GO:0019834 phospholipase_A2_inhibitor_activity1 0.32% GO:0016301 kinase_activity 1 0.40% GO:0005545 phosphatidylinositol_binding1 0.49%
GO:0005545 phosphatidylinositol_binding1 0.38% GO:0043499 eukaryotic_cell_surface_binding1 0.27% GO:0047274 galactinol-sucrose_galactosyltransferase_activity1 0.24% GO:0004300 enoyl-CoA_hydratase_activity1 0.51% GO:0017137 Rab_GTPase_binding 1 0.32% GO:0015459 potassium_channel_regulator_activity1 0.40% GO:0005545 1-phosphatidylinositol_binding1 0.49%
GO:0005545 1-phosphatidylinositol_binding1 0.38% GO:0043498 cell_surface_binding 1 0.27% GO:0047268 galactinol-raffinose_galactosyltransferase_activity1 0.24% GO:0003714 transcription_corepressor_activity1 0.51% GO:0017111 nucleoside-triphosphatase_activity1 0.32% GO:0015288 porin_activity 1 0.40% GO:0005539 glycosaminoglycan_binding 1 0.49%
GO:0005539 glycosaminoglycan_binding 1 0.38% GO:0042803 protein_homodimerization_activity1 0.27% GO:0046915 transition_metal_ion_transmembrane_transporter_activity1 0.24% GO:0003713 transcription_coactivator_activity1 0.51% GO:0016847 1-aminocyclopropane-1-carboxylate_synthase_activity1 0.32% GO:0015234 thiamin_transmembrane_transporter_activity1 0.40% GO:0005529 sugar_binding 1 0.49%
GO:0005529 sugar_binding 1 0.38% GO:0042623 ATPase_activity,_coupled 1 0.27% GO:0046872 metal_ion_binding 1 0.24% GO:0003712 transcription_cofactor_activity1 0.51% GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.32% GO:0015228 coenzyme_A_transmembrane_transporter_activity1 0.40% GO:0005525 GTP_binding 1 0.49%
GO:0005525 GTP_binding 1 0.38% GO:0035091 phosphoinositide_binding 1 0.27% GO:0046332 SMAD_binding 1 0.24% GO:0003704 specific_RNA_polymerase_II_transcription_factor_activity1 0.51% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.32% GO:0015205 nucle base_transmembrane_transporter_activity1 0.40% GO:0005509 calcium_ion_binding 1 0.49%
GO:0005507 copper_ion_binding 1 0.38% GO:0030971 receptor_tyrosine_kinase_binding1 0.27% GO:0045296 cadherin_binding 1 0.24% GO:0003700 transcription_factor_activity 1 0.51% GO:0016566 specific_transcriptional_repressor_activity1 0.32% GO:0015112 nitrate_transmembrane_transporter_activity1 0.40% GO:0005507 copper_ion_binding 1 0.49%
GO:0005476 carnitine:acyl_carnitine_antiporter_activity1 0.38% GO:0030674 protein_binding,_bridging 1 0.27% GO:0045295 gamma-catenin_binding 1 0.24% GO:0000287 magnesium_ion_binding 1 0.51% GO:0016564 transcription_repressor_activity1 0.32% GO:0015066 alpha-amylase_inhibitor_activity1 0.40% GO:0005476 carnitine:acyl_carnitine_antiporter_activity1 0.49%
GO:0005471 ATP:ADP_antiporter_activity1 0.38% GO:0030528 transcription_regulator_activity1 0.27% GO:0042626 ATPase_activity,_coupled_to_transmembrane_movement_of_substances1 0.24% GO:0015459 potassium_channel_regulator_activity1 0.32% GO:0009978 allene_oxide_synthase_activity1 0.40% GO:0005471 ATP:ADP_antiporter_activity1 0.49%
GO:0005246 calcium_channel_regulator_activity1 0.38% GO:0030276 clathrin_binding 1 0.27% GO:0042054 histone_methyltransferase_activity1 0.24% GO:0015288 porin_activity 1 0.32% GO:0008565 protein_transporter_activity 1 0.40% GO:0005261 cation_channel_activity 1 0.49%
GO:0005215 transporter_activity 1 0.38% GO:0030234 enzyme_regulator_activity 1 0.27% GO:0031957 very_long-chain_fatty_acid-CoA_ligase_activity1 0.24% GO:0015234 thiamin_transmembrane_transporter_activity1 0.32% GO:0008453 alanine-glyoxylate_transaminase_activity1 0.40% GO:0005212 structural_constituent_of_eye_lens1 0.49%
GO:0005212 structural_constituent_of_eye_lens1 0.38% GO:0030145 manganese_ion_binding 1 0.27% GO:0030528 transcription_regulator_activity1 0.24% GO:0015228 coenzyme_A_transmembrane_transporter_activity1 0.32% GO:0008396 oxysterol_7-alpha-hydroxylase_activity1 0.40% GO:0005198 structural_molecule_activity 1 0.49%
GO:0005198 structural_molecule_activity 1 0.38% GO:0019899 enzyme_binding 1 0.27% GO:0030234 enzyme_regulator_activity 1 0.24% GO:0015205 nucleobase_transmembrane_transporter_activity1 0.32% GO:0008395 steroid_hydroxylase_activity1 0.40% GO:0005138 interleukin-6_receptor_binding1 0.49%
GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.38% GO:0019834 phospholipase_A2_inhibitor_activity1 0.27% GO:0030145 manganese_ion_binding 1 0.24% GO:0015112 nitrate_transmembrane_transporter_activity1 0.32% GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.40% GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.49%
GO:0005057 receptor_signaling_protein_activity1 0.38% GO:0019783 small_conjugating_protein-specific_protease_activity1 0.27% GO:0022857 transmembrane_transporter_activity1 0.24% GO:0010283 pinoresinol_reductase_activity1 0.32% GO:0008391 arachidonic_acid_monooxygenase_activity1 0.40% GO:0005057 receptor_signaling_protein_activity1 0.49%
GO:0005003 ephrin_receptor_activity 1 0.38% GO:0019199 transmembrane_receptor_protein_kinase_activity1 0.27% GO:0019899 enzyme_binding 1 0.24% GO:0008565 protein_transporter_activity 1 0.32% GO:0008375 acetylglucosaminyltransferase_activity1 0.40% GO:0005003 ephrin_receptor_activity 1 0.49%
GO:0004867 serine-type_endopeptidase_inhibitor_activity1 0.38% GO:0017137 Rab_GTPase_binding 1 0.27% GO:0019199 transmembrane_receptor_protein_kinase_activity1 0.24% GO:0008453 alanine-glyoxylate_transaminase_activity1 0.32% GO:0008081 phosphoric_diester_hydrolase_activity1 0.40% GO:0004722 protein_serine/threonine_phosphatase_activity1 0.49%
GO:0004843 ubiquitin-specific_protease_activity1 0.38% GO:0017111 nucleoside-triphosphatase_activity1 0.27% GO:0018024 histone-lysine_N-methyltransferase_activity1 0.24% GO:0008395 steroid_hydroxylase_activity1 0.32% GO:0008048 calcium_sensitive_guanylate_cyclase_activator_activity1 0.40% GO:0004693 cyclin-dependent_protein_kinase_activity1 0.49%
GO:0004819 glutamine-tRNA_ligase_activity1 0.38% GO:0017048 Rho_GTPase_binding 1 0.27% GO:0017137 Rab_GTPase_binding 1 0.24% GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.32% GO:0008026 ATP-dependent_helicase_activity1 0.40% GO:0004601 peroxidase_activity 1 0.49%
GO:0004818 glutamate-tRNA_ligase_activity1 0.38% GO:0016887 ATPase_activity 1 0.27% GO:0016887 ATPase_activity 1 0.24% GO:0008391 arachidonic_acid_monooxygenase_activity1 0.32% GO:0008022 protein_C-terminus_binding 1 0.40% GO:0003824 catalytic_activity 1 0.49%
GO:0004723 calcium-dependent_protein_serine/threonine_phosphatase_activity1 0.38% GO:0016836 hydro-lyase_activity 1 0.27% GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.24% GO:0008081 phosphoric_diester_hydrolase_activity1 0.32% GO:0008017 microtubule_binding 1 0.40% GO:0003774 motor_activity 1 0.49%
GO:0004722 protein_serine/threonine_phosphatase_activity1 0.38% GO:0016787 hydrolase_activity 1 0.27% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.24% GO:0008048 calcium_sensitive_guanylate_cyclase_activator_activity1 0.32% GO:0005546 phosphatidylinositol-4,5-bisphosphate_binding1 0.40% GO:0001595 angiotensin_receptor_activity1 0.49%
GO:0004706 JUN_kinase_kinase_kinase_activity1 0.38% GO:0016747 transferase_activity,_transferring_acyl_groups_other_than_amino-acyl_groups1 0.27% GO:0016705 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen1 0.24% GO:0008026 ATP-dependent_helicase_activity1 0.32% GO:0005545 phosphatidylinositol_binding1 0.40% GO:0000295 adenine_nucleotide_transmembrane_transporter_activity1 0.49%
GO:0004693 cyclin-dependent_protein_kinase_activity1 0.38% GO:0016706 oxidoreductase_activity,_acting_on_paired_donors,_with_incorporation_or_reduction_of_molecular_oxygen,_2-oxoglutarate_as_one_donor,_and_incorporation_of_one_atom_each_of_oxygen_into_both_donors1 0.27% GO:0016688 L-ascorbate_peroxidase_activity1 0.24% GO:0008022 pr ein_C-terminus_binding 1 0.32% GO:0005545 1-phosphatidylinositol_binding1 0.40% GO:0000287 magnesium_ion_binding 1 0.49%
GO:0004497 monooxygenase_activity 1 0.38% GO:0016688 L-ascorbate_peroxidase_activity1 0.27% GO:0016566 specific_transcriptional_repressor_activity1 0.24% GO:0005546 phosphatidylinositol-4,5-bisphosphate_binding1 0.32% GO:0005544 calcium-dependent_phospholipid_binding1 0.40%
GO:0004304 estrone_sulfotransferase_activity1 0.38% GO:0016566 specific_transcriptional_repressor_activity1 0.27% GO:0016564 transcription_repressor_activity1 0.24% GO:0005544 calcium-dependent_phospholipid_binding1 0.32% GO:0005539 glycosaminoglycan_binding 1 0.40%
GO:0004300 enoyl-CoA_hydratase_activity1 0.38% GO:0016301 kinase_activity 1 0.27% GO:0016301 kinase_activity 1 0.24% GO:0005539 glycosaminoglycan_binding 1 0.32% GO:0005507 copper_ion_binding 1 0.40%
GO:0004221 ubiquitin_thiolesterase_activity1 0.38% GO:0015459 potassium_channel_regulator_activity1 0.27% GO:0015459 potassium_channel_regulator_activity1 0.24% GO:0005529 sugar_binding 1 0.32% GO:0005476 carnitine:acyl_carnitine_antiporter_activity1 0.40%
GO:0004177 aminopeptidase_activity 1 0.38% GO:0015288 porin_activity 1 0.27% GO:0015288 porin_activity 1 0.24% GO:0005525 GTP_binding 1 0.32% GO:0005471 ATP:ADP_antiporter_activity1 0.40%
GO:0003700 transcription_factor_activity 1 0.38% GO:0015234 thiamin_transmembrane_transporter_activity1 0.27% GO:0015205 nucleobase_transmembrane_transporter_activity1 0.24% GO:0005507 copper_ion_binding 1 0.32% GO:0005246 calcium_channel_regulator_activity1 0.40%
GO:0003700 sequence-specific_DNA_binding_transcription_factor_activity1 0.38% GO:0015228 coenzyme_A_transmembrane_transporter_activity1 0.27% GO:0015112 nitrate_transmembrane_transporter_activity1 0.24% GO:0005476 carnitine:acyl_carnitine_antiporter_activity1 0.32% GO:0005212 structural_constituent_of_eye_lens1 0.40%
GO:0003690 double-stranded_DNA_binding1 0.38% GO:0015205 nucleobase_transmembrane_transporter_activity1 0.27% GO:0015082 di-,_tri-valent_inorganic_cation_transmembrane_transporter_activity1 0.24% GO:0005471 ATP:ADP_antiporter_activity1 0.32% GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.40%
GO:0000295 adenine_nucleotide_transmembrane_transporter_activity1 0.38% GO:0015112 nitrate_transmembrane_transporter_activity1 0.27% GO:0010283 pinoresinol_reductase_activity1 0.24% GO:0005246 calcium_channel_regulator_activity1 0.32% GO:0005057 receptor_signaling_protein_activity1 0.40%
GO:0000166 nucleotide_binding 1 0.38% GO:0015066 alpha-amylase_inhibitor_activity1 0.27% GO:0008415 acyltransferase_activity 1 0.24% GO:0005215 transporter_activity 1 0.32% GO:0004867 serine-type_endopeptidase_inhibitor_activity1 0.40%
GO:0008824 cyanate_hydratase_activity 1 0.27% GO:0008395 steroid_hydroxylase_activity1 0.24% GO:0005212 structural_constituent_of_eye_lens1 0.32% GO:0004819 glutamine-tRNA_ligase_activity1 0.40%
GO:0008565 protein_transporter_activity 1 0.27% GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.24% GO:0005198 structural_molecule_activity 1 0.32% GO:0004818 glutamate-tRNA_ligase_activity1 0.40%
GO:0008499 UDP-galactose:beta-N-acetylglucosamine_beta-1,3-galactosyltransferase_activity1 0.27% GO:0008391 arachidonic_acid_monooxygenase_activity1 0.24% GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.32% GO:0004723 calcium-dependent_protein_serine/threonine_phosphatase_activity1 0.40%
GO:0008415 acyltransferase_activity 1 0.27% GO:0008176 tRNA_(guanine-N7-)-methyltransferase_activity1 0.24% GO:0005057 receptor_signaling_protein_activity1 0.32% GO:0004601 peroxidase_activity 1 0.40%
GO:0008395 steroid_hydroxylase_activity1 0.27% GO:0008081 phosphoric_diester_hydrolase_activity1 0.24% GO:0005003 ephrin_receptor_activity 1 0.32% GO:0004507 steroid_11-beta-monooxygenase_activity1 0.40%
GO:0008393 fatty_acid_(omega-1)-hydroxylase_activity1 0.27% GO:0008048 calcium_sensitive_guanylate_cyclase_activator_activity1 0.24% GO:0004819 glutamine-tRNA_ligase_activity1 0.32% GO:0004021 L-alanine:2-oxoglutarate_aminotransferase_activity1 0.40%
GO:0008391 arachidonic_acid_monooxygenase_activity1 0.27% GO:0008026 ATP-dependent_helicase_activity1 0.24% GO:0004818 glutamate-tRNA_ligase_activity1 0.32% GO:0004021 alanine_transaminase_activity1 0.40%
GO:0008378 galactosyltransferase_activity1 0.27% GO:0008022 protein_C-terminus_binding 1 0.24% GO:0004723 calcium-dependent_protein_serine/threonine_phosphatase_activity1 0.32% GO:0003843 1,3-beta-glucan_synthase_activity1 0.40%
GO:0008081 phosphoric_diester_hydrolase_activity1 0.27% GO:0005545 phosphatidylinositol_binding1 0.24% GO:0004722 protein_serine/threonine_phosphatase_activity1 0.32% GO:0003774 motor_activity 1 0.40%
GO:0008048 calcium_sensitive_guanylate_cyclase_activator_activity1 0.27% GO:0005545 1-phosphatidylinositol_binding1 0.24% GO:0004693 cyclin-dependent_protein_kinase_activity1 0.32% GO:0003700 transcription_factor_activity 1 0.40%
GO:0008022 protein_C-terminus_binding 1 0.27% GO:0005539 glycosaminoglycan_binding 1 0.24% GO:0004673 protein_histidine_kinase_activity1 0.32% GO:0003700 sequence-specific_DNA_binding_transcription_factor_activity1 0.40%
GO:0008017 microtubule_binding 1 0.27% GO:0005529 sugar_binding 1 0.24% GO:0004497 monooxygenase_activity 1 0.32% GO:0000295 adenine_nucleotide_transmembrane_transporter_activity1 0.40%
GO:0005546 phosphatidylinositol-4,5-bisphosphate_binding1 0.27% GO:0005525 GTP_binding 1 0.24% GO:0004386 helicase_activity 1 0.32% GO:0000287 magnesium_ion_binding 1 0.40%
GO:0005545 phosphatidylinositol_binding1 0.27% GO:0005509 calcium_ion_binding 1 0.24% GO:0004114 3',5'-cyclic-nucleotide_phosphodiesterase_activity1 0.32%
GO:0005545 1-phosphatidylinositol_binding1 0.27% GO:0005246 calcium_channel_regulator_activity1 0.24% GO:0004021 L-alanine:2-oxoglutarate_aminotransferase_activity1 0.32%
GO:0005544 calcium-dependent_phospholipid_binding1 0.27% GO:0005212 structural_constituent_of_eye_lens1 0.24% GO:0004021 alanine_transaminase_activity1 0.32%
GO:0005539 glycosaminoglycan_binding 1 0.27% GO:0005198 structural_molecule_activity 1 0.24% GO:0003712 transcription_cofactor_activity1 0.32%
GO:0005529 sugar_binding 1 0.27% GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.24% GO:0003700 sequence-specific_DNA_binding_transcription_factor_activity1 0.32%
GO:0005525 GTP_binding 1 0.27% GO:0005057 receptor_signaling_protein_activity1 0.24% GO:0003690 double-stranded_DNA_binding1 0.32%
GO:0005476 carnitine:acyl_carnitine_antiporter_activity1 0.27% GO:0005003 ephrin_receptor_activity 1 0.24% GO:0000295 adenine_nucleotide_transmembrane_transporter_activity1 0.32%
GO:0005471 ATP:ADP_antiporter_activity1 0.27% GO:0004872 receptor_activity 1 0.24% GO:0000156 two-component_response_regulator_activity1 0.32%
GO:0005246 calcium_channel_regulator_activity1 0.27% GO:0004843 ubiquitin-specific_protease_activity1 0.24%
GO:0005215 transporter_activity 1 0.27% GO:0004819 glutamine-tRNA_ligase_activity1 0.24%
GO:0005212 structural_constituent_of_eye_lens1 0.27% GO:0004818 glutamate-tRNA_ligase_activity1 0.24%
GO:0005126 hematopoietin/interferon-class_(D200-domain)_cytokine_receptor_binding1 0.27% GO:0004723 calcium-dependent_protein_serine/threonine_phosphatase_activity1 0.24%
GO:0005057 receptor_signaling_protein_activity1 0.27% GO:0004722 protein_serine/threonine_phosphatase_activity1 0.24%
GO:0005003 ephrin_receptor_activity 1 0.27% GO:0004721 phosphoprotein_phosphatase_activity1 0.24%
GO:0004872 receptor_activity 1 0.27% GO:0004693 cyclin-dependent_protein_kinase_activity1 0.24%
GO:0004867 serine-type_endopeptidase_inhibitor_activity1 0.27% GO:0004673 protein_histidine_kinase_activity1 0.24%
GO:0004842 ubiquitin-protein_ligase_activity1 0.27% GO:0004601 peroxidase_activity 1 0.24%
GO:0004819 glutamine-tRNA_ligase_activity1 0.27% GO:0004467 long-chain-fatty-acid-CoA_ligase_activity1 0.24%
GO:0004818 glutamate-tRNA_ligase_activity1 0.27% GO:0004467 long-chain_fatty_acid-CoA_ligase_activity1 0.24%
GO:0004723 calcium-dependent_protein_serine/threonine_phosphatase_activity1 0.27% GO:0004386 helicase_activity 1 0.24%
GO:0004722 protein_serine/threonine_phosphatase_activity1 0.27% GO:0004304 estrone_sulfotransferase_activity1 0.24%
GO:0004693 cyclin-dependent_protein_kinase_activity1 0.27% GO:0004221 ubiquitin_thiolesterase_activity1 0.24%
GO:0004673 protein_histidine_kinase_activity1 0.27% GO:0004197 cysteine-type_endopeptidase_activity1 0.24%
GO:0004601 peroxidase_activity 1 0.27% GO:0004114 3',5'-cyclic-nucleotide_phosphodiesterase_activity1 0.24%
GO:0004497 monooxygenase_activity 1 0.27% GO:0003987 acetate-CoA_ligase_activity 1 0.24%
GO:0004386 helicase_activity 1 0.27% GO:0003725 double-stranded_RNA_binding1 0.24%
GO:0004114 3',5'-cyclic-nucleotide_phosphodiesterase_activity1 0.27% GO:0003714 transcription_corepressor_activity1 0.24%
GO:0004004 ATP-dependent_RNA_helicase_activity1 0.27% GO:0003712 transcription_cofactor_activity1 0.24%
GO:0003714 transcription_corepressor_activity1 0.27% GO:0003704 specific_RNA_polymerase_II_transcription_factor_activity1 0.24%
GO:0003704 specific_RNA_polymerase_II_transcription_factor_activity1 0.27% GO:0000166 nucleotide_binding 1 0.24%
GO:0003697 single-stranded_DNA_binding1 0.27% GO:0000156 two-component_response_regulator_activity1 0.24%
GO:0003690 double-stranded_DNA_binding1 0.27%
GO:0003688 DNA_replication_origin_binding1 0.27%
GO:0002039 p53_binding 1 0.27%
GO:0002020 protease_binding 1 0.27%
GO:0001530 lipopolysaccharide_binding 1 0.27%
GO:0000295 adenine_nucleotide_transmembrane_transporter_activity1 0.27%
GO:0000156 two-component_response_regulator_activity1 0.27%
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Table S4.5. Salt stress 48 hour (Ss-48): 3'UTRs of salt stress responsive genes, the 24nt 
smRNA sequence and target genes  
(*The entire table cannot be displayed due to limitation of dissertation page size (only the top 
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WT Stress WT Stress Locus Genomic feature
Bradi1g20200.1 7 36 1.20 8.45 7.06 ID_32177 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.1 7 36 1.20 8.45 7.06 ID_54593 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.1 7 36 1.20 8.45 7.06 ID_63844 GAATTATGAAACGGAGGGAGTAGA - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 36 1.20 8.45 7.06 ID_32177 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 36 1.20 8.45 7.06 ID_54593 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 36 1.20 8.45 7.06 ID_63844 GAATTATGAAACGGAGGGAGTAGA - Bradi4g09040.1 mRNA
Bradi1g29350.1 2 8 0.34 1.88 5.49 ID_50613 AGATACATGTAATATTTTGACAAA + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 8 0.34 1.88 5.49 ID_50613 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 8 0.34 1.88 5.49 ID_50613 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 three_prime_utr
Bradi1g34230.1 1 8 0.17 1.88 10.97 ID_1589161 GTGTCCGGTTTTGAAAATTGAGGG + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 8 0.17 1.88 10.97 ID_1589161 GTGTCCGGTTTTGAAAATTGAGGG + Bradi2g12900.2 mRNA
Bradi1g35480.1 2 5 0.34 1.17 3.43 ID_1169859 AATTTGTCCAAATATATATGTATC + Bradi3g44790.1 mRNA
Bradi1g35480.1 2 5 0.34 1.17 3.43 ID_126335 AAAAAATATCTAGATACATGTAAT + Bradi3g43350.1 mRNA
Bradi1g35480.1 2 5 0.34 1.17 3.43 ID_1414946 TTGTCCAAATATATATGTATCTAT + Bradi3g44790.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi2g10400.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.2 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.3 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_166389 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_166389 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.2 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.3 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.1 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.2 mRNA
Bradi1g45270.1 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.3 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi2g10400.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.2 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_124236 ATTTCGACAAGAATTATGGAATGG + Bradi4g14870.3 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_166389 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_166389 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.2 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_34153 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.3 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.1 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.2 mRNA
Bradi1g45270.2 8 21 1.37 4.93 3.60 ID_54386 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.3 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_1106186 TAGGCTTTGTTTGGATGTAGACAT - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_34040 TTAGGCTTTGTTTGGATGTAGACA - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.2 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.3 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi4g21780.1 CDS
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi5g25290.1 mRNA
Bradi1g51450.2 20 66 3.42 15.49 4.53 ID_6242 AGGCTTTGTTTGGATGTAGACATT - Bradi5g25290.2 mRNA
Bradi1g54000.1 10 26 1.71 6.10 3.57 ID_17439 AGAGATCAATCGACATGTTAGCCA - Bradi4g27390.1 mRNA
Bradi1g57590.1 3 15 0.51 3.52 6.86 ID_110851 AAATAAGTGACGTGGATTTGTACA + Bradi1g04850.1 mRNA
Bradi1g57590.1 3 15 0.51 3.52 6.86 ID_110851 AAATAAGTGACGTGGATTTGTACA + Bradi1g04850.2 mRNA
Bradi1g57590.1 3 15 0.51 3.52 6.86 ID_110851 AAATAAGTGACGTGGATTTGTACA + Bradi1g41770.1 mRNA
Bradi1g57590.1 3 15 0.51 3.52 6.86 ID_110851 AAATAAGTGACGTGGATTTGTACA + Bradi3g20440.1 mRNA
Bradi1g57590.1 3 15 0.51 3.52 6.86 ID_259650 AAAATAAGTGACGTGGATTTGTAC + Bradi3g57690.1 mRNA
Bradi1g59920.1 1 5 0.17 1.17 6.86 ID_1012007 TTTCGTTAAGACAAGGCTTTGATC - Bradi3g53090.1 mRNA
Bradi1g59920.2 1 5 0.17 1.17 6.86 ID_1012007 TTTCGTTAAGACAAGGCTTTGATC - Bradi3g53090.1 mRNA
Bradi1g62460.1 3 169 0.51 39.68 77.28 ID_2576 ACGGAAAGTGTATCAAGCACGAGC + Bradi3g20550.1 mRNA
Bradi1g62460.1 3 169 0.51 39.68 77.28 ID_2576 ACGGAAAGTGTATCAAGCACGAGC + Bradi3g20550.2 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_10960 AGATTAATGTAGGTCCGATGGATA + Bradi1g74070.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_10960 AGATTAATGTAGGTCCGATGGATA + Bradi2g08190.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_10960 AGATTAATGTAGGTCCGATGGATA + Bradi3g08550.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_10960 AGATTAATGTAGGTCCGATGGATA + Bradi3g39920.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_10960 AGATTAATGTAGGTCCGATGGATA + Bradi3g39920.2 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_11565 GAGATTCGTGTAAGATTAATGTAG + Bradi1g74070.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_11565 GAGATTCGTGTAAGATTAATGTAG + Bradi2g08190.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_11565 GAGATTCGTGTAAGATTAATGTAG + Bradi3g36880.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_11565 GAGATTCGTGTAAGATTAATGTAG + Bradi3g39920.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_11565 GAGATTCGTGTAAGATTAATGTAG + Bradi3g39920.2 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_152574 AATGTAGGTCCGATGGATAAGAAA + Bradi1g63560.1 mRNA
Bradi1g64890.1 32 95 5.48 22.30 4.07 ID_152574 AATGTAGGTCCGATGGATAAGAAA + Bradi1g63560.1 three_prime_utr
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Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_2134519 CCCACTACTTGATTTCTCTCAACA + Bradi2g02200.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_2134519 CCCACTACTTGATTTCTCTCAACA + Bradi2g09350.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_2134519 CCCACTACTTGATTTCTCTCAACA + Bradi2g09350.2 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_2134519 CCCACTACTTGATTTCTCTCAACA + Bradi2g26310.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_2546951 GATTTCTCTCAACATACAAGCATG + Bradi3g06350.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_348874 ACCCACTACTTGATTTCTCTCAAC + Bradi2g02200.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_348874 ACCCACTACTTGATTTCTCTCAAC + Bradi2g09350.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_348874 ACCCACTACTTGATTTCTCTCAAC + Bradi2g09350.2 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_348874 ACCCACTACTTGATTTCTCTCAAC + Bradi2g26310.1 mRNA
Bradi1g09050.1 2 10 0.34 1.05 3.07 ID_727634 ATTTCTCTCAACATACAAGCATGC + Bradi3g06350.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_172518 TTTGAATACATCTATACACTAAGT + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_2347533 TGAGACATCTTTTGTTGGATGGAG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_2347533 TGAGACATCTTTTGTTGGATGGAG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_2347533 TGAGACATCTTTTGTTGGATGGAG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_283251 CATCTTTTGTTGGATGGAGGGAGT + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_283251 CATCTTTTGTTGGATGGAGGGAGT + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_283251 CATCTTTTGTTGGATGGAGGGAGT + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_307233 TGACTAAATTTGAATACATCTATA + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_310094 AATACATCTATACACTAAGTCATG + Bradi5g07190.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_315584 TTGACTAAATTTGAATACATCTAT + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_38188 GAGACATCTTTTGTTGGATGGAGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_38188 GAGACATCTTTTGTTGGATGGAGG + Bradi2g58840.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_38188 GAGACATCTTTTGTTGGATGGAGG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_38188 GAGACATCTTTTGTTGGATGGAGG + Bradi4g39410.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_38188 GAGACATCTTTTGTTGGATGGAGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_497603 ATTTGAATACATCTATACACTAAG + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_512864 AGACATCTTTTGTTGGATGGAGGG + Bradi4g39410.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_512864 AGACATCTTTTGTTGGATGGAGGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_786462 CTAAATTTGAATACATCTATACAC + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 42 0.68 4.42 6.46 ID_989547 TTGAATACATCTATACACTAAGTC + Bradi4g22590.1 mRNA
Bradi1g15590.1 2 31 0.34 3.26 9.53 ID_49515 AATGTATCTAGACATGACTTAGTG + Bradi5g03590.1 mRNA
Bradi1g15590.1 2 31 0.34 3.26 9.53 ID_78673 TGTCAAAATTTGAATGTATCTAGA + Bradi4g32830.1 mRNA
Bradi1g15590.1 2 31 0.34 3.26 9.53 ID_78673 TGTCAAAATTTGAATGTATCTAGA + Bradi4g36680.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi1g68720.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi2g00630.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_2843604 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.2 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.3 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.4 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi2g42470.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi3g41090.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.2 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.3 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.1 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi2g42470.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi2g00630.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_2843604 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.2 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.3 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.4 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi2g42470.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi3g41090.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.2 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.3 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi2g42470.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_2709997 TACGTATCATGATCTTTTGACTAT + Bradi2g00630.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_2843604 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.2 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.3 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi1g78560.4 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi2g42470.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi3g41090.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.2 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_321011 TAAAGATCTGAGTTGGTGGTCGCG + Bradi4g07970.3 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 21 0.51 2.21 4.30 ID_45474 ATACGTATCATGATCTTTTGACTA + Bradi2g42470.1 mRNA
Bradi1g18990.1 14 236 2.40 24.83 10.36 ID_2519722 TTTGAGACATCTTTTATTGGACGG + Bradi3g27990.1 mRNA
Bradi1g18990.1 14 236 2.40 24.83 10.36 ID_7412 TTTGAATGCATTTATACACTAAGT + Bradi1g29190.1 mRNA
Bradi1g18990.1 14 236 2.40 24.83 10.36 ID_7412 TTTGAATGCATTTATACACTAAGT + Bradi1g29190.2 mRNA
Bradi1g18990.1 14 236 2.40 24.83 10.36 ID_7412 TTTGAATGCATTTATACACTAAGT + Bradi3g46570.1 mRNA
Bradi1g20200.1 7 116 1.20 12.21 10.19 ID_27813 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
3' UTR loci Raw Count RPM Fold difference in expression smRNA ID 24 nt smRNA sequence smRNA polarity
Genes predicted to be targeted by smRNA
 170 
Table S4.7. Cold stress 24 hour (Cs-24): 3'UTRs of cold stress responsive genes, the 24nt 
smRNA sequence and target genes  
(*The entire table cannot be displayed due to limitation of dissertation page size (only the top 
80/2283 rows were displayed, please enlarge the table electronically and refer to the RNA 
journal publication website) 
 
 
  
WT Stress WT Stress Locus Genomic feature
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1125348 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_1641247 TGACTAAATCTGAATGCATCTATA - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2098492 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2157064 GACTAAATCTGAATGCATCTATAC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_2586645 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 7 0.17 0.80 4.69 ID_687457 AACTTTGACTAAATCTGAATGCAT - Bradi5g22310.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_148697 AGACATCTTTTGTTGGATGGAGGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_148697 AGACATCTTTTGTTGGATGGAGGG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_148697 AGACATCTTTTGTTGGATGGAGGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_21417 GAGACATCTTTTGTTGGATGGAGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_21417 GAGACATCTTTTGTTGGATGGAGG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_21417 GAGACATCTTTTGTTGGATGGAGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_2246359 TTGACTAAATTTGAATACATCTAT + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_511372 GACATCTTTTGTTGGATGGAGGGA + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_511372 GACATCTTTTGTTGGATGGAGGGA + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_511372 GACATCTTTTGTTGGATGGAGGGA + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_536617 AATACATCTATACACTAAGTCATG + Bradi5g07190.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_552039 ACATCTTTTGTTGGATGGAGGGAG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_552039 ACATCTTTTGTTGGATGGAGGGAG + Bradi2g58840.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_552039 ACATCTTTTGTTGGATGGAGGGAG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_552039 ACATCTTTTGTTGGATGGAGGGAG + Bradi4g39410.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_552039 ACATCTTTTGTTGGATGGAGGGAG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_606694 ATCTTTTGTTGGATGGAGGGAGTA + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_606694 ATCTTTTGTTGGATGGAGGGAGTA + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 44 0.68 5.04 7.37 ID_606694 ATCTTTTGTTGGATGGAGGGAGTA + Bradi4g40550.1 mRNA
Bradi1g14160.1 1 7 0.17 0.80 4.69 ID_205322 GTCGAAATATTACATATATCTAGA + Bradi4g20450.1 mRNA
Bradi1g14160.1 1 7 0.17 0.80 4.69 ID_268639 ATACTAAATTGTTGTCGAAATATT + Bradi3g51760.1 mRNA
Bradi1g14160.1 1 7 0.17 0.80 4.69 ID_268639 ATACTAAATTGTTGTCGAAATATT + Bradi3g51760.2 mRNA
Bradi1g16510.1 3 29 0.51 3.32 6.47 ID_22801 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.1 3 29 0.51 3.32 6.47 ID_3499542 ATCTGAGTTGGTGGTCGCGAGTTC + Bradi1g78560.1 mRNA
Bradi1g16510.1 3 29 0.51 3.32 6.47 ID_3499542 ATCTGAGTTGGTGGTCGCGAGTTC + Bradi1g78560.2 mRNA
Bradi1g16510.1 3 29 0.51 3.32 6.47 ID_3499542 ATCTGAGTTGGTGGTCGCGAGTTC + Bradi1g78560.3 mRNA
Bradi1g16510.1 3 29 0.51 3.32 6.47 ID_3499542 ATCTGAGTTGGTGGTCGCGAGTTC + Bradi1g78560.4 mRNA
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Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g66150.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.2 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.3 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.4 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.2 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi3g41090.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi1g68720.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi2g42470.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.1 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi2g00630.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g66150.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.2 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.3 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.4 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.2 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi3g41090.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi2g42470.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi2g00630.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g66150.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.2 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.3 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi1g78560.4 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi2g03580.2 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1145709 AGATCTGAGTTGGTGGTCGCGAGT + Bradi3g41090.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1291784 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_1532685 TATACGTATCATGATCTTTTGACT + Bradi2g42470.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 19 0.51 2.02 3.93 ID_53634 ATACGTATCATGATCTTTTGACTA + Bradi2g00630.1 mRNA
Bradi1g20200.1 7 40 1.20 4.25 3.55 ID_129609 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.1 7 40 1.20 4.25 3.55 ID_157445 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 40 1.20 4.25 3.55 ID_129609 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 40 1.20 4.25 3.55 ID_157445 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g29350.1 2 12 0.34 1.28 3.73 ID_69255 AGATACATGTAATATTTTGACAAA + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 12 0.34 1.28 3.73 ID_69255 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 12 0.34 1.28 3.73 ID_69255 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 three_prime_utr
Bradi1g43430.1 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi1g52680.1 mRNA
Bradi1g43430.1 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi1g72800.1 mRNA
Bradi1g43430.1 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi2g56500.1 mRNA
Bradi1g43430.1 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi4g27590.1 mRNA
Bradi1g43430.2 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi1g52680.1 mRNA
Bradi1g43430.2 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi1g72800.1 mRNA
Bradi1g43430.2 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi2g56500.1 mRNA
Bradi1g43430.2 1 10 0.17 1.06 6.21 ID_1311474 TTTGCCCAAATATGGATGTATCTG - Bradi4g27590.1 mRNA
Bradi1g45270.1 8 42 1.37 4.46 3.26 ID_103455 GACAAGAATTATGGAATGGAGGGA + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 42 1.37 4.46 3.26 ID_103455 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 42 1.37 4.46 3.26 ID_103455 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 42 1.37 4.46 3.26 ID_1612693 TTCGACAAGAATTATGGAATGGAG + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 42 1.37 4.46 3.26 ID_1612693 TTCGACAAGAATTATGGAATGGAG + Bradi4g08570.1 mRNA
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Bradi1g18990.1 14 132 2.40 12.55 5.24 ID_1111445 ACACTAAGTCATGTCTAGATACAT + Bradi1g65800.1 mRNA
Bradi1g18990.1 14 132 2.40 12.55 5.24 ID_1111445 ACACTAAGTCATGTCTAGATACAT + Bradi3g29700.1 mRNA
Bradi1g18990.1 14 132 2.40 12.55 5.24 ID_2095941 TTTGAGACATCTTTTATTGGACGG + Bradi3g27990.1 mRNA
Bradi1g18990.1 14 132 2.40 12.55 5.24 ID_587917 AAATTTGAGACATCTTTTATTGGA + Bradi3g27990.1 mRNA
Bradi1g20200.1 7 82 1.20 7.79 6.51 ID_51502 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.1 7 82 1.20 7.79 6.51 ID_52820 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 82 1.20 7.79 6.51 ID_51502 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 82 1.20 7.79 6.51 ID_52820 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g29350.1 2 19 0.34 1.81 5.28 ID_242996 ATCTAGATACATGTAATATTTTGA + Bradi1g21030.1 mRNA
Bradi1g29350.1 2 19 0.34 1.81 5.28 ID_242996 ATCTAGATACATGTAATATTTTGA + Bradi3g21320.1 mRNA
Bradi1g29350.1 2 19 0.34 1.81 5.28 ID_83009 AGATACATGTAATATTTTGACAAA + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 19 0.34 1.81 5.28 ID_83009 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 19 0.34 1.81 5.28 ID_83009 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 three_prime_utr
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_1806249 TGAAAATTGAGGGACGAAAAAAGT + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_1806249 TGAAAATTGAGGGACGAAAAAAGT + Bradi2g12900.2 mRNA
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_2717208 TTGAAAATTGAGGGACGAAAAAAG + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_2717208 TTGAAAATTGAGGGACGAAAAAAG + Bradi2g12900.2 mRNA
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_434498 CCGGTTTTGAAAATTGAGGGACGA + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 16 0.17 1.52 8.89 ID_434498 CCGGTTTTGAAAATTGAGGGACGA + Bradi2g12900.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.3 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi2g10400.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi5g05230.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_2313627 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_2313627 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi1g55670.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.3 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi2g10400.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi4g08570.1 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi4g08570.2 mRNA
Bradi1g45270.1 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi5g05230.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_1126468 AAGAATTATGGAATGGAGGGAGTA + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_130142 CAAGAATTATGGAATGGAGGGAGT + Bradi4g14870.3 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi2g10400.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_140236 ATTTCGACAAGAATTATGGAATGG + Bradi5g05230.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_2313627 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_2313627 ACAAGAATTATGGAATGGAGGGAG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_246373 GACAAGAATTATGGAATGGAGGGA + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi1g55670.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_27812 CGACAAGAATTATGGAATGGAGGG + Bradi4g14870.3 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi2g10400.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi4g08570.1 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi4g08570.2 mRNA
Bradi1g45270.2 8 56 1.37 5.32 3.89 ID_51379 TCGACAAGAATTATGGAATGGAGG + Bradi5g05230.1 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.1 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.2 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.3 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 CDS
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 121 3.42 11.50 3.36 ID_2619724 TTTGTTTGGATGTAGACATTGGGA - Bradi5g25290.1 mRNA
3' UTR loci Raw Count RPM Fold difference in expression smRNA ID 24 nt smRNA sequence smRNA polarity
Genes predicted to be targeted by smRNA
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Table S4.10. Heat stress by immersion in water 1 hour (HsW-1): 3'UTRs of heat stress 
responsive genes, the 24nt smRNA sequence and target genes  
(*The entire table cannot be displayed due to limitation of dissertation page size (only the top 
80/1308 rows were displayed, please enlarge the table electronically and refer to the RNA 
journal publication website) 
 
  
WT Stress WT Stress Locus Genomic feature
Bradi1g07480.1 1 2 0.17 0.64 3.76 ID_837509 AAATTATTGTCAAAATATTACATG + Bradi3g33740.1 mRNA
Bradi1g07480.1 1 2 0.17 0.64 3.76 ID_837509 AAATTATTGTCAAAATATTACATG + Bradi3g33740.2 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_152258 GAGACATCTTTTGTTGGATGGAGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_152258 GAGACATCTTTTGTTGGATGGAGG + Bradi2g58840.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_152258 GAGACATCTTTTGTTGGATGGAGG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_152258 GAGACATCTTTTGTTGGATGGAGG + Bradi4g39410.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_152258 GAGACATCTTTTGTTGGATGGAGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_508506 CATCTTTTGTTGGATGGAGGGAGT + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_508506 CATCTTTTGTTGGATGGAGGGAGT + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_508506 CATCTTTTGTTGGATGGAGGGAGT + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_588529 AGACATCTTTTGTTGGATGGAGGG + Bradi4g39410.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_588529 AGACATCTTTTGTTGGATGGAGGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_60126 TTTGAATACATCTATACACTAAGT + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 9 0.68 2.90 4.23 ID_987212 ATTTGAATACATCTATACACTAAG + Bradi4g22590.1 mRNA
Bradi1g16510.1 3 12 0.51 3.86 7.53 ID_131397 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.1 3 12 0.51 3.86 7.53 ID_24515 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 12 0.51 3.86 7.53 ID_131397 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.2 3 12 0.51 3.86 7.53 ID_24515 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 12 0.51 3.86 7.53 ID_131397 ATTGGTTTTCATGACTTTCAAGAG + Bradi1g66150.1 mRNA
Bradi1g16510.3 3 12 0.51 3.86 7.53 ID_24515 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_1038038 ATTTGAGACATCTTTTATTGGACG + Bradi3g27990.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_180119 AAATTTGAGACATCTTTTATTGGA + Bradi3g27990.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_498219 TTGAATGCATTTATACACTAAGTC + Bradi1g29190.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_498219 TTGAATGCATTTATACACTAAGTC + Bradi1g29190.2 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_498219 TTGAATGCATTTATACACTAAGTC + Bradi3g46570.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_578006 AGACATCTTTTATTGGACGGAGGA + Bradi5g16700.1 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_578006 AGACATCTTTTATTGGACGGAGGA + Bradi5g16700.2 mRNA
Bradi1g18990.1 14 51 2.40 16.42 6.85 ID_578006 AGACATCTTTTATTGGACGGAGGA + Bradi5g16700.3 mRNA
Bradi1g20200.1 7 30 1.20 9.66 8.06 ID_27144 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.1 7 30 1.20 9.66 8.06 ID_76175 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 30 1.20 9.66 8.06 ID_27144 ATTATGAAACGGAGGGAGTAGAAC - Bradi4g09040.1 mRNA
Bradi1g20200.2 7 30 1.20 9.66 8.06 ID_76175 AATTATGAAACGGAGGGAGTAGAA - Bradi4g09040.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_196001 ATCTAGATACATGTAATATTTTGA + Bradi1g21030.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_196001 ATCTAGATACATGTAATATTTTGA + Bradi3g21320.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_196001 ATCTAGATACATGTAATATTTTGA + Bradi4g08740.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_66528 AGATACATGTAATATTTTGACAAA + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_66528 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_66528 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 three_prime_utr
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_862466 TCTAGATACATGTAATATTTTGAC + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_862466 TCTAGATACATGTAATATTTTGAC + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_862466 TCTAGATACATGTAATATTTTGAC + Bradi1g77410.2 three_prime_utr
Bradi1g29350.1 2 7 0.34 2.25 6.58 ID_862466 TCTAGATACATGTAATATTTTGAC + Bradi4g08740.1 mRNA
Bradi1g34230.1 1 4 0.17 1.29 7.53 ID_1285389 TTGAAAATTGAGGGACGAAAAAAG + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 4 0.17 1.29 7.53 ID_1285389 TTGAAAATTGAGGGACGAAAAAAG + Bradi2g12900.2 mRNA
Bradi1g48480.1 1 2 0.17 0.64 3.76 ID_261525 ATGTATCTAGACACATTTTAGACA - Bradi3g02520.1 mRNA
Bradi1g48480.1 1 2 0.17 0.64 3.76 ID_261525 ATGTATCTAGACACATTTTAGACA - Bradi3g02520.2 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_17262 TTAGGCTTTGTTTGGATGTAGACA - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.2 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi3g53110.3 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi4g21780.1 CDS
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi5g25290.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_3702 AGGCTTTGTTTGGATGTAGACATT - Bradi5g25290.2 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.2 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.3 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 CDS
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi5g25290.1 mRNA
Bradi1g51450.2 20 69 3.42 22.22 6.49 ID_732447 TTTGTTTGGATGTAGACATTGGGA - Bradi5g25290.2 mRNA
Bradi1g54000.1 10 20 1.71 6.44 3.76 ID_1239902 GAGATCAATCGACATGTTAGCCAT - Bradi4g27390.1 mRNA
Bradi1g54000.1 10 20 1.71 6.44 3.76 ID_19818 AGAGATCAATCGACATGTTAGCCA - Bradi4g27390.1 mRNA
Bradi1g54000.1 10 20 1.71 6.44 3.76 ID_413932 AGATCAATCGACATGTTAGCCATC - Bradi4g27390.1 mRNA
Bradi1g57590.1 3 23 0.51 7.41 14.42 ID_21397 AAATAAGTGACGTGGATTTGTACA + Bradi1g04850.1 mRNA
Bradi1g57590.1 3 23 0.51 7.41 14.42 ID_21397 AAATAAGTGACGTGGATTTGTACA + Bradi1g04850.2 mRNA
Bradi1g57590.1 3 23 0.51 7.41 14.42 ID_21397 AAATAAGTGACGTGGATTTGTACA + Bradi1g41770.1 mRNA
Bradi1g57590.1 3 23 0.51 7.41 14.42 ID_21397 AAATAAGTGACGTGGATTTGTACA + Bradi3g20440.1 mRNA
Bradi1g57590.1 3 23 0.51 7.41 14.42 ID_65030 AAAATAAGTGACGTGGATTTGTAC + Bradi3g57690.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1072062 CGACATTTTTTATGGATCGGAGGG - Bradi3g31480.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1072062 CGACATTTTTTATGGATCGGAGGG - Bradi3g31480.2 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1177272 GACATTTTTTATGGATCGGAGGGA - Bradi3g31480.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1177272 GACATTTTTTATGGATCGGAGGGA - Bradi3g31480.2 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1177272 GACATTTTTTATGGATCGGAGGGA - Bradi4g02930.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1218318 ACATTTTTTATGGATCGGAGGGAG - Bradi3g31480.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1218318 ACATTTTTTATGGATCGGAGGGAG - Bradi3g31480.2 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_1218318 ACATTTTTTATGGATCGGAGGGAG - Bradi4g02930.1 mRNA
Bradi1g60100.1 7 16 1.20 5.15 4.30 ID_19763 CATTTTTTATGGATCGGAGGGAGT - Bradi3g31480.1 mRNA
3' UTR loci Raw Count RPM Fold difference in expression smRNA ID 24 nt smRNA sequence smRNA polarity
Genes predicted to be targeted by smRNA
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Table S4.11. Heat stress by immersion in water 3 hour (HsW-3): 3'UTRs of heat stress 
responsive genes, the 24nt smRNA sequence and target genes  
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WT Stress WT Stress Locus Genomic feature
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.1 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.2 1 4 0.17 0.54 3.18 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1183603 TCAACTTTGACTAAATCTGAATGC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_1445471 ACTTTGACTAAATCTGAATGCATC - Bradi5g22310.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi1g67740.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi4g36730.1 mRNA
Bradi1g02630.4 1 5 0.17 0.68 3.98 ID_222014 CTAAATCTGAATGCATCTATACAC - Bradi5g22310.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_169799 TTTGAATACATCTATACACTAAGT + Bradi4g22590.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_264704 AGACATCTTTTGTTGGATGGAGGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_264704 AGACATCTTTTGTTGGATGGAGGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_52970 GAGACATCTTTTGTTGGATGGAGG + Bradi2g10120.2 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_52970 GAGACATCTTTTGTTGGATGGAGG + Bradi4g14610.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_52970 GAGACATCTTTTGTTGGATGGAGG + Bradi4g40550.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_747620 ACATCTTTTGTTGGATGGAGGGAG + Bradi2g38220.1 mRNA
Bradi1g13920.1 4 16 0.68 2.18 3.18 ID_747620 ACATCTTTTGTTGGATGGAGGGAG + Bradi4g40550.1 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.1 3 15 0.51 2.04 3.98 ID_52693 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.2 3 15 0.51 2.04 3.98 ID_52693 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g66150.1 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.1 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.2 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.3 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi1g78560.4 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.1 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi2g03580.2 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_187411 AAGATCTGAGTTGGTGGTCGCGAG + Bradi3g41090.1 mRNA
Bradi1g16510.3 3 15 0.51 2.04 3.98 ID_52693 ATACGTATCATGATCTTTTGACTA + Bradi1g68720.1 mRNA
Bradi1g29350.1 2 8 0.34 1.09 3.18 ID_193933 AGATACATGTAATATTTTGACAAA + Bradi1g77410.1 mRNA
Bradi1g29350.1 2 8 0.34 1.09 3.18 ID_193933 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 mRNA
Bradi1g29350.1 2 8 0.34 1.09 3.18 ID_193933 AGATACATGTAATATTTTGACAAA + Bradi1g77410.2 three_prime_utr
Bradi1g34230.1 1 4 0.17 0.54 3.18 ID_1055175 CCGGTTTTGAAAATTGAGGGACGA + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 4 0.17 0.54 3.18 ID_1055175 CCGGTTTTGAAAATTGAGGGACGA + Bradi2g12900.2 mRNA
Bradi1g34230.1 1 4 0.17 0.54 3.18 ID_1655351 TGAAAATTGAGGGACGAAAAAAGT + Bradi2g12900.1 mRNA
Bradi1g34230.1 1 4 0.17 0.54 3.18 ID_1655351 TGAAAATTGAGGGACGAAAAAAGT + Bradi2g12900.2 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_1679839 GATATTGATATTGAGGTTGAATGT - Bradi4g21780.1 CDS
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_1679839 GATATTGATATTGAGGTTGAATGT - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.1 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.2 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi3g53110.3 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 CDS
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi4g21780.1 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi4g22120.1 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi5g25290.1 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_288540 TTTGTTTGGATGTAGACATTGGGA - Bradi5g25290.2 mRNA
Bradi1g51450.2 20 108 3.42 14.71 4.30 ID_305351 TAGGCTTTGTTTGGATGTAGACAT - Bradi4g22120.1 mRNA
3' UTR loci Raw Count RPM Fold difference in expression smRNA ID 24 nt smRNA sequence smRNA polarity
Genes predicted to be targeted by smRNA
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Table S4.12. The list of smRNA generating 3’UTRs that are either stress-specific or 
common among different stress treatments 
 
A. Short Durations B. Long Durations 
Stress condition Coding Genes Stress condition Coding Genes 
A share Bradi1g20200.1 A share Bradi1g29350.1 
  Bradi1g20200.2   Bradi1g51450.2 
  Bradi1g29350.1   Bradi1g57590.1 
  Bradi1g57590.1   Bradi1g59920.1 
  Bradi1g62460.1   Bradi1g59920.2 
  Bradi1g64890.1   Bradi1g62460.1 
  Bradi1g66620.1   Bradi1g74980.1 
  Bradi1g70000.2   Bradi2g27980.1 
  Bradi2g12140.1   Bradi2g59320.1 
  Bradi2g12850.1   Bradi3g12950.1 
  Bradi2g59320.1   Bradi3g17500.1 
  Bradi3g12950.1   Bradi3g19240.1 
  Bradi3g17500.1   Bradi3g33210.1 
  Bradi3g19240.1   Bradi3g34310.1 
  Bradi3g32500.1   Bradi3g42990.1 
  Bradi3g33210.1   Bradi3g43230.1 
  Bradi3g34310.1   Bradi4g11510.2 
  Bradi3g42990.1   Bradi4g11670.1 
  Bradi3g43230.1   Bradi4g35320.1 
  Bradi3g51260.1   Bradi5g16760.1 
  Bradi3g51850.1   Bradi5g18170.1 
  Bradi3g51850.2 Ss-48 specific Bradi1g35480.1 
  Bradi4g06390.1   Bradi1g54000.1 
  Bradi4g11670.1   Bradi2g04380.1 
  Bradi4g35320.1   Bradi2g05980.1 
  Bradi5g18170.1   Bradi2g57150.1 
Ss-48 specific Bradi1g35480.1   Bradi3g00440.1 
  Bradi2g04380.1   Bradi3g00440.2 
  Bradi2g05980.1   Bradi3g25680.1 
  Bradi2g18450.1   Bradi3g45010.1 
  Bradi2g57150.1   Bradi3g45010.2 
  Bradi3g20790.1   Bradi3g45010.3 
  Bradi3g22490.3   Bradi3g53300.1 
  Bradi3g53300.1 Cs-24 specific Bradi1g14160.1 
  Bradi4g38600.1   Bradi1g43430.1 
  Bradi4g38600.2   Bradi1g43430.2 
  Bradi5g06120.4   Bradi1g48480.1 
  Bradi5g06120.5   Bradi1g52430.1 
  Bradi5g06120.6   Bradi1g54210.1 
  Bradi5g18180.1   Bradi1g57220.1 
  Bradi5g18180.2   Bradi1g59580.1 
  Bradi5g18180.3   Bradi1g59580.2 
  Bradi5g18180.4   Bradi1g60100.1 
Cs-6 specific Bradi1g09050.1   Bradi1g70140.1 
  Bradi1g15590.1   Bradi2g40510.1 
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  Bradi1g21220.1   Bradi2g51200.1 
  Bradi1g23620.1   Bradi2g52160.1 
  Bradi1g41800.1   Bradi2g52160.2 
  Bradi1g52430.1   Bradi2g53590.1 
  Bradi1g54210.1   Bradi2g53590.2 
  Bradi1g58250.1   Bradi2g59770.1 
  Bradi1g61880.1   Bradi2g60430.1 
  Bradi1g65670.1   Bradi2g62790.1 
  Bradi1g70140.1   Bradi3g35470.1 
  Bradi2g52160.1   Bradi3g45890.1 
  Bradi2g52160.2   Bradi3g46930.1 
  Bradi2g53590.1   Bradi3g52600.1 
  Bradi2g53590.2   Bradi3g52600.2 
  Bradi2g54580.1   Bradi3g52600.3 
  Bradi2g58080.2   Bradi4g00570.1 
  Bradi2g58920.1   Bradi4g02530.1 
  Bradi2g60430.1   Bradi4g11000.1 
  Bradi3g25920.2   Bradi4g11000.2 
  Bradi3g28470.2   Bradi4g11000.3 
  Bradi3g45890.1   Bradi4g33290.1 
  Bradi3g56090.1   Bradi4g44540.1 
  Bradi4g02530.1   Bradi5g04580.1 
  Bradi4g11000.2   Bradi5g04580.2 
  Bradi4g11000.3   Bradi5g16460.1 
  Bradi4g24970.1 HsA-3 specific Bradi1g18990.1 
  Bradi5g01710.1   Bradi2g46970.1 
  Bradi5g02890.1   Bradi3g23160.1 
  Bradi5g05920.1   Bradi3g56090.1 
  Bradi5g05920.2   Bradi4g31010.1 
HsA-1 specific Bradi1g43430.1   Bradi5g01710.1 
  Bradi1g43430.2 HsW-3 specific Bradi2g55770.1 
  Bradi1g59910.1   Bradi3g08120.2 
  Bradi1g59910.2 Ss-48,Cs-24,HsA-3 Bradi1g20200.1 
  Bradi1g59910.3   Bradi1g20200.2 
  Bradi1g66030.1   Bradi1g45270.1 
HsW-1 specific Bradi1g07480.1   Bradi1g45270.2 
  Bradi1g48480.1   Bradi1g70000.2 
  Bradi1g64460.1   Bradi2g12140.1 
  Bradi1g64460.3   Bradi2g12850.1 
  Bradi1g64460.4   Bradi2g25050.1 
  Bradi1g77250.1   Bradi2g28000.1 
  Bradi2g55770.1   Bradi2g51430.1 
  Bradi3g19480.1   Bradi2g51430.2 
  Bradi3g23160.1   Bradi2g51430.3 
  Bradi3g46930.1   Bradi3g10640.1 
Ss-48,Cs-6,HsA-1 Bradi1g45270.1   Bradi3g13400.2 
  Bradi1g45270.2   Bradi3g32500.1 
  Bradi1g59920.1   Bradi3g51850.1 
  Bradi1g59920.2   Bradi3g51850.2 
  Bradi1g74980.1   Bradi4g12770.1 
  Bradi2g27980.1   Bradi5g14250.1 
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  Bradi2g51430.1   Bradi5g14250.2 
  Bradi2g51430.2   Bradi5g18200.6 
  Bradi2g51430.3   Bradi5g24090.1 
  Bradi3g36500.1   Bradi5g24090.2 
  Bradi4g11510.2   Bradi5g24090.3 
  Bradi5g16760.1 Cs-24,HsA-3,HsW-3 Bradi2g09710.2 
Cs-6,HsA-1,HsW-1 Bradi1g16510.1   Bradi2g58080.1 
  Bradi1g16510.2   Bradi2g58080.2 
  Bradi1g16510.3   Bradi3g10180.1 
  Bradi3g09120.1   Bradi3g10180.2 
  Bradi5g00780.1   Bradi4g00730.1 
  Bradi5g00780.2   Bradi4g00730.2 
Ss-48,HsA-1,HsW-1 Bradi5g14250.1 Ss-48,HsA-3,HsW-3 Bradi1g34230.1 
  Bradi5g14250.2   Bradi1g71800.2 
Ss-48,Cs-6,HsW-1 Bradi1g34230.1 Ss-48,Cs-24,HsW-3 Bradi1g66620.1 
  Bradi1g51450.2   Bradi3g36500.1 
  Bradi1g54000.1   Bradi4g06390.1 
  Bradi1g71800.2 Ss-48,Cs-24 Bradi1g64890.1 
  Bradi1g74790.1   Bradi2g12880.1 
  Bradi2g25050.1   Bradi2g18450.1 
  Bradi3g10640.1   Bradi2g38830.1 
  Bradi3g13400.2   Bradi3g01670.1 
  Bradi3g38970.3   Bradi3g01670.2 
  Bradi4g12770.1   Bradi3g20790.1 
  Bradi4g34910.1   Bradi3g22490.3 
Ss-48,Cs-6 Bradi2g12880.1   Bradi3g38970.3 
  Bradi2g21080.1   Bradi3g51260.1 
  Bradi2g28000.1   Bradi4g34910.1 
  Bradi3g00440.1   Bradi4g38600.1 
  Bradi3g00440.2   Bradi4g38600.2 
  Bradi3g01670.1   Bradi5g20950.1 
  Bradi3g01670.2 Ss-48,HsA-3 Bradi1g74790.1 
  Bradi3g45010.1   Bradi2g21080.1 
  Bradi3g45010.2   Bradi5g18180.1 
  Bradi3g45010.3   Bradi5g18180.2 
  Bradi5g18200.6   Bradi5g18180.3 
  Bradi5g20950.1   Bradi5g18180.4 
Ss-48,HsA-1 Bradi5g24090.1 Ss-48,HsW-3 Bradi5g06120.4 
  Bradi5g24090.2   Bradi5g06120.5 
  Bradi5g24090.3   Bradi5g06120.6 
Ss-48,HsW-1 Bradi2g38830.1 Cs-24,HsA-3 Bradi1g59910.1 
  Bradi3g25680.1   Bradi1g59910.2 
Cs-6,HsA-1 Bradi1g59580.1   Bradi1g59910.3 
  Bradi1g59580.2   Bradi1g61880.1 
  Bradi2g09710.2   Bradi2g24860.1 
  Bradi2g11610.1   Bradi2g24860.2 
  Bradi2g11610.2   Bradi2g24860.3 
  Bradi3g22920.1   Bradi2g24860.4 
  Bradi3g27970.1   Bradi2g24860.5 
  Bradi4g00730.1   Bradi3g05900.1 
  Bradi4g00730.2   Bradi3g27970.1 
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  Bradi4g33290.1   Bradi4g24970.1 
  Bradi5g04580.1   Bradi4g39260.1 
  Bradi5g04580.2   Bradi5g00780.1 
Cs-6,HsW-1 Bradi1g13920.1   Bradi5g00780.2 
  Bradi1g18990.1   Bradi5g05920.1 
  Bradi1g60100.1   Bradi5g05920.2 
  Bradi2g08710.4 Cs-24,HsW-3 Bradi1g02630.1 
  Bradi2g58080.1   Bradi1g02630.2 
  Bradi2g62790.1   Bradi1g02630.4 
  Bradi3g05900.1   Bradi1g13920.1 
  Bradi3g10180.1   Bradi1g16510.1 
  Bradi3g10180.2   Bradi1g16510.2 
  Bradi4g24890.1   Bradi1g16510.3 
HsA-1,HsW-1 Bradi3g35470.1   Bradi1g64460.1 
      Bradi1g64460.3 
      Bradi1g64460.4 
      Bradi3g09120.1 
      Bradi4g44870.1 
      Bradi4g44870.2 
    HsA-3,HsW-3 N/A 
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Table S4.13. Gene ontology analysis of genes predicted to be targeted by sutr-siRNAs 
*The entire table cannot be displayed due to limitation of dissertation page size (only the top 
100/732 rows were displayed, please enlarge the table electronically and refer to the RNA 
journal publication website. 
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Table S4.14. Target genes with the target site predicted to be located in their 3’UTRs 
 
Stress 
condition Coding Genes 
Stress 
condition Coding Genes 
Stress 
condition Coding Genes 
Stress 
condition Coding Genes 
Ss-48 Bradi1g33100.1 Cs-6 Bradi1g02790.1 HsA-1 Bradi1g02790.1 HsW-1 Bradi1g33100.1 
Bradi1g41740.1 Bradi1g33100.1 Bradi1g41740.1 Bradi1g41740.1 
Bradi1g63560.1 Bradi1g41740.1 Bradi1g70140.1 Bradi1g63560.1 
Bradi1g70140.1 Bradi1g46270.1 Bradi1g77410.2 Bradi1g70140.1 
Bradi1g77410.2 Bradi1g63560.1 Bradi2g03460.2 Bradi1g77410.2 
Bradi2g13010.2 Bradi1g70140.1 Bradi2g03460.3 Bradi2g16840.1 
Bradi2g13010.3 Bradi1g77410.2 Bradi2g03460.4 Bradi2g54580.1 
Bradi2g54580.1 Bradi2g25510.1 Bradi2g03460.5 Bradi3g37170.1 
Bradi4g35310.1 Bradi2g35850.1 Bradi2g54580.1 Bradi3g56090.1 
Bradi5g01850.1 Bradi2g54580.1 Bradi3g58070.1 Bradi4g35310.1 
Bradi5g18170.1 Bradi2g58080.2 Bradi4g35310.1 Bradi5g18180.1 
Bradi5g18180.1 Bradi3g37170.1 Bradi4g38600.1 Bradi5g18180.2 
Bradi5g18180.2 Bradi3g43740.1 Bradi4g38600.2 Bradi5g18180.3 
Bradi5g18180.3 Bradi3g43740.2 Bradi5g18180.1 Bradi5g18180.4 
Bradi5g18180.4 Bradi4g35310.1 Bradi5g18180.2 Bradi5g23940.1 
Bradi5g19590.1 Bradi4g38600.1 Bradi5g18180.3 HsW-3 Bradi1g41740.1 
Bradi5g25420.1 Bradi4g38600.2 Bradi5g18180.4 Bradi1g46270.1 
  
Bradi5g18180.1 Bradi5g23940.1 Bradi1g70140.1 
  
Bradi5g18180.2 HsA-3 Bradi1g41740.1 Bradi1g77410.2 
  
Bradi5g18180.3 Bradi1g46270.1 Bradi2g35850.1 
  
Bradi5g18180.4 Bradi1g63560.1 Bradi2g54580.1 
  
Bradi5g23940.1 Bradi1g70140.1 Bradi4g35310.1 
  
Bradi5g24090.1 Bradi1g77410.2 Bradi4g38600.1 
  
Bradi5g24090.2 Bradi2g03460.2 Bradi4g38600.2 
  
Bradi5g24090.3 Bradi2g03460.3 Bradi5g18180.1 
  
Cs-24 Bradi1g02790.1 Bradi2g03460.4 Bradi5g18180.2 
  
Bradi1g33100.1 Bradi2g03460.5 Bradi5g18180.3 
  
Bradi1g41740.1 Bradi2g28000.1 Bradi5g18180.4 
  
Bradi1g63560.1 Bradi2g54580.1 
  
  
Bradi1g70140.1 Bradi3g37170.1 
  
  
Bradi1g77410.2 Bradi4g35310.1 
  
  
Bradi2g13010.2 Bradi4g38600.1 
  
  
Bradi2g13010.3 Bradi4g38600.2 
  
  
Bradi2g18170.1 Bradi5g18170.1 
  
  
Bradi2g25510.1 Bradi5g18180.2 
  
  
Bradi2g54580.1 Bradi5g18180.3 
  
  
Bradi2g58070.1 Bradi5g18180.4 
  
  
Bradi3g13400.2 Bradi5g23940.1 
  
  
Bradi3g37170.1 
    
  
Bradi4g35310.1 
    
  
Bradi4g38600.1 
    
  
Bradi4g38600.2 
    
  
Bradi5g18180.1 
    
  
Bradi5g18180.2 
    
  
Bradi5g18180.3 
    
  
Bradi5g18180.4 
    
  
Bradi5g19590.1 
    
  
Bradi5g23940.1 
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Supplemental file 2: Supplementary information. 
Comparative analysis of genomic clusters producing smRNAs in response to various 
stresses  
We also analyzed and compared the genomic regions producing smRNAs in response 
to various stresses. Brachypodium chromosomes were binned into non-overlapping 500 bp 
clusters and smRNAs were mapped to these genomic clusters. Since the majority of 
functional smRNAs in plants range from 20 to 25 nt in length, only populations of 20-25 nt 
smRNAs were used in this analysis. The expression of smRNAs produced from each cluster 
was then calculated and the expression of smRNAs from each cluster was compared between 
unstressed plants and plants subjected to various stresses. Most of the genomic clusters did 
not exhibit significant changes in smRNA production in response to stresses (based on 3-fold 
difference in expression), and the majority of clusters that exhibited changes in smRNA 
expression in response to stresses showed increases in smRNA production, while a relatively 
small number of genomic clusters produced fewer smRNAs in response to all stresses 
(Supplemental file 3: Figure S4.1 A-G, Supplemental file 1: Table S4.3, Supplemental 
file 4: Figure S4.2). It is worth noting that a high number of genomic clusters showed a 
greater than a 10-fold increase in smRNA production in response to cold stress 
(Supplemental file 4: Figure S4.2). 
We then cross-compared the genomic clusters that exhibited either increases or 
decreases in smRNA expression between different stresses. The area-proportional Venn 
diagrams show the number of smRNA generating clusters that are affected in either a stress-
specific way or affected similarly in response to various stress treatments (Supplemental file 
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3: Figure S4.1 H-K). The comparison was done separately for short (Supplemental file 3: 
Figure S4.1 H and J) or long (Supplemental file 3: Figure S4.1 I and K) stress treatments. 
Many genomic clusters showed increased smRNA production in all stresses used in our study. 
However, cold stress and heat stress (by air) affected the production of smRNAs from many 
identical genomic clusters (depicted as overlap between affected clusters in the area-
proportional Venn diagrams), suggesting that similar smRNA pathways could be activated in 
response to these two abiotic stresses (Supplemental file 3: Figure S4.1 H-K). 
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Supplemental file 3:  
 
Figure S4.1. The analysis of genomic clusters producing smRNAs in response to various 
stresses. A-G. Comparison of all smRNA clusters in response to stresses: Cold stress 6 hours 
(A), 24 hours (B); Heat stress-air 1 hour (C), 3 hours (D); Heat stress by immersion in water, 
1 hour (E), 3 hours (F); Salt stress 48 hours (G). H-K. Cross-comparison of genomic clusters 
that exhibit changed smRNA production in response to stresses. Area proportional Venn 
diagram demonstrates the number of smRNA generating clusters that are either stress-specific 
or common among different stress treatments. The comparison was done separately for short 
(H and J) or long (I and K) time point of stress treatment duration, and also based on the 
observed stress effect that resulted in either up-regulation (H and I) or down-regulation (J and 
K) of smRNAs production from these regions. 
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Supplemental file 4: 
 
Figure S4.2. The analysis of genomic clusters affected in response to different stresses, 
based on abundances of smRNAs (in RPM) per each individual 500 bp cluster. For each 
individual 500 bp cluster, we compared the smRNA expression (in RPM) in unstressed Bd21 
library relative to the smRNA expression (in RPM) in libraries of stresses plants. To compare 
the clusters that exhibit decreases in smRNA production in response to each stress we took the 
ratio of Bd21 versus each stress (shown as negative value). To compare the clusters that 
exhibit increases in smRNA production in response to each stress we took the ratio of each 
stress versus Bd21 (shown as positive value). Cold stress 6 hours (A), 24 hours (B); Heat 
stress-air 1 hour (C), 3 hours (D); Heat stress-by immersing in water 1 hour (E), 3 hours (F); 
Salt stress 48 hours (G). 
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Supplemental file 5: 
 
Figure S4.3. Fold difference in expression of smRNAs from 3’UTRs in response to 
different stresses. For each 3’UTR, we compared the smRNA expression (in RPM) in 
stressed plants relative to the smRNA expression from the identical 3’UTR in Bd21 
unstressed plants. Cold stress 6 hours (A), 24 hours (B); Heat stress-air 1 hour (C), 3 hours 
(D); Heat stress by immersion in water, 1 hour (E), 3 hours (F). 
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Supplemental file 6: 
Figure S4.4. Enriched biological processes among genes producing smRNAs from their 
3’UTRs in response to various stresses. The genes harboring smRNAs producing 3’UTRs 
were subjected to GO-term enrichment and the analysis was performed separately for each 
stress condition and duration. The figure represents the GO-terms enriched genes, which 
produce smRNAs in response to various stresses. Similar functional categories are clustered 
together and connected within the same network using REVIGO and Cytoscape. Nodes (green 
circles) reflect the GO-terms, and edges (blue lines) connect the similar functional categories. 
The node color indicates the frequency of the GO terms and corresponds to the color scale 
indicated on the figure.  
A. Cs-6, 251 coding genes were subjected to GO-term analysis and a total of 167 GO-terms 
were used for the GO-term enrichment;  
B. Cs-24, 275 coding genes were subjected to GO-term analysis and a total of 160 GO-terms 
were used for the GO- term enrichment;  
C. HsA-1, 145 coding genes were subjected to GO-term analysis and a total of 90 GO-terms 
were used for the GO- term enrichment;  
D. HsA-3, 182 coding genes were subjected to GO-term analysis and a total of 137 GO-terms 
were used for the GO- term enrichment;  
E. HsW-1, 177 coding genes were subjected to GO-term analysis and a total of 129 GO-terms 
were used for the GO- term enrichment;  
F. HsW-3, 138 coding genes were subjected to GO-term analysis and a total of 106 GO-terms 
were used for the GO- term enrichment. 
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Supplemental file 7:  
Figure S4.5. Enriched biological processes among genes targeted in trans by sutr-
siRNAs in response to various stresses. The genes targeted by sutr-siRNA in trans were 
subjected to GO-term enrichment and the analysis was performed separately/independently 
for each stress condition and stress durations. The figure represent the GO-terms enriched in 
targeted coding genes in response to various stresses. Similar functional categories are 
clustered together and connected within the same network using REVIGO and Cytoscape 
applications. Nodes (green circles/bubbles) reflect the GO-terms, and edges (blue lines) 
connect the similar functional categories. The node color indicates/represents the frequency of 
the GO terms and correspond to the color scale indicated on the figure. 
A. Cs-6, 685 coding genes were subjected to GO-term analysis and a total of 728 GO-terms 
were used for the GO-term enrichment; 
B. Cs-24, 653 coding genes were subjected to GO-term analysis and a total of 640 GO-terms 
were used for the GO- term enrichment; 
C. HsA-1, 390 coding genes were subjected to GO-term analysis and a total of 468 GO-terms 
were used for the GO- term enrichment; 
D. HsA-3, 401 coding genes were subjected to GO-term analysis and a total of 506 GO-terms 
were used for the GO- term enrichment; 
E. HsW-1, 336 coding genes were subjected to GO-term analysis and a total of 435 GO-terms 
were used for the GO- term enrichment; 
F. HsW-3, 268 coding genes were subjected to GO-term analysis and a total of 356 GO-terms 
were used for the GO- term enrichment. 
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protein dimerization activity
unfolded protein binding
SAM domain binding
microtubule binding
protein kinase binding
nucleoside-triphosphatase activity
protein heterodimerization activity
motor activity
ATP-dependent DNA helicase activity
protein tyrosine kinase activity
more 
represented
less 
represented
C. HsA-1
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heme binding
cation binding
catalytic activity
sequence-specific DNA binding 
transcription factor activity 
transcription regulator activity
amino acid binding
binding
signal transducer activity
calcium ion binding
enzyme activator activity
electron carrier activity
nucleic acid binding
transcription activator activity
oxidoreductase activity
glucose binding
sequence-specific DNA bindingRNA binding
zinc ion binding
peptide binding
magnesium ion binding
transcription coactivator activity
protein domain specific binding
transcription factor binding
cytoskeletal protein binding
SAM domain binding
calmodulin binding
protein complex binding
protein serine/threonine kinase activity
protein tyrosine kinase activity
UDP-N-acetylglucosamine 
diphosphorylase activity 
interleukin-1 receptor binding
actin binding
ATPase activity
ATP-dependent DNA helicase activity
NADP binding
motor activity
pyridoxal phosphate binding
coenzyme binding
enzyme binding
protein dimerization activity
identical protein binding
protein heterodimerization activity
histone binding
protein C-terminus binding
protein kinase binding
protein homodimerization activity
mRNA binding
structural constituent of ribosome
metal ion binding
double-stranded DNA binding
ubiquitin-protein ligase activity
oxidoreductase activity, acting on 
paired donors, with incorporation or 
reduction of molecular oxygen 
transferase activity, transferring 
glycosyl groups 
protein serine/threonine phosphatase 
activity 
copper ion binding
GTP binding
transferase activityintracellular cyclic nucleotide activated cation channel activity 
phospholipid binding
DNA binding
ATP binding
1-acylglycerol-3-phosphate 
O-acyltransferase activity 
structural molecule activity
protein binding
hydrolase activity, hydrolyzing 
O-glycosyl compounds 
more 
represented
less 
represented
D. HsA-3
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catalytic activity
calcium ion binding
nucleic acid binding
binding
RNA binding
ubiquitin-protein ligase activity
cation binding
enzyme activator activity enzyme regulator activity
transcription cofactor activity
transcription repressor activity
electron carrier activity
transcription regulator activity
heme binding
protein serine/threonine kinase activity
nucleoside-triphosphatase activity
UDP-N-acetylglucosamine 
diphosphorylase activity 
MAP kinase kinase kinase activity
motor activity
protein tyrosine kinase activity
nuclear hormone receptor binding
protein kinase bindingprotein dimerization activity
protein domain specific binding
protein complex binding
identical protein binding
enzyme binding
transcription factor binding
SAM domain binding
protein homodimerization activity
protein C-terminus binding
hydrolase activity
phospholipid binding
sequence-specific DNA binding 
transcription factor activity 
metalloendopeptidase activity
translation initiation factor activity
protein serine/threonine phosphatase 
activity 
thiol oxidase activity
transferase activity
magnesium ion binding
protein binding
transcription activator activity
flavin adenine dinucleotide binding
protein disulfide isomerase activityATP binding
oxidoreductase activity, acting on 
paired donors, with incorporation or 
reduction of molecular oxygen 
DNA binding
structural constituent of ribosome
ATPase activity
cytoskeletal protein binding
protein heterodimerization activity
structural molecule activity
metal ion binding
ATPase activity, coupled
chromatin binding
NAD+ ADP-ribosyltransferase activity
hydrolase activity, hydrolyzing 
O-glycosyl compounds amino acid binding
zinc ion binding
more 
represented
less 
represented
E. HsW-1
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enzyme regulator activity
calcium ion binding
oxidoreductase activity
protein disulfide oxidoreductase activity
transcription regulator activitytranscription cofactor activity
catalytic activityprotein serine/threonine phosphatase activity 
transferase activity
protein homodimerization activity
protein dimerization activity
protein kinase binding
protein domain specific binding
enzyme binding
transcription factor binding
cytoskeletal protein binding
protein heterodimerization activity
copper ion binding
transcription repressor activity
hydrolase activity
NAD+ ADP-ribosyltransferase activity
protein disulfide isomerase activity
ubiquitin-protein ligase activity
ATP binding
flavin adenine dinucleotide binding
RNA binding
metal ion bindingmagnesium ion binding
structural molecule activity
protein binding
endonuclease activity
zinc ion binding
protein serine/threonine kinase activity
protein tyrosine kinase activity
UDP-N-acetylglucosamine 
diphosphorylase activity 
motor activity
MAP kinase kinase kinase activity
nucleoside-triphosphatase activity
nucleic acid binding
ATPase activity
cysteine-type endopeptidase activator 
activity involved in apoptotic process 
SAM domain binding
identical protein binding
protein N-terminus binding
nuclear hormone receptor binding
DNA binding
binding
transcription activator activity
unfolded protein binding
protein C-terminus binding
more 
represented
less 
represented
F. HsW-3
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
5.1 Computational methods to identify novel smRNAs through analyzing high-
throughput sequencing data 
 The development of high-throughput (HT) sequencing technology has supported a 
rapid growth of biological research and discovery, especially in the field of RNA biology. The 
advancement of HT sequencing of various RNA populations has been used widely to 
overcome the technical hurdles of experimental methods based on expression screening 
including RNA Northern blotting and PCR assays. The data generated by HT sequencing is 
far more sensitive and reliable. However, effectively analyzing the massive data generated by 
large-scale HT sequencing, which are cluttered by various types of endogenous mRNAs, 
lncRNAs, and smRNAs, has become the main challenge. Despite the fact that smRNAs are 
shorter in length, the analysis of smRNAs is not any simpler than other types of ncRNAs.  
Numerous computational strategies have been developed to try to productively classify and 
separate different populations of smRNAs. There is still yet a “perfect” discriminative model 
to analyze the diverse populations of smRNAs in various experimental and biological 
conditions.   
In chapter 2, 3, and 4, we proposed a new way to analyze the high-throughput 
sequencing data of smRNAs, which led to the identification of the novel class of stress-
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induced sutr-siRNAs. In contrast to other methods, we first characterized the smRNAs based 
on their genomic features and examined the smRNAs mapped to different genomic features 
independently, termed feature-specific analysis. We then further analyzed the size and level of 
expression of smRNAs originated from the same genomic feature, such as 5’ and 3’ UTRs of 
coding genes, transposons, and repetitive elements… etc. Combining the smRNA sequencing 
data and functional genomic data, this method allowed us to vigorously filter the massive data 
and specifically focus on individual groups of smRNAs based on their genomic features and 
origin. The ability to funnel the large number of smRNAs using the feature-specific method 
allowed us to narrow down our focus to a small set of candidate smRNAs and the logic 
behind this computational method may seems extremely similar to traditional wet bench 
experimental design. The most successful example is the consistent identification of stress-
responsive sutr-siRNAs in seven different large-scale HT sequencing data when generated in 
different abiotic stress conditions (chapter 4). 
We also used the feature-specific analysis of smRNA population in response to the 
loss of Arabidopsis exosome (chapter 2 and 3). Interestingly, we found that in contrast to S. 
pome, the Arabidopsis exosome core subunits, AtRRP4 and AtRRP41, did not regulate 
smRNA expression on the global scale (chapter 2). We did observed minor changes of 
smRNAs that did not affect the global expression level. Therefore, in order to clearly identify 
the origin of those minor changes and uncover the possible subset of smRNAs that are 
regulated by AtRRP4 and AtRRP41, we utilized a hybrid approach, combing the clustering 
analysis with feature-specific analysis in order to efficiently re-examine the previously 
sequenced smRNA populations (chapter 3). Indeed, we uncovered the hidden subset of 
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smRNA-generating loci that were regulated by RRP4 and RRP41, which only occupy around 
4-7% of total smRNA-generating loci in the genome. This result also shows that by combing 
the “biased” and genomic features focused approach with “unbiased” clustering approach has 
allowed us to uncover the small subset of smRNAs that were hidden within the large 
populations of smRNA. This is also a clear example that no one-size fits all computational 
analysis can address every goal and hypothesis of each study. Like wet-bench experiments, 
computational strategies also need to be logically and carefully designed in order to efficiently 
address the same or similar biological questions. Therefore, the analytical methods developed 
during the course of this dissertation research, including both feature-specific and hybrid 
methods, has resulted in identifying a novel class of smRNA in Brachypodium and 
distinguishing the role of Arabidopsis core exosome in regulating different smRNAs arising 
from different genomic origins. These methods have become the foundation to build more 
complex and sophisticated analytical strategies to investigate the more massive HT 
sequencing data. An example of such would be whole genome transcriptomes including 
various groups of coding and non-coding RNAs, chromatin immunoprecipitation of various 
epigenetic modifications, and the binding profiles for nucleic acid binding proteins.     
 
5.2 SmRNAs and splicing in response to stresses 
Exposure to environmental changes, including biotic and abiotic stresses, triggers 
global changes in the expression of eukaryotic genes at the transcriptional and post-
transcriptional levels. Abiotic stresses greatly impair plant growth and development as well as 
crop yield. Plants have evolved a large array of adaptive responses to allow them to survive 
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and acclimate to changes in their environment. While the research efforts resulted in 
information about signaling cascades, transcription factors and defense pathways involved in 
stress responses, interference of stress with epigenetic factors, such as smRNAs, became 
evident only recently. Several studies have demonstrated that miRNAs play important roles in 
the responses to biotic and abiotic stimuli. Abiotic stress-regulated miRNAs were first 
investigated in the land plant, Arabidopsis [140-142]; however, very few studies demonstrated 
the importance of siRNAs in abiotic stress responses [39-41,164]. Nonetheless, the 
mechanistic functions of these stress responsive smRNA were limited to their role in RNA 
degradation, translational repression and chromatin compaction including involvement in 
siRNA-dependent DNA methylation (RdDM) [89,102,103,165].   
In addition to smRNA pathways, regulation of splicing in response to environmental 
stresses is especially important in modulating gene expression. In eukaryotes, the outcome of 
differential splicing leads to changes in post-transcriptional mechanisms, which results in 
rapid responses during developmental processes and when encountered various environmental 
conditions [166-169]. Splicing, including both the canonical splicing and 
alternative/differential splicing, is executed by the spliceosome together with other trans-
acting regulatory proteins recognizing different cis-regulatory sequences within each intron to 
promote or repress particular splice site [170,171]. Although there is some evidence 
suggesting the connection between splicing and the RNAi pathways in various systems [157-
161], the direct involvement of smRNAs in splicing remain unclear in plants. In chapter 4, we 
examined the smRNA transcriptomes in Brachypodium plants challenged by various abiotic 
stresses, and identified a specific group of stress that gives rise to a novel group of siRNAs 
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from their 3’UTRs, termed sutr-siRNAs. These sutr-siRNAs are 24nt in length and purine rich 
in sequences. Based on a series of vigorous filters, we found that sutr-siRNAs mainly target 
the intronic region of coding genes, and a subgroup of sutr-siRNAs targets specifically at the 
branch point sequences. We hypothesized a novel mechanism that under the stress conditions, 
sutr-siRNAs may affect the choice of splice sites by either masking or blocking cis 
determinants of specific cryptic or alternative splice sites, or by affecting pre-mRNA overall 
secondary structure by steric interference.     
The stresses conditions triggered higher expression of sutr-siRNAs including heat, 
cold, and high salt. These are all important stress conditions increasingly affecting modern 
agriculture. However, plants are not alone in defending themselves against these stress 
conditions; other organisms encounter similar abiotic stresses during developmental stages as 
well. Also, the mechanisms of splicing were well established in the animal systems, and the 
conveniences of in vitro splicing extracts, which are lacking in the plant system, have aid in 
accelerating those discoveries. It remain to be determined if a similar group of smRNAs exists 
in different plant species or other organisms. To our knowledge, our study, conducted in 
Brachypodium, represents the first genome-wide identification of endogenous smRNAs that 
have a potential to regulate splicing of pre-mRNA in response to abiotic stresses. Future 
experimental work is still needed to determine the significance of this observation. 
Importantly, this novel hypothesis provides a framework for researchers studying mechanisms 
of splicing regulations in other eukaryotes, as well as reveals an intriguing direct connection 
between smRNAs and splicing that was never unveiled before.  
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5.3 The role of Arabidopsis exosome in smRNA pathway 
 Evolutionarily conserved from Archaea to humans, the exosome is a stable complex of 
RNase-like and RNA binding proteins that catalyze 3’ to 5’ processing and decay of various 
RNA substrates. The exosome complex has a prominent role in gene silencing in yeast, 
human and plants; however, the relationship between the exosome complex and other gene 
silencing pathways still remain to be elucidated. In fission yeast (Schizosaccharomyces 
pombe), it was shown that the exosome acts in several smRNA pathways to affect constitutive 
and facultative heterochromatin silencing, in either RNA interference (RNAi) dependent or 
RNAi-independent manner [111,151-153]. In plants, the relationship between exosome and 
smRNAs in gene silencing remains largely unknown.  
 In chapter 2 and 3, we utilized two different methods to explore the role of the 
Arabidopsis core complex in smRNA pathway. We found that unlike the data shown in 
fission yeast, the Arabidopsis exosome complex has little effect on smRNA metabolism 
globally [65]. Later, we also uncovered the hidden subset of smRNA-generating loci that were 
regulated by the Arabidopsis exosome, which only occupied 4-7% of total smRNA-generating 
loci in the genome. Although this subset of loci only accounted for a small proportion in the 
genome, they exhibited specific and different genome localizations pattern corresponding to 
either up- or down-regulated smRNA expression upon exosome depletion.  
 Although we identified that the Arabidopsis exosome core complex regulate only a 
very small subset of smRNA-generating loci genome-wide; this result is still significantly 
different from that in fission yeast. In fission yeast, the defect of the nuclear exosome subunit, 
RRP6, had a dramatic effect on siRNA leading to redistribution of the spectrum of AGO1-
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associated siRNAs, ranging from mostly repeat-associated transcripts to those derived from 
known exosome substrates, such as rRNA and tRNA [151], indicating the exosome may act 
as a negative regulator of siRNA biogenesis. Regulation of gene silencing mechanism is 
shown to vary from organism to organism. Plants have evolved two plant-specific RNA 
polymerases Pol IV and Pol V, which specialized in siRNA-mediated TGS and PTGS that 
were absent in other systems. It is also plausible that in Arabidopsis, the core exosome 
complex and the nuclear associated catalytic subunit RRP6, have different functions in 
processing diverse populations of ncRNAs, including smRNAs, in a direct or indirect fashion. 
Consistent with our speculations, the recent study by Zhang et al. showed that in Arabidopsis, 
the AtRRP6L1 controls DNA methylation via regulation of scaffold RNAs and 24nt siRNAs. 
They also proposed that this may be independent of the core exosome complex’s function in 
RNA degradation and seems to be specific to this particular AtRRP6L1 allele [172]. 
Therefore, it is plausible that the catalytic subunits and the exosome core complex may 
function differently in regulating varies ncRNAs, including a fraction of smRNAs, in a 
sequence- and locus- specific manner which may led to changes in epigenetic modifications, 
including DNA methylation and diverse histone methylations.  
In Arabidopsis, the RdDM pathway is known for mediating siRNA-based silencing of 
heterochromatic loci, including repetitive elements and transposons [103]. However, the 
relationship between the exosome and RdDM in regulating both smRNAs and ncRNAs 
remain unexplored until recently, and the investigation was one of the research focuses of this 
dissertation (chapter 2 and 3). While we observed majority of the exosome-dependent 
smRNA-generating loci were also dependent on the components in the RdDM, we could not 
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rule out the possibility that the exosome may act in collaboration with other factors in 
maintaining smRNA expression. Indeed, when we analyzed in depth these small subsets of 
RRP41-downregulated smRNA-generation loci that were independent of RNA Pol IV and Pol 
V function, many of them were associated with specific transposons. Our results suggest that 
the Arabidopsis core exosome complex may have a minor role in regulating smRNA 
metabolism originate from a small subset of specific genomic loci. Although the exosome 
core complex might not have served as the general mechanism in controlling smRNA 
expression in Arabidopsis. In those particular genomic regions, the core exosome complex 
might provide an additional layer of control in achieving the precise management of dynamic 
smRNA level, thus allowing the smRNAs to maintain proper activity in heterochromatin 
silencing. 
 
5.4 The role of Arabidopsis exosome in heterochromatic silencing through 
modulating lncRNAs 
 The large genome of higher eukaryotes is revealed to be stably packaged, particularly 
in the non-coding regions of the genome, which mainly consist of repetitive DNA sequences 
and foreign retrotransposons and transposable elements. Heterochromatin is referred to as the 
tightly packed repetitious DNA, and these condense form limits transcription [173]. During 
the past decade, remarkable progress has been made in gaining the understanding of 
heterochromatin formation and maintenance as well as the players involved in regulating 
these processes. Most importantly, inherited epigenetically, heterochromatin silencing largely 
contributes to development, differentiation, and genome stability in eukaryotic organisms.  
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The exosome complex in various organisms broadly affects epigenetic silencing of 
heterochromatic and euchromatic loci through regulating a wide-range of ncRNAs [48,50,52-
54]. In addition to reports made in fission yeast (Schizosaccharomyces pombe), budding yeast 
(Saccharomyces cerevisiae) and human, the role of Arabidopsis exosome in silencing 
heterochromatic loci was only recently revealed [2,65,66]. The core exosome complex is not 
catalytically active in yeast and human, instead, the catalytic activity of exosome were 
contributed by either the Rrp44/Dis3 or the nuclear subunit RRP6 [73,174-176]. However, the 
core subunit AtRrp41 in Arabidopsis appears to be catalytically active when tested in vitro 
[2,76], suggesting the possible differences in plant exosome and exosome found in other 
eukaryotes.  
Both the data presented in this dissertation, as well as the genome-wide survey 
previously performed in our group, we have demonstrated that the Arabidopsis exosome 
regulates transcript expression from non-coding regions and many of them are 
heterochromatic loci [2,65,66]. We also further demonstrated that these silencing may be 
associated with the epigenetic marks that are involved in maintenance of chromatin structure, 
such as histone H3K9me2 and H3K27me3 [65,66]. Surprisingly, we found that exosome loss 
does not alter levels of smRNAs nor DNA methylation at a well studied heterochromatic 
locus, soloLTR, in Arabidopsis [65]. In addition to the tiling microarray profiling, the 
majority of the heterochromatin silencing was studied in individual loci instead of the 
systematic and genome-wide fashion. The tiling microarray technology we used in the past 
has a limitation rooted in the fact that microarray chips are manufactured based on the 
genome annotation available at the time of chip manufacturing. Thus, these results led to the 
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investigation of Arabidopsis exosome in regulating ncRNA genome-wide using the HT 
sequencing techniques presented in chapter 2. Although we have not yet conclusively 
categorized lncRNAs that were regulated by the Arabidopsis exosome genome-wide, we 
identified forty lncRNAs with average length of 760nt that were regulated by the Arabidopsis 
core subunit. The expression of these lncRNAs was greatly affected upon exosome loss; 
however, other silencing mechanisms involved in regulating these lncRNAs remains to be 
determined.  
RNA processing and turnover, including both the exosome and RNAi, have been 
linked to the establishment of heterochromatin through the lncRNAs [177]. Unlike the 
exosome, which is conserved in all phyla, some unicellular organisms have lost components 
of the RNAi. This may be correlated as the complexity of genome increased, the demand for 
additional surveillance of lncRNAs also multiplied, thus leading to the acquisition of 
additional RNA degradation machinery. The redundancy would ensure proper modulation of 
transcription through lncRNAs and heterochromatin formation, and increase the fidelity of 
transcription. These additional layers of control would rapidly suppress any transcriptional 
errors and ensure that the errors are promptly recognized.  
The advancement of sensitive microarray and HT sequencing technology has led to 
the emergence of lncRNAs. The complexity of the HT data warrants specific analytical 
strategies to efficiently dissect the involvement of lncRNAs at the transcriptional and 
posttranscriptional level. Subsequently, the exosome played a critical role in regulating a wide 
range of ncRNA metabolism. Our results also indicate the possibility that Arabidopsis core 
exosome complex is involved in transcriptional regulation by controlling the nascent 
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transcripts arising near transcription start sites genome-wide. The flexibility of the exosome in 
modulating the quantity and quality of a wide range of lncRNAs, as well as the relationship 
with the heterochromatic modifications, led to the speculations about the exosome’s 
involvement in transcriptional silencing of coding and non-coding regions of the genome. 
Also, it is intriguing to contemplate that the exosome might participate in modulating histone 
modifications via regulating synthesis of lncRNAs. The exact detail of this mechanism 
remains to be elucidated. More investigation will be needed to determine how the exosome 
complex and the lncRNAs controlled by the exosome are involved in recruiting chromatin 
modifiers to maintain the silencing status of heterochromatic loci through transcriptional 
repression.  
 
5.5 Concluding Remarks 
Expansion of high-throughput sequencing technology has increased our understanding 
of the importance of pervasive transcription and the recently recognized indispensable 
molecules, ncRNAs. Recently, a significant effort has been made in determining the 
biological relevance of ncRNAs, including both the smRNAs and lncRNAs. The work 
presented and discussed in this dissertation has added to our understanding in regulation of 
gene expression through ncRNAs in plants. First, the identification of a novel group of 
endogenous stress induced siRNAs, sutr-siRNAs, and its novel mechanism in targeting cis 
elements involved in splice site selection. The novel hypothesis of sutr-siRNAs’ function in 
regulation of splicing presents a new perspective on transcriptome changes in response to 
abiotic stresses in plant. This finding will stimulate research of smRNA mediated stress 
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responses in agricultural important crops. Also, it provides a framework for more suitable 
experimental systems, such as the Drosophila and mammalian cell cultures, to further 
investigate the mechanistic details due to the in depth foundation on the understanding of 
splicing regulations.  
Second, the role of Arabidopsis exosome complex in regulating smRNA metabolism 
was extensively investigated and we revealed the differences between Arabidopsis core 
exosome, yeast and human exosome in modulating smRNAs. Although we have only began 
to categorize the lncRNAs regulated by the Arabidopsis exosome, our data so far led to 
intriguing speculations, including the possible role of exosome in transcriptional regulation 
via controlling lncRNAs. The challenges still remain, including establishing the regulatory 
role of specific lncRNAs regulated by the exosome and other factors at transcriptional or post-
transcriptional levels in different cellular contexts. Most importantly, how is the interaction 
between these lncRNAs and the chromatin is mediated? The complete answer awaits further 
investigations of the full spectrum of regulatory roles of the exosome in various organisms. 
 The work presented in this dissertation revealed new insight and detailed molecular 
mechanism of the Arabidopsis exosome complex in regulation of gene expression, as well as 
provided a novel regulatory mechanism of endogenous siRNAs that modulate mRNA stability 
by being involved in splicing.  
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